MVChem commited on
Commit ·
536e8ca
0
Parent(s):
initial commit
Browse filesThis view is limited to 50 files because it contains too many changes. See raw diff
- README.md +73 -0
- atoms/PMC12862275_atoms.json +71 -0
- atoms/PMC12862283_atoms.json +127 -0
- atoms/PMC12863993_atoms.json +91 -0
- atoms/PMC12863997_atoms.json +42 -0
- atoms/PMC12865447_atoms.json +100 -0
- atoms/PMC12867003_atoms.json +67 -0
- atoms/PMC12867464_atoms.json +57 -0
- atoms/PMC12867536_atoms.json +60 -0
- atoms/PMC12868566_atoms.json +47 -0
- atoms/PMC12868984_atoms.json +42 -0
- atoms/PMC12870944_atoms.json +82 -0
- atoms/PMC12871403_atoms.json +116 -0
- atoms/PMC12872036_atoms.json +45 -0
- atoms/PMC12875340_atoms.json +41 -0
- atoms/PMC12875659_atoms.json +76 -0
- atoms/PMC12875833_atoms.json +86 -0
- atoms/PMC12875838_atoms.json +49 -0
- atoms/PMC12875844_atoms.json +54 -0
- atoms/PMC12875846_atoms.json +72 -0
- atoms/PMC12876038_atoms.json +72 -0
- atoms/PMC12876632_atoms.json +60 -0
- atoms/PMC12881196_atoms.json +52 -0
- atoms/PMC12881202_atoms.json +100 -0
- atoms/PMC12881697_atoms.json +80 -0
- atoms/PMC12881888_atoms.json +73 -0
- atoms/PMC12882434_atoms.json +111 -0
- atoms/PMC12882586_atoms.json +59 -0
- atoms/PMC12883056_atoms.json +50 -0
- atoms/PMC12883664_atoms.json +104 -0
- atoms/PMC12884002_atoms.json +112 -0
- atoms/PMC12884671_atoms.json +54 -0
- atoms/PMC12885676_atoms.json +48 -0
- atoms/PMC12886187_atoms.json +59 -0
- atoms/PMC12886194_atoms.json +102 -0
- atoms/PMC12886303_atoms.json +62 -0
- atoms/PMC12886739_atoms.json +76 -0
- atoms/PMC12887256_atoms.json +66 -0
- atoms/PMC12888404_atoms.json +68 -0
- atoms/PMC12890575_atoms.json +87 -0
- atoms/PMC12891435_atoms.json +42 -0
- atoms/PMC12892171_atoms.json +77 -0
- atoms/PMC12895833_atoms.json +93 -0
- atoms/PMC12898139_atoms.json +83 -0
- atoms/PMC12898264_atoms.json +79 -0
- atoms/PMC12910172_atoms.json +77 -0
- atoms/PMC12910663_atoms.json +97 -0
- atoms/PMC12911946_atoms.json +58 -0
- atoms/PMC12914096_atoms.json +59 -0
- atoms/PMC12914110_atoms.json +43 -0
README.md
ADDED
|
@@ -0,0 +1,73 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
---
|
| 2 |
+
pretty_name: MedCase-Bench
|
| 3 |
+
size_categories:
|
| 4 |
+
- n<1K
|
| 5 |
+
tags:
|
| 6 |
+
- medical-literature
|
| 7 |
+
- case-reports
|
| 8 |
+
- clinical-atoms
|
| 9 |
+
configs:
|
| 10 |
+
- config_name: metadata
|
| 11 |
+
default: true
|
| 12 |
+
data_files:
|
| 13 |
+
- split: evaluation
|
| 14 |
+
path: metadata.json
|
| 15 |
+
---
|
| 16 |
+
|
| 17 |
+
# MedCase-Bench
|
| 18 |
+
|
| 19 |
+
[Project page](https://huggingface.co/spaces/PediaMedAI/MedCaseAgent)
|
| 20 |
+
· MedCase-150K
|
| 21 |
+
· [Agent code](https://github.com/PediaMedAI/MedCaseAgent)
|
| 22 |
+
|
| 23 |
+
MedCase-Bench contains **584 cases** for medical case-report generation, with
|
| 24 |
+
one clinical-atom JSON file per case and source bibliography. Clinical atoms
|
| 25 |
+
are patient-specific facts extracted from published case reports, covering
|
| 26 |
+
history, presentation, examinations, treatment and outcome.
|
| 27 |
+
|
| 28 |
+
Each atom file contains five lists of strings:
|
| 29 |
+
|
| 30 |
+
| Field | Contents |
|
| 31 |
+
| --- | --- |
|
| 32 |
+
| `history` | Patient background and relevant medical history. |
|
| 33 |
+
| `presentation` | Symptoms and findings at presentation. |
|
| 34 |
+
| `diagnostics` | Examinations, laboratory results and diagnostic observations. |
|
| 35 |
+
| `management` | Treatments, procedures and clinical decisions. |
|
| 36 |
+
| `outcome` | Clinical course, response and follow-up. |
|
| 37 |
+
|
| 38 |
+
## Files
|
| 39 |
+
|
| 40 |
+
| File | Contents |
|
| 41 |
+
| --- | --- |
|
| 42 |
+
| `atoms/<PMCID>_atoms.json` | 584 clinical-atom files. |
|
| 43 |
+
| `metadata.json` | 584 corresponding source records, including article identifiers, publication dates, licenses and source download links. |
|
| 44 |
+
|
| 45 |
+
This package contains textual inputs and source metadata. Full articles and
|
| 46 |
+
medical images can be obtained through the source links in `metadata.json`.
|
| 47 |
+
Source publications retain the licenses recorded in their metadata.
|
| 48 |
+
|
| 49 |
+
## Use
|
| 50 |
+
|
| 51 |
+
```python
|
| 52 |
+
import json
|
| 53 |
+
from pathlib import Path
|
| 54 |
+
|
| 55 |
+
files = sorted(Path("atoms").glob("*_atoms.json"))
|
| 56 |
+
assert len(files) == 584
|
| 57 |
+
atoms = json.loads(files[0].read_text(encoding="utf-8"))
|
| 58 |
+
print(atoms["history"])
|
| 59 |
+
```
|
| 60 |
+
|
| 61 |
+
After installing [MedCaseAgent](https://github.com/PediaMedAI/MedCaseAgent) and
|
| 62 |
+
configuring a compatible model API:
|
| 63 |
+
|
| 64 |
+
```bash
|
| 65 |
+
medcase-agent validate atoms/<PMCID>_atoms.json
|
| 66 |
+
medcase-agent generate atoms/<PMCID>_atoms.json \
|
| 67 |
+
--exclude-ids path/to/your-exclusions.json --output runs
|
| 68 |
+
```
|
| 69 |
+
|
| 70 |
+
For generation with images, prepare each case's source images following the
|
| 71 |
+
[preprocessing guide](https://github.com/PediaMedAI/MedCaseAgent/blob/main/docs/preprocessing.md).
|
| 72 |
+
For retrieval-based evaluation, prepare your own PMCID, PMID and DOI exclusion
|
| 73 |
+
list for the benchmark sources and any related publications.
|
atoms/PMC12862275_atoms.json
ADDED
|
@@ -0,0 +1,71 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"21-year-old right-handed female",
|
| 4 |
+
"History of Rasmussen's encephalitis",
|
| 5 |
+
"History of medically refractory epilepsy",
|
| 6 |
+
"Medical journey began at the age of 9",
|
| 7 |
+
"Normal early developmental trajectory",
|
| 8 |
+
"Over the course of 12 years, the patient's disease exhibited a gradual yet relentless progression",
|
| 9 |
+
"Initially presenting with infrequent focal seizures at age 9"
|
| 10 |
+
],
|
| 11 |
+
"presentation": [
|
| 12 |
+
"Persistent seizures",
|
| 13 |
+
"Seizure episodes occurring two to three times per week",
|
| 14 |
+
"Seizure episodes characterized by automotor features",
|
| 15 |
+
"Seizure episodes characterized by head deviation",
|
| 16 |
+
"Seizure episodes characterized by automatisms lasting 45–80 s",
|
| 17 |
+
"Episodes progressed to tonic–clonic movements",
|
| 18 |
+
"Postictal confusion following seizures",
|
| 19 |
+
"Improved awareness during postictal phase compared to earlier condition",
|
| 20 |
+
"Visual hallucinations during some seizures",
|
| 21 |
+
"Visual hallucinations of perceiving spiders",
|
| 22 |
+
"Persistent fatigue",
|
| 23 |
+
"Mild cognitive decline",
|
| 24 |
+
"Cognitive decline affecting attention span",
|
| 25 |
+
"Cognitive decline affecting processing speed",
|
| 26 |
+
"Cognitive decline affecting short‐term memory",
|
| 27 |
+
"Increasing difficulty in academic tasks since early adolescence",
|
| 28 |
+
"Increasing difficulty in daily planning since early adolescence"
|
| 29 |
+
],
|
| 30 |
+
"diagnostics": [
|
| 31 |
+
"MRI from 2012 through 2024 showed significant atrophy of the right cerebral hemisphere",
|
| 32 |
+
"MRI from 2012 through 2024 showed encephalomalacia",
|
| 33 |
+
"MRI from 2012 through 2024 showed gliosis",
|
| 34 |
+
"MRI from 2012 through 2024 showed compensatory dilation of the right lateral ventricle",
|
| 35 |
+
"MRI findings included unilateral cerebral atrophy",
|
| 36 |
+
"MRI findings included low‐lying cerebellar tonsils",
|
| 37 |
+
"Vascular imaging noted hypoplasia of the left posterior communicating artery",
|
| 38 |
+
"Vascular imaging ruled out intracranial stenosis",
|
| 39 |
+
"Vascular imaging ruled out aneurysmal changes",
|
| 40 |
+
"EEG studies demonstrated progressive hemispheric dysfunction predominantly affecting the right hemisphere",
|
| 41 |
+
"EEG studies demonstrated asymmetric background slowing",
|
| 42 |
+
"EEG studies demonstrated reduced amplitude",
|
| 43 |
+
"EEG studies demonstrated interictal epileptiform discharges were multifocal",
|
| 44 |
+
"Ictal recordings showed forced head deviation to the left",
|
| 45 |
+
"Laboratory evaluations revealed persistent hypokalemia (3.2 mmol/L)",
|
| 46 |
+
"Laboratory evaluations revealed bicarbonate deficits (20 mmol/L)",
|
| 47 |
+
"Laboratory evaluations revealed periodic hyperchloremia (108 mmol/L)",
|
| 48 |
+
"Renal function remained normal"
|
| 49 |
+
],
|
| 50 |
+
"management": [
|
| 51 |
+
"Right temporal lobectomy performed at age 14",
|
| 52 |
+
"Initial regimens with phenytoin discontinued",
|
| 53 |
+
"Initial regimens with carbamazepine discontinued",
|
| 54 |
+
"Trials of valproic acid",
|
| 55 |
+
"Trials of lamotrigine",
|
| 56 |
+
"Trials of levetiracetam",
|
| 57 |
+
"Trials of topiramate",
|
| 58 |
+
"Trials of cenobamate",
|
| 59 |
+
"Current regimen includes valproic acid",
|
| 60 |
+
"Current regimen includes lacosamide",
|
| 61 |
+
"Current regimen includes brivaracetam",
|
| 62 |
+
"Current regimen includes zonisamide",
|
| 63 |
+
"Immunomodulation with azathioprine initiated in 2015"
|
| 64 |
+
],
|
| 65 |
+
"outcome": [
|
| 66 |
+
"Transient reduction in seizure frequency post‐temporal lobectomy at age 14",
|
| 67 |
+
"Clinical and radiological deterioration resumed within two years post-lobectomy",
|
| 68 |
+
"Current regimen providing partial seizure control",
|
| 69 |
+
"Metabolic side effects contributed to current regimen"
|
| 70 |
+
]
|
| 71 |
+
}
|
atoms/PMC12862283_atoms.json
ADDED
|
@@ -0,0 +1,127 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Patient is a 34-year-old woman.",
|
| 4 |
+
"Patient is Gravida 2, Para 1.",
|
| 5 |
+
"Gestational age at admission: 32 + 2 weeks.",
|
| 6 |
+
"Weight: 67 kg.",
|
| 7 |
+
"Height: 158 cm.",
|
| 8 |
+
"Conception via IVF.",
|
| 9 |
+
"Pregnancy type: Triplet pregnancy.",
|
| 10 |
+
"Past medical history: Hypothyroidism (well-managed).",
|
| 11 |
+
"Past medical history: Gestational diabetes mellitus (GDM).",
|
| 12 |
+
"Past medical history: Acute fatty liver of pregnancy (AFLP) at 30 weeks (resolved).",
|
| 13 |
+
"Medication: Levothyroxine 75 μg daily.",
|
| 14 |
+
"Medication: Metformin 500 mg twice a day.",
|
| 15 |
+
"Baseline TSH: 1.8 mIU/L.",
|
| 16 |
+
"Baseline HbA1c: 6.2%.",
|
| 17 |
+
"Admission platelet count: 98,000/L.",
|
| 18 |
+
"Admission AST: 48 U/L.",
|
| 19 |
+
"Admission ALT: 52 U/L.",
|
| 20 |
+
"Admission INR: 1.07–1.18.",
|
| 21 |
+
"Admission urine protein: negative.",
|
| 22 |
+
"Admission serum LDH: 690."
|
| 23 |
+
],
|
| 24 |
+
"presentation": [
|
| 25 |
+
"Presenting symptom: Severe epigastric pain.",
|
| 26 |
+
"Admitted to local hospital.",
|
| 27 |
+
"Transferred to tertiary center.",
|
| 28 |
+
"Planned for elective lower‐segment cesarean section (LSCS) after 3 days.",
|
| 29 |
+
"Intraoperative blood pressure: 120–130/70–80 mmHg.",
|
| 30 |
+
"Intraoperative estimated blood loss: 800 mL.",
|
| 31 |
+
"Postoperative time: 2 hours.",
|
| 32 |
+
"Postoperative symptom: Severe hypertension (200/110 mmHg).",
|
| 33 |
+
"Postoperative symptom: Occipital headache.",
|
| 34 |
+
"Postoperative symptom: Visual scotomata.",
|
| 35 |
+
"Postoperative symptom: Nausea.",
|
| 36 |
+
"Postoperative time: 1 hour after hypertension onset.",
|
| 37 |
+
"Event: Generalized seizure with loss of consciousness.",
|
| 38 |
+
"GCS score: 7 (E2V1M4).",
|
| 39 |
+
"Physical exam finding: Tongue bite.",
|
| 40 |
+
"Physical exam finding: Tonic posturing.",
|
| 41 |
+
"Differential diagnosis consideration: Hypertensive ischemic stroke, PRES, cerebral venous sinus thrombosis, ICH, ruptured aneurysm, or AVM."
|
| 42 |
+
],
|
| 43 |
+
"diagnostics": [
|
| 44 |
+
"MRI revealed ICH with a large blood clot in the right basal ganglia.",
|
| 45 |
+
"MRI clot measurement: 48.9 × 28.4 × 30.8 mm.",
|
| 46 |
+
"MRI finding: Intraventricular extension.",
|
| 47 |
+
"MRI finding: Subarachnoid extension.",
|
| 48 |
+
"MRI finding: Hydrocephalus.",
|
| 49 |
+
"MRI finding: Leftward midline shift.",
|
| 50 |
+
"MRA finding: No abnormalities in distal internal carotid artery, vertebral artery, basilar artery, or major cerebral arterial branches.",
|
| 51 |
+
"Postoperative day 1 CT: Blood clot in right basal ganglia and right frontal lobe.",
|
| 52 |
+
"Postoperative day 1 CT measurement: 51 × 38 × 25 mm.",
|
| 53 |
+
"Postoperative day 1 CT: 5.5 mm shift of the brain towards the left side.",
|
| 54 |
+
"EEG performed: Day 2 post‐decompressive craniectomy.",
|
| 55 |
+
"EEG finding: Intermittent abnormal focal sharp and spike waves rising from the right centrotemporal region.",
|
| 56 |
+
"Postoperative day 11 (4/10/2025) Hb: 9.5 g/dL.",
|
| 57 |
+
"Postoperative day 11 (4/10/2025) Platelets: 357,000 μ/L.",
|
| 58 |
+
"Postoperative day 11 (4/10/2025) PT: 15.2 sec.",
|
| 59 |
+
"Postoperative day 11 (4/10/2025) INR: 1.4.",
|
| 60 |
+
"Postoperative day 11 (4/10/2025) AST: 120 U/L.",
|
| 61 |
+
"Postoperative day 11 (4/10/2025) ALT: 95 U/L.",
|
| 62 |
+
"Postoperative day 11 (4/10/2025) Bilirubin: 3.2 mg/dL.",
|
| 63 |
+
"Postoperative day 11 (4/10/2025) Albumin: 2.8 g/dL.",
|
| 64 |
+
"Postoperative day 11 (4/10/2025) Creatinine: 1.1 mg/dL.",
|
| 65 |
+
"Postoperative day 11 (4/10/2025) BUN: 28 mg/dL.",
|
| 66 |
+
"Postoperative day 15 (4/14/2025) Hb: 10.3 g/dL.",
|
| 67 |
+
"Postoperative day 15 (4/14/2025) Platelets: 366,000 μ/L.",
|
| 68 |
+
"Postoperative day 15 (4/14/2025) PT: 12.8 sec.",
|
| 69 |
+
"Postoperative day 15 (4/14/2025) INR: 1.1.",
|
| 70 |
+
"Postoperative day 15 (4/14/2025) AST: 80 U/L.",
|
| 71 |
+
"Postoperative day 15 (4/14/2025) ALT: 65 U/L.",
|
| 72 |
+
"Postoperative day 15 (4/14/2025) Bilirubin: 2.0 mg/dL.",
|
| 73 |
+
"Postoperative day 15 (4/14/2025) Albumin: 3.2 g/dL.",
|
| 74 |
+
"Postoperative day 15 (4/14/2025) Creatinine: 1.0 mg/dL.",
|
| 75 |
+
"Postoperative day 15 (4/14/2025) BUN: 22 mg/dL.",
|
| 76 |
+
"Postoperative day 17 (4/16/2025) Hb: 10.7 g/dL.",
|
| 77 |
+
"Postoperative day 17 (4/16/2025) Platelets: 330,000 μ/L.",
|
| 78 |
+
"Postoperative day 17 (4/16/2025) PT: 12.5 sec.",
|
| 79 |
+
"Postoperative day 17 (4/16/2025) INR: 1.1.",
|
| 80 |
+
"Postoperative day 17 (4/16/2025) AST: 55 U/L.",
|
| 81 |
+
"Postoperative day 17 (4/16/2025) ALT: 45 U/L.",
|
| 82 |
+
"Postoperative day 17 (4/16/2025) Bilirubin: 1.2 mg/dL.",
|
| 83 |
+
"Postoperative day 17 (4/16/2025) Albumin: 3.5 g/dL.",
|
| 84 |
+
"Postoperative day 17 (4/16/2025) Creatinine: 0.9 mg/dL.",
|
| 85 |
+
"Postoperative day 17 (4/16/2025) BUN: 20 mg/dL."
|
| 86 |
+
],
|
| 87 |
+
"management": [
|
| 88 |
+
"Planned procedure: Elective lower‐segment cesarean section (LSCS).",
|
| 89 |
+
"Anesthesia: Spinal anesthesia.",
|
| 90 |
+
"Postpartum medication: IV nitroglycerin.",
|
| 91 |
+
"Postpartum medication: Oral amlodipine.",
|
| 92 |
+
"Postpartum medication: IV midazolam.",
|
| 93 |
+
"Postpartum medication: Levetiracetam.",
|
| 94 |
+
"Procedure: Rapid sequence induction and intubation.",
|
| 95 |
+
"Procedure: MRI and MRA performed.",
|
| 96 |
+
"Consultation: Urgent neurosurgical consultation.",
|
| 97 |
+
"Planned intervention: Decompressive craniectomy.",
|
| 98 |
+
"Planned intervention: EVD placement.",
|
| 99 |
+
"Post-craniectomy management: Conservative management of hematoma (self‐resorption).",
|
| 100 |
+
"ICP management: Maintained below 20 mmHg with osmotic therapy.",
|
| 101 |
+
"Microbiology: Endotracheal aspirate culture positive for Pseudomonas aeruginosa.",
|
| 102 |
+
"Microbiology: Vaginal swab positive for Citrobacter koseri.",
|
| 103 |
+
"Medication (Infection): Piperacillin–tazobactam.",
|
| 104 |
+
"Medication (Infection): Polymyxin B.",
|
| 105 |
+
"Procedure: Tracheostomy on postoperative day 14.",
|
| 106 |
+
"Procedure: Removal of endotracheal tube on postoperative day 14.",
|
| 107 |
+
"Transfer: Transferred to another institution on postoperative day 18 due to financial constraints.",
|
| 108 |
+
"Procedure: Weaned from mechanical ventilation to Venturi mask on postoperative day 25.",
|
| 109 |
+
"Procedure: Decannulation of tracheostomy tube on postoperative day 32.",
|
| 110 |
+
"Follow-up plan: Physiotherapy‐based rehabilitation.",
|
| 111 |
+
"Follow-up plan: Scheduled in 2–4 weeks.",
|
| 112 |
+
"Planned intervention: Cranioplasty (6–12 weeks later)."
|
| 113 |
+
],
|
| 114 |
+
"outcome": [
|
| 115 |
+
"Neonatal outcome: Delivery of three viable newborns.",
|
| 116 |
+
"Neonatal outcome: Apgar scores of 8, 9, and 9 at 5 min.",
|
| 117 |
+
"Neonatal outcome: Estimated fetal weights of approximately 1600 g, 1700 g, and 2200 g.",
|
| 118 |
+
"Neonatal outcome: Discharged all three neonates without complications.",
|
| 119 |
+
"Neurological outcome: Steady improvement in neurological condition.",
|
| 120 |
+
"Neurological outcome: GCS improved from E3VtM5 to E4VtM6 in HDU.",
|
| 121 |
+
"Neurological outcome: GCS improved to 13 (E4V3M6) on neurosurgery ward.",
|
| 122 |
+
"Neurological outcome: Maintaining oxygen saturation on room air.",
|
| 123 |
+
"Neurological outcome: Chest physiotherapy.",
|
| 124 |
+
"Neurological outcome: Discharged from ward one week after transfer to neurosurgery ward.",
|
| 125 |
+
"Neurological outcome: Cranioplasty planned 6–12 weeks later depending on neurological recovery."
|
| 126 |
+
]
|
| 127 |
+
}
|
atoms/PMC12863993_atoms.json
ADDED
|
@@ -0,0 +1,91 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"57-year-old male",
|
| 4 |
+
"Admitted December 2023",
|
| 5 |
+
"No prior history of malignancy"
|
| 6 |
+
],
|
| 7 |
+
"presentation": [
|
| 8 |
+
"1-week history of cough",
|
| 9 |
+
"1-week history of shortness of breath",
|
| 10 |
+
"Worsening dyspnea 5 days after pleural biopsy",
|
| 11 |
+
"Progressive anemia 5 days after pleural biopsy",
|
| 12 |
+
"Hemoglobin dropped from 120 to 62 g/L",
|
| 13 |
+
"High fever reaching up to 39°C on seventh postoperative day",
|
| 14 |
+
"Worsening respiratory distress",
|
| 15 |
+
"Rapid heart rate",
|
| 16 |
+
"Widespread wheezing and crackles in both lungs",
|
| 17 |
+
"Drop in blood pressure",
|
| 18 |
+
"Exacerbated dyspnea",
|
| 19 |
+
"Persistent high fever",
|
| 20 |
+
"Diagnosis of septic shock",
|
| 21 |
+
"Diagnosis of acute kidney injury",
|
| 22 |
+
"Diagnosis of hyperkalemia",
|
| 23 |
+
"Diagnosis of metabolic acidosis",
|
| 24 |
+
"Patient succumbed to illness"
|
| 25 |
+
],
|
| 26 |
+
"diagnostics": [
|
| 27 |
+
"Enhanced chest CT: large, lobulated, hypermetabolic mass in anterior mediastinum, measuring 6.7 × 7.5 × 13.5 cm",
|
| 28 |
+
"Enhanced chest CT: heterogeneous density",
|
| 29 |
+
"Enhanced chest CT: no obvious calcification or fat density",
|
| 30 |
+
"Enhanced chest CT: involvement of pericardium",
|
| 31 |
+
"Enhanced chest CT: compression and narrowing of left and right brachiocephalic veins",
|
| 32 |
+
"Enhanced chest CT: compression and narrowing of superior vena cava",
|
| 33 |
+
"Enhanced chest CT: extensive right-sided pleural metastasis",
|
| 34 |
+
"Enhanced chest CT: massive right-sided pleural effusion",
|
| 35 |
+
"Enhanced chest CT: multiple small nodules in both lungs",
|
| 36 |
+
"PET-CT: hypermetabolic mass",
|
| 37 |
+
"White blood cell count: 15.84 × 10^9/L",
|
| 38 |
+
"Neutrophils percentage: 64.1%",
|
| 39 |
+
"Hemoglobin level: 144 g/L",
|
| 40 |
+
"NSE level: 27.80 ng/mL",
|
| 41 |
+
"CA125 level: 60.50 U/mL",
|
| 42 |
+
"CEA level: within normal ranges",
|
| 43 |
+
"CA153 level: within normal ranges",
|
| 44 |
+
"SCC level: within normal ranges",
|
| 45 |
+
"CYFRA21-1 level: within normal ranges",
|
| 46 |
+
"Cardiac function: normal",
|
| 47 |
+
"Liver function: normal",
|
| 48 |
+
"Renal function: normal",
|
| 49 |
+
"Coagulation profile: normal",
|
| 50 |
+
"Infection markers: normal",
|
| 51 |
+
"Routine urine test: normal",
|
| 52 |
+
"Routine stool test: normal",
|
| 53 |
+
"Procedure: thoracentesis on right side",
|
| 54 |
+
"Procedure: pleural biopsy on right side",
|
| 55 |
+
"Procedure: ultrasound-guided fine-needle aspiration biopsy of mediastinal mass",
|
| 56 |
+
"Pleural fluid appearance: red, turbid, free of clots",
|
| 57 |
+
"Pleural fluid Rivolta test: positive",
|
| 58 |
+
"Pleural fluid Pandy test: strongly positive (+++)",
|
| 59 |
+
"Pleural fluid white blood cell count: 3167 × 10^6/L",
|
| 60 |
+
"Pleural fluid red blood cell count: 276 000 × 10^6/L",
|
| 61 |
+
"Pleural fluid differential: 95% segmented neutrophils, 5% mononuclear cells",
|
| 62 |
+
"Pleural fluid large cells: 3–5 per high power field",
|
| 63 |
+
"Pleural fluid total protein: 37.7 g/L",
|
| 64 |
+
"Pleural fluid LDH: 1889 U/L",
|
| 65 |
+
"Pleural fluid ADA: 20.50 U/L",
|
| 66 |
+
"Pleural fluid NSE: 79.10 ng/mL",
|
| 67 |
+
"Pleural fluid CEA: 1.63 ng/mL",
|
| 68 |
+
"Pleural fluid CA125: 746.0 U/mL",
|
| 69 |
+
"Pleural fluid glucose: 5.41 mmol/L",
|
| 70 |
+
"Pleural fluid eosinophils: 0.5%",
|
| 71 |
+
"Pleural fluid TB-DNA: negative",
|
| 72 |
+
"Pleural fluid tuberculosis smear: negative",
|
| 73 |
+
"Pleural fluid bacterial/fungal cultures: negative",
|
| 74 |
+
"Pleural fluid sediment cytology: numerous cells with thickened nuclear membranes and prominent nucleoli, some containing pigments, indicative of malignant tumor cells",
|
| 75 |
+
"Pleural tissue morphology: fragments of tissue exhibiting sheet-like distributions of tumor cells",
|
| 76 |
+
"Immunohistochemistry CK: negative",
|
| 77 |
+
"Immunohistochemistry HMB45: positive",
|
| 78 |
+
"Immunohistochemistry S-100: positive",
|
| 79 |
+
"Immunohistochemistry Ki67: approximately 50% positive",
|
| 80 |
+
"Immunohistochemistry ERG: positive in blood vessels",
|
| 81 |
+
"Immunohistochemistry SALL4: negative",
|
| 82 |
+
"Pathology morphology: round or oval nuclei with deep staining and sparse cytoplasm",
|
| 83 |
+
"Pathology morphology: focal necrosis and pigment deposition",
|
| 84 |
+
"Head MRI: no evidence of primary or metastatic lesions",
|
| 85 |
+
"Diagnosis: malignant melanoma"
|
| 86 |
+
],
|
| 87 |
+
"management": [
|
| 88 |
+
"Exploratory thoracoscopy and hemostasis under general anesthesia 5 days after pleural biopsy"
|
| 89 |
+
],
|
| 90 |
+
"outcome": []
|
| 91 |
+
}
|
atoms/PMC12863997_atoms.json
ADDED
|
@@ -0,0 +1,42 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"68-year-old man",
|
| 4 |
+
"Regular checkup setting",
|
| 5 |
+
"No clinical evidence of arthritis after rheumatologist assessment"
|
| 6 |
+
],
|
| 7 |
+
"presentation": [
|
| 8 |
+
"Abnormal shadows on chest radiograph",
|
| 9 |
+
"Joint pain and swelling",
|
| 10 |
+
"Tenderness in wrist, fingers and shoulder",
|
| 11 |
+
"Swelling in wrist, fingers and shoulder",
|
| 12 |
+
"Fine crackles on inhalation in lower lungs",
|
| 13 |
+
"Grade 1 dyspnea according to modified Medical Research Council (mMRC) dyspnea scale",
|
| 14 |
+
"Two years later, developed joint pain and swelling"
|
| 15 |
+
],
|
| 16 |
+
"diagnostics": [
|
| 17 |
+
"RF 199 IU/mL",
|
| 18 |
+
"Anti-CCP antibody 1040 U/mL",
|
| 19 |
+
"Forced vital capacity (FVC) 2.75 L",
|
| 20 |
+
"C-reactive protein (CRP) level 4.2 mg/dL",
|
| 21 |
+
"Krebs von den Lungen-6 (KL-6) level 2494 U/mL",
|
| 22 |
+
"Disease Activity Score 28 with CRP (DAS28-CRP) level 4.85",
|
| 23 |
+
"Chest images revealed reticular shadows",
|
| 24 |
+
"Chest images revealed ground-glass opacities (GGOs)",
|
| 25 |
+
"Chest images revealed subpleural spared area",
|
| 26 |
+
"FVC decreased to 2.51 L in 2 years"
|
| 27 |
+
],
|
| 28 |
+
"management": [
|
| 29 |
+
"Started on salazosulfapyridine 500 mg/day",
|
| 30 |
+
"Filgotinib 200 mg/day added to control arthritis"
|
| 31 |
+
],
|
| 32 |
+
"outcome": [
|
| 33 |
+
"No clinical effect on arthritis with salazosulfapyridine",
|
| 34 |
+
"DAS28-CRP level decreased to 2.06 in 2 weeks",
|
| 35 |
+
"Visual analogue scale score decreased to 19 mm in 2 weeks",
|
| 36 |
+
"KL-6 level decreased and remained below 1000 U/mL",
|
| 37 |
+
"Dyspnea resolved to mMRC dyspnea scale 0",
|
| 38 |
+
"Percentage FVC improved to 80.7%",
|
| 39 |
+
"Followed-up for arthritis and ILD for up to 4 years",
|
| 40 |
+
"No exacerbation, flare, or specific adverse events due to filgotinib treatment for up to 4 years"
|
| 41 |
+
]
|
| 42 |
+
}
|
atoms/PMC12865447_atoms.json
ADDED
|
@@ -0,0 +1,100 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Patient is a 47-year-old woman.",
|
| 4 |
+
"History of hypothyroidism.",
|
| 5 |
+
"History of mitral valve replacement (MVR) 15 years ago.",
|
| 6 |
+
"MVR used a 31-mm Mosaic Porcine bioprosthetic valve.",
|
| 7 |
+
"History of tricuspid valve repair (TVR) 15 years ago.",
|
| 8 |
+
"History of rheumatic valvular involvement.",
|
| 9 |
+
"Peri-operative TTE demonstrated normal coronary anatomy 15 years ago.",
|
| 10 |
+
"Post-operative follow-up imaging showed no evidence of coronary injury 15 years ago.",
|
| 11 |
+
"No reported history of diabetes mellitus.",
|
| 12 |
+
"No reported history of hypertension.",
|
| 13 |
+
"No reported history of dyslipidaemia.",
|
| 14 |
+
"No reported history of chronic kidney disease.",
|
| 15 |
+
"No reported history of tobacco use.",
|
| 16 |
+
"No reported history of alcohol use.",
|
| 17 |
+
"Six years after initial MVR, patient presented with recurrent exertional dyspnoea.",
|
| 18 |
+
"Percutaneous closure of fistula was attempted 6 years ago.",
|
| 19 |
+
"Percutaneous closure attempt was unsuccessful.",
|
| 20 |
+
"Surgical intervention was recommended 6 years ago but declined by patient.",
|
| 21 |
+
"Patient managed conservatively with acetylsalicylic acid 80 mg daily since 6-year mark."
|
| 22 |
+
],
|
| 23 |
+
"presentation": [
|
| 24 |
+
"Presented with exertional dyspnoea (New York Heart Association Function Class II).",
|
| 25 |
+
"Reported fatigue.",
|
| 26 |
+
"Reported effort-induced chest discomfort.",
|
| 27 |
+
"Denied episodes of syncope.",
|
| 28 |
+
"Denied peripheral oedema.",
|
| 29 |
+
"Denied rest angina.",
|
| 30 |
+
"Physical examination revealed a continuous grade 3/6 murmur along the left sternal border.",
|
| 31 |
+
"Heart rate 94 b.p.m.",
|
| 32 |
+
"Blood pressure 110/70 mmHg.",
|
| 33 |
+
"Oxygen saturation 98%.",
|
| 34 |
+
"Electrocardiography revealed atrial fibrillation.",
|
| 35 |
+
"Electrocardiography showed no signs of ischaemic changes."
|
| 36 |
+
],
|
| 37 |
+
"diagnostics": [
|
| 38 |
+
"Transthoracic echocardiogram 6 years ago revealed continuous turbulent flow near the coronary sinus.",
|
| 39 |
+
"Coronary angiography 6 years ago confirmed coronary artery fistula.",
|
| 40 |
+
"Angiography demonstrated markedly ectatic segments in the proximal and distal LCX.",
|
| 41 |
+
"Angiography demonstrated ectatic segments in the first obtuse marginal branch.",
|
| 42 |
+
"Angiography showed segments draining into the coronary sinus.",
|
| 43 |
+
"Angiography showed remaining epicardial coronary arteries were normal.",
|
| 44 |
+
"Echocardiographic evaluation demonstrated severe left atrial enlargement.",
|
| 45 |
+
"Echocardiographic evaluation demonstrated moderate right atrial enlargement.",
|
| 46 |
+
"Echocardiographic evaluation demonstrated preserved left ventricular systolic function.",
|
| 47 |
+
"Echocardiographic evaluation demonstrated left ventricular ejection fraction 50%–55%.",
|
| 48 |
+
"Echocardiographic evaluation demonstrated bioprosthetic mitral valve degeneration.",
|
| 49 |
+
"Echocardiographic evaluation demonstrated elevated transvalvular gradients.",
|
| 50 |
+
"Echocardiographic evaluation demonstrated mild mitral regurgitation.",
|
| 51 |
+
"Echocardiographic evaluation demonstrated mean mitral gradient 11 mmHg.",
|
| 52 |
+
"Echocardiographic evaluation demonstrated moderate aortic regurgitation.",
|
| 53 |
+
"Echocardiographic evaluation demonstrated moderate tricuspid regurgitation.",
|
| 54 |
+
"Echocardiographic evaluation demonstrated estimated pulmonary artery systolic pressure 43 mmHg.",
|
| 55 |
+
"Echocardiographic evaluation demonstrated LCX markedly dilated with continuous turbulent flow.",
|
| 56 |
+
"Echocardiographic evaluation demonstrated dilated inferior vena cava with reduced inspiratory collapse.",
|
| 57 |
+
"Coronary computed tomography angiography demonstrated right-dominant coronary circulation.",
|
| 58 |
+
"Coronary computed tomography angiography demonstrated 11-mm aneurysmal dilation of the proximal LCX.",
|
| 59 |
+
"Coronary computed tomography angiography demonstrated tortuous mid-to-distal LCX.",
|
| 60 |
+
"Coronary computed tomography angiography demonstrated fistulous communication to the CS in LCX.",
|
| 61 |
+
"Coronary computed tomography angiography demonstrated mild proximal ectasia of the left anterior descending artery.",
|
| 62 |
+
"Coronary computed tomography angiography demonstrated left anterior descending artery ectasia 6 mm.",
|
| 63 |
+
"Coronary computed tomography angiography identified fistula opening at the distal segment of the left main coronary artery.",
|
| 64 |
+
"Coronary computed tomography angiography identified fistula opening positioned posterior to the proximal portion of the LCX ostium.",
|
| 65 |
+
"Intraoperative transoesophageal echocardiography confirmed satisfactory positioning and function of prostheses.",
|
| 66 |
+
"Intraoperative transoesophageal echocardiography showed no evidence of paravalvular leakage.",
|
| 67 |
+
"Intraoperative transoesophageal echocardiography showed no evidence of residual fistula flow in the LCX or CS."
|
| 68 |
+
],
|
| 69 |
+
"management": [
|
| 70 |
+
"Patient was enlisted for percutaneous closure of the fistula.",
|
| 71 |
+
"Catheter access using JR4, MPA, AR1, and AL2 catheters was prevented due to tortuous and complex anatomy of the LCX.",
|
| 72 |
+
"Surgical intervention was recommended 6 years ago but declined by patient.",
|
| 73 |
+
"Patient managed conservatively with optimal medical therapy.",
|
| 74 |
+
"Patient managed conservatively with acetylsalicylic acid 80 mg daily.",
|
| 75 |
+
"Patient was scheduled for surgical intervention including mitral and aortic valve replacement.",
|
| 76 |
+
"Patient was scheduled for tricuspid valve repair.",
|
| 77 |
+
"Patient was scheduled for ligation of the coronary fistula.",
|
| 78 |
+
"Patient underwent median sternotomy.",
|
| 79 |
+
"Patient underwent aorta-bicaval cardiopulmonary bypass.",
|
| 80 |
+
"Total cardiopulmonary bypass time was 160 minutes.",
|
| 81 |
+
"Aortic cross-clamp time was 85 minutes.",
|
| 82 |
+
"Mitral valve replacement was performed using a 31-mm St. Jude mechanical prosthesis.",
|
| 83 |
+
"Aortic valve replacement was performed using a 23-mm Carbomedics prosthesis.",
|
| 84 |
+
"Tricuspid valve repair was achieved using an Alfieri stitch approximating the anterior and septal leaflets.",
|
| 85 |
+
"Permanent annuloplasty ring was placed during tricuspid valve repair.",
|
| 86 |
+
"Coronary fistula was surgically ligated and secured with multiple sutures.",
|
| 87 |
+
"Surgical ligation achieved complete occlusion."
|
| 88 |
+
],
|
| 89 |
+
"outcome": [
|
| 90 |
+
"Fifth day post-operative transthoracic echocardiography was acceptable.",
|
| 91 |
+
"Patient's post-operative course was uneventful.",
|
| 92 |
+
"Patient was discharged in stable condition.",
|
| 93 |
+
"Patient's symptoms improved post-discharge.",
|
| 94 |
+
"Patient discharged on metoprolol succinate.",
|
| 95 |
+
"Patient discharged on furosemide.",
|
| 96 |
+
"Patient discharged on digoxin.",
|
| 97 |
+
"Long-term outcome data are lacking.",
|
| 98 |
+
"Patient was not available for subsequent evaluation."
|
| 99 |
+
]
|
| 100 |
+
}
|
atoms/PMC12867003_atoms.json
ADDED
|
@@ -0,0 +1,67 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"54-year-old female",
|
| 4 |
+
"Gravida 6 Para 6 (G6P6)",
|
| 5 |
+
"Postmenopausal",
|
| 6 |
+
"Previously healthy",
|
| 7 |
+
"Smoking history 30 pack-years",
|
| 8 |
+
"Smoking history: one pack per day for 30 years"
|
| 9 |
+
],
|
| 10 |
+
"presentation": [
|
| 11 |
+
"Presented for urinary incontinence",
|
| 12 |
+
"Presented for lower abdominal pain",
|
| 13 |
+
"Symptoms started 4 months ago",
|
| 14 |
+
"Urinary dribbling",
|
| 15 |
+
"Increased frequency of urination",
|
| 16 |
+
"Dysuria",
|
| 17 |
+
"Persistent lower abdominal pain",
|
| 18 |
+
"Alopecia",
|
| 19 |
+
"12-kg weight loss"
|
| 20 |
+
],
|
| 21 |
+
"diagnostics": [
|
| 22 |
+
"Multiple urinalyses ordered",
|
| 23 |
+
"Urinalysis result: 20–25 white blood cells (WBCs)",
|
| 24 |
+
"Urine culture: Streptococcus species",
|
| 25 |
+
"Pelvic ultrasound 1: right 7-cm ovarian cyst",
|
| 26 |
+
"Pelvic ultrasound 2: no signs of previously found ovarian cyst",
|
| 27 |
+
"Pelvic ultrasound 2: nonspecific but suspicious bladder findings",
|
| 28 |
+
"Cystoscopy: suspicious and irregularly shaped mucosa",
|
| 29 |
+
"CT scan: patient refused to do",
|
| 30 |
+
"Pathology (TURBT): SRCC of the bladder",
|
| 31 |
+
"PET scan: peritoneal carcinomatosis",
|
| 32 |
+
"PET scan: no evidence of distant metastasis",
|
| 33 |
+
"Second biopsy postlaparotomy: confirmed results of previous biopsy",
|
| 34 |
+
"Tumor cells negative for CDX-2",
|
| 35 |
+
"Tumor cells negative for ER",
|
| 36 |
+
"Tumor cells positive for PDL-1",
|
| 37 |
+
"PDL-1 total proportion score (TPS): 100%",
|
| 38 |
+
"PDL-1 combined positive score (CPS): 100%",
|
| 39 |
+
"Staging: T4b N0 M1b",
|
| 40 |
+
"Staging: Stage IV bladder cancer (AJCC eighth edition)"
|
| 41 |
+
],
|
| 42 |
+
"management": [
|
| 43 |
+
"Antibiotic: amoxicillin and clavulanic acid",
|
| 44 |
+
"Procedure: transurethral resection of bladder tumor (TURBT)",
|
| 45 |
+
"Procedure: laparotomy to debulk tumor",
|
| 46 |
+
"Surgical cytoreduction of peritoneal carcinomatosis",
|
| 47 |
+
"Midline laparotomy",
|
| 48 |
+
"Omentectomy",
|
| 49 |
+
"Resection of visible peritoneal implants along anterior abdominal wall",
|
| 50 |
+
"Peritoneal stripping",
|
| 51 |
+
"Excision of nodular deposits over mesenteric surfaces",
|
| 52 |
+
"Excision of nodular deposits over pelvic peritoneum",
|
| 53 |
+
"Chemotherapy: cisplatin and Gemzar (gemcitabine)",
|
| 54 |
+
"Chemotherapy cycles: six-cycle",
|
| 55 |
+
"Immunotherapy: avelumab (Bavencio)",
|
| 56 |
+
"Immunotherapy doses: 20 out of expected 36 doses",
|
| 57 |
+
"Immunotherapy duration: 18 months",
|
| 58 |
+
"Patient directive: against further urological surgical procedures (partial cystectomy or RC)",
|
| 59 |
+
"Treatment decision: elected to proceed with drug therapy"
|
| 60 |
+
],
|
| 61 |
+
"outcome": [
|
| 62 |
+
"Patient remained in stable condition (during surgery)",
|
| 63 |
+
"Follow-up abdominal and pelvic CT imaging: reduction in tumor burden",
|
| 64 |
+
"Last scan: improvement and tumor shrinkage compared to previous scans",
|
| 65 |
+
"Follow-up schedule: Cyclic scans done every 3 months"
|
| 66 |
+
]
|
| 67 |
+
}
|
atoms/PMC12867464_atoms.json
ADDED
|
@@ -0,0 +1,57 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"56 year old woman",
|
| 4 |
+
"Past medical history noncontributory",
|
| 5 |
+
"No known history of immunosuppression",
|
| 6 |
+
"No known history of diabetes",
|
| 7 |
+
"No known history of recurrent skin infections",
|
| 8 |
+
"Received Bellafill (Suneva Medical Inc) approximately 6 years prior",
|
| 9 |
+
"Received Restylane (Galderma Laboratories) approximately 10 years earlier",
|
| 10 |
+
"Bellafill and Restylane received for treatment of acne scarring on the cheeks"
|
| 11 |
+
],
|
| 12 |
+
"presentation": [
|
| 13 |
+
"Presented with chronic nonhealing draining abscess localized to right cheek",
|
| 14 |
+
"Nodule persisted for approximately 3 years",
|
| 15 |
+
"Sought care from specialists on at least one occasion",
|
| 16 |
+
"Denied systemic symptoms such as fever",
|
| 17 |
+
"Denied systemic symptoms such as chills",
|
| 18 |
+
"Denied systemic symptoms such as dental caries",
|
| 19 |
+
"Denied systemic symptoms such as oral drainage",
|
| 20 |
+
"Denied systemic symptoms such as pain with salivation",
|
| 21 |
+
"Denied systemic symptoms such as malaise",
|
| 22 |
+
"Deep nodule was ulcerated",
|
| 23 |
+
"Erythematous borders localized to right inferior central malar cheek",
|
| 24 |
+
"Ulcer base exhibited crusting",
|
| 25 |
+
"Ulcer base exhibited purulent material",
|
| 26 |
+
"3 cm of surrounding induration",
|
| 27 |
+
"No regional lymphadenopathy was present"
|
| 28 |
+
],
|
| 29 |
+
"diagnostics": [
|
| 30 |
+
"Tissue culture negative for bacterial growth",
|
| 31 |
+
"Tissue culture negative for fungal growth",
|
| 32 |
+
"Tissue culture negative for atypical mycobacterial growth",
|
| 33 |
+
"Histopathologic analysis revealed foreign body granulomas",
|
| 34 |
+
"Histopathologic analysis revealed abundant reactive lymphoid tissue",
|
| 35 |
+
"Histopathologic analysis revealed accumulation of PMMA microspheres",
|
| 36 |
+
"Histopathologic analysis revealed accumulation of hyaluronic acid",
|
| 37 |
+
"Histopathologic analysis consistent with semipermanent dermal fillers",
|
| 38 |
+
"Surrounding granulomatous inflammation noted",
|
| 39 |
+
"Grocott methenamine silver stain negative",
|
| 40 |
+
"Fite stain negative",
|
| 41 |
+
"Gram stain negative",
|
| 42 |
+
"Stains negative for fungi",
|
| 43 |
+
"Stains negative for mycobacteria",
|
| 44 |
+
"Stains negative for bacteria"
|
| 45 |
+
],
|
| 46 |
+
"management": [
|
| 47 |
+
"Punch biopsy performed",
|
| 48 |
+
"Excisional biopsy performed",
|
| 49 |
+
"Suture removal at 1 week"
|
| 50 |
+
],
|
| 51 |
+
"outcome": [
|
| 52 |
+
"Uneventful postoperative course",
|
| 53 |
+
"Surgical site well healed at 4 weeks postoperatively",
|
| 54 |
+
"No signs of infection at 4 weeks postoperatively",
|
| 55 |
+
"No signs of recurrence at 4 weeks postoperatively"
|
| 56 |
+
]
|
| 57 |
+
}
|
atoms/PMC12867536_atoms.json
ADDED
|
@@ -0,0 +1,60 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"52-year-old woman",
|
| 4 |
+
"History of right breast cancer",
|
| 5 |
+
"Past smoking history",
|
| 6 |
+
"Normal pulmonary function",
|
| 7 |
+
"Adequate surgical tolerance"
|
| 8 |
+
],
|
| 9 |
+
"presentation": [
|
| 10 |
+
"Asymptomatic",
|
| 11 |
+
"Presented on routine follow-up CT",
|
| 12 |
+
"Bilateral multiple ground-glass nodules"
|
| 13 |
+
],
|
| 14 |
+
"diagnostics": [
|
| 15 |
+
"Dominant lesion 22-mm heterogeneous GGN with 2-mm solid component in incomplete fissure area between right upper and lower lobes",
|
| 16 |
+
"15-mm pure GGN in S2 segment",
|
| 17 |
+
"7-mm pure GGN in S2 segment",
|
| 18 |
+
"7-mm pure GGN in S6 segment",
|
| 19 |
+
"12-mm pure GGN with barely perceptible density in middle lobe",
|
| 20 |
+
"7-mm part-solid GGN with 1-mm solid component in left upper lobe",
|
| 21 |
+
"8-mm pure GGN in left upper lobe",
|
| 22 |
+
"PET standardized uptake value maximum of 1.4 in dominant lesion",
|
| 23 |
+
"Other nodules showed no significant uptake on PET",
|
| 24 |
+
"Dominant lesion positioned adjacent to B2 and B6 bronchi",
|
| 25 |
+
"Dense parenchymal fusion noted at right oblique fissure",
|
| 26 |
+
"Common trunk of ascending A2 serving as common branch for both A2a and A2b",
|
| 27 |
+
"A6 and intersegmental venous connection from S6 to central vein",
|
| 28 |
+
"Intraoperative findings confirmed a fused fissure",
|
| 29 |
+
"None of the lesions demonstrated pleural changes",
|
| 30 |
+
"All lesions impalpable",
|
| 31 |
+
"Dominant lesion pathological diagnosis adenocarcinoma (pT1miN0M0; tumor size 15 mm, invasive size 1 mm, surgical margin 10 mm)",
|
| 32 |
+
"15-mm S2 lesion pathological diagnosis adenocarcinoma in situ (pTis; tumor size 8 mm, surgical margin 14 mm)",
|
| 33 |
+
"7-mm pure GGNs in S2 and S6 pathological diagnosis chronic inflammatory scarring tissue"
|
| 34 |
+
],
|
| 35 |
+
"management": [
|
| 36 |
+
"Treatment plan included combined S2+S6 segmentectomy",
|
| 37 |
+
"Middle lobe and contralateral lesions designated for CT surveillance",
|
| 38 |
+
"Re-evaluation planned at 6-month intervals for conservatively managed lesions",
|
| 39 |
+
"General anesthesia",
|
| 40 |
+
"1-lung ventilation",
|
| 41 |
+
"Left lateral decubitus position",
|
| 42 |
+
"Video-assisted thoracoscopic surgery",
|
| 43 |
+
"3-port completely thoracoscopic approach",
|
| 44 |
+
"Surgeon standing on the dorsal side",
|
| 45 |
+
"3.5-cm access port at midaxillary line at sixth intercostal space",
|
| 46 |
+
"5-mm camera port at midaxillary line at eighth intercostal space",
|
| 47 |
+
"11.5-mm assistant port at sixth intercostal space on anterior axillary line",
|
| 48 |
+
"Division of B2 and B6 bronchi",
|
| 49 |
+
"Division of V2 and V6",
|
| 50 |
+
"Division of common trunk of ascending A2 and A6"
|
| 51 |
+
],
|
| 52 |
+
"outcome": [
|
| 53 |
+
"Operative time 249 min",
|
| 54 |
+
"Blood loss 10 mL",
|
| 55 |
+
"No postoperative air leak observed",
|
| 56 |
+
"Pleural effusion of 300 mL/day noted on PODs 1-2",
|
| 57 |
+
"Chest tube removal on POD 4 after effusion reduction",
|
| 58 |
+
"Patient discharged on POD 7"
|
| 59 |
+
]
|
| 60 |
+
}
|
atoms/PMC12868566_atoms.json
ADDED
|
@@ -0,0 +1,47 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Male patient in his 40s",
|
| 4 |
+
"Referred to Thoracic Surgery Department October 2018"
|
| 5 |
+
],
|
| 6 |
+
"presentation": [
|
| 7 |
+
"Cough with sputum",
|
| 8 |
+
"Occasional hemoptysis",
|
| 9 |
+
"Oral surgery consultation revealed no obvious abnormalities in head and neck area",
|
| 10 |
+
"Odynophagia in May 2022"
|
| 11 |
+
],
|
| 12 |
+
"diagnostics": [
|
| 13 |
+
"Chest CT revealed space-occupying lesion in right lung hilum",
|
| 14 |
+
"Biopsy of middle stem of right lung confirmed TAdCC",
|
| 15 |
+
"Postoperative immunohistochemical analysis positive for CK8/18",
|
| 16 |
+
"Postoperative immunohistochemical analysis positive for CK19",
|
| 17 |
+
"Postoperative immunohistochemical analysis positive for CD117",
|
| 18 |
+
"Postoperative immunohistochemical analysis positive for CK7",
|
| 19 |
+
"ARMS-PCR testing revealed no mutations in EGFR",
|
| 20 |
+
"ARMS-PCR testing revealed no mutations in ALK",
|
| 21 |
+
"ARMS-PCR testing revealed no mutations in ROS",
|
| 22 |
+
"ARMS-PCR testing revealed no mutations in BRAF",
|
| 23 |
+
"Reexamination in December 2020 revealed suspicious liver lesion on routine chest CT",
|
| 24 |
+
"PET-CT showed irregular low-density mass near inferior vena cava in upper segment of right posterior lobe of the liver",
|
| 25 |
+
"PET-CT showed uneven metabolic uptake in liver mass",
|
| 26 |
+
"PET-CT showed no abnormal metabolic activity in lungs",
|
| 27 |
+
"PET-CT showed no abnormal metabolic activity in head and neck",
|
| 28 |
+
"Biopsy confirmed metastatic AdCC in the liver",
|
| 29 |
+
"Biopsy confirmed AdCC at base of tongue"
|
| 30 |
+
],
|
| 31 |
+
"management": [
|
| 32 |
+
"Robot-assisted sleeve resection and regional lymph node dissection of middle and lower lobes of right lung",
|
| 33 |
+
"Achieved R0 resection",
|
| 34 |
+
"Six cycles of pemetrexed 500 mg/m2 combined with nedaplatin 80 mg/m2 on day 1 of 21-day cycle",
|
| 35 |
+
"28 sessions of thoracic radiotherapy",
|
| 36 |
+
"Laparoscopic partial hepatectomy",
|
| 37 |
+
"Combination therapy with camrelizumab 200 mg day 1",
|
| 38 |
+
"Combination therapy with nab-paclitaxel 300 mg day 1",
|
| 39 |
+
"Combination therapy with carboplatin 600 mg day 1",
|
| 40 |
+
"Combination therapy administered every 3 weeks for six cycles",
|
| 41 |
+
"Radiotherapy administered to head and neck tumor region 6000 cGy/24F"
|
| 42 |
+
],
|
| 43 |
+
"outcome": [
|
| 44 |
+
"Follow-up MR imaging revealed no further progression of liver metastasis",
|
| 45 |
+
"Patient succumbed to drug-induced liver damage and bone marrow suppression following chemotherapy and radiotherapy"
|
| 46 |
+
]
|
| 47 |
+
}
|
atoms/PMC12868984_atoms.json
ADDED
|
@@ -0,0 +1,42 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"35-year-old male",
|
| 4 |
+
"underwent open rhinoplasty 2 years ago",
|
| 5 |
+
"no history of wearing glasses",
|
| 6 |
+
"no history of trauma to the nose after surgery",
|
| 7 |
+
"no relevant medical or medication use history",
|
| 8 |
+
"discontinued follow-up after the 3-month examination"
|
| 9 |
+
],
|
| 10 |
+
"presentation": [
|
| 11 |
+
"presented with progressive swelling on the left side of the nose for the past year",
|
| 12 |
+
"no difficulty breathing through the nose",
|
| 13 |
+
"slight subluxation of the nasal caudal septum from the nasal spine toward the right side",
|
| 14 |
+
"slight deviation of the nasal axis to the right starting from the rhinion",
|
| 15 |
+
"3 mm firm fixed ovoid subcutaneous mass approximately 7 mm from the left medial canthus",
|
| 16 |
+
"mass had a smooth surface and was not tender",
|
| 17 |
+
"endoscopic examination showed slight deviation to the left",
|
| 18 |
+
"no nasal passage obstruction on endoscopic examination"
|
| 19 |
+
],
|
| 20 |
+
"diagnostics": [
|
| 21 |
+
"laboratory tests were unremarkable",
|
| 22 |
+
"CT of the paranasal sinuses conducted using coronal and axial imaging planes",
|
| 23 |
+
"3-mm free bone fragment seen at the junction of the previous lateral and medial osteotomy lines on the left side"
|
| 24 |
+
],
|
| 25 |
+
"management": [
|
| 26 |
+
"removal of the mass planned using a minimally invasive endonasal endoscopic approach (EEA)",
|
| 27 |
+
"infiltration anesthesia administered externally around the mass",
|
| 28 |
+
"infiltration anesthesia administered internally at the caudal end of the left nasal bone",
|
| 29 |
+
"1 mL of 20 mg of lidocaine hydrochloride administered",
|
| 30 |
+
"0.0125 mg of epinephrine administered",
|
| 31 |
+
"ENT endoscope of 0°, 4 × 175 mm used for the procedure",
|
| 32 |
+
"mucosal incision approximately 1 cm long made along the caudal border of the left nasal bone",
|
| 33 |
+
"tunnel created approximately 1 cm wide in a vertical plane",
|
| 34 |
+
"hemostasis achieved using gauze pads soaked in 1 mg/10 mL (1:10,000) epinephrine",
|
| 35 |
+
"bone fragment extracted under endoscopic visualization using otologic alligator forceps",
|
| 36 |
+
"incision site left unsutured",
|
| 37 |
+
"operation completed without complications"
|
| 38 |
+
],
|
| 39 |
+
"outcome": [
|
| 40 |
+
"patient did not develop complications during the 13-month follow-up"
|
| 41 |
+
]
|
| 42 |
+
}
|
atoms/PMC12870944_atoms.json
ADDED
|
@@ -0,0 +1,82 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"21-year-old female",
|
| 4 |
+
"North Sumatran",
|
| 5 |
+
"History of shortness of breath 2 weeks prior to admission",
|
| 6 |
+
"Complaint worsened 1 week prior to admission",
|
| 7 |
+
"No history of hypertension",
|
| 8 |
+
"No history of diabetes mellitus",
|
| 9 |
+
"No history of heart disease",
|
| 10 |
+
"No family history of SLE",
|
| 11 |
+
"History of systemic lupus erythematosus (SLE)",
|
| 12 |
+
"SLE treated with corticosteroids at regional lung hospital 1 week prior",
|
| 13 |
+
"Hospitalized for 5 days at regional lung hospital"
|
| 14 |
+
],
|
| 15 |
+
"presentation": [
|
| 16 |
+
"Shortness of breath",
|
| 17 |
+
"Swelling in both legs",
|
| 18 |
+
"No history of fever",
|
| 19 |
+
"No history of cough",
|
| 20 |
+
"No history of respiratory wheezes",
|
| 21 |
+
"Fully conscious",
|
| 22 |
+
"Blood pressure 118/87 mmHg",
|
| 23 |
+
"Pulse rate 81 x/minute",
|
| 24 |
+
"Respiratory rate 26 x/minute",
|
| 25 |
+
"Blood oxygen saturation 88% with 15 L per minute of oxygen through a nonrebreathing mask",
|
| 26 |
+
"Dullness on percussion over lower two-third of lung area",
|
| 27 |
+
"Diminished breath sounds over lower two-third of lung area",
|
| 28 |
+
"Rhonchi on auscultation over lower two-third of lung area"
|
| 29 |
+
],
|
| 30 |
+
"diagnostics": [
|
| 31 |
+
"Hemoglobin level 13.6 g/dL",
|
| 32 |
+
"Hematocrit 41.1%",
|
| 33 |
+
"Leukocyte count 9.490 cells/mm3",
|
| 34 |
+
"Thrombocyte count 470.000 platelets/µl",
|
| 35 |
+
"Albumin level 2.7 g/dL",
|
| 36 |
+
"Ureum level 34.9 mg/dL",
|
| 37 |
+
"Creatinine level 0.51 mg/dL",
|
| 38 |
+
"Sodium level 140 mEq/L",
|
| 39 |
+
"Potassium level 3.9 mEq/L",
|
| 40 |
+
"Random blood sugar level 89 mg/dL",
|
| 41 |
+
"Blood gas pH 7.358",
|
| 42 |
+
"Blood gas pCO2 50.5",
|
| 43 |
+
"Blood gas pO2 68.8",
|
| 44 |
+
"Blood gas HCO3 28.7",
|
| 45 |
+
"Blood gas BE 3.1",
|
| 46 |
+
"Blood gas SaO2 91.9",
|
| 47 |
+
"Chest X-ray pleural effusion in both lungs",
|
| 48 |
+
"Thoracotomy performed",
|
| 49 |
+
"Chylous pleural fluid evacuated from both hemithoraxes",
|
| 50 |
+
"Initial chylous drainage 600 mL/24 h from each tube",
|
| 51 |
+
"No air bubbles observed in drain system",
|
| 52 |
+
"Respiratory fluctuation positive",
|
| 53 |
+
"Pleural fluid Rivalta positive",
|
| 54 |
+
"Pleural fluid lactate dehydrogenase 45.0 U/L",
|
| 55 |
+
"Pleural fluid glucose 91 mg/dL",
|
| 56 |
+
"Pleural fluid protein 2.900 mg/L",
|
| 57 |
+
"Pleural fluid albumin 1.400 mg/L",
|
| 58 |
+
"Pleural fluid cell count 77 cells/µL",
|
| 59 |
+
"Pleural fluid triglyceride 610 mg/dL",
|
| 60 |
+
"Blood smear demonstrated microfilariae consistent with Brugia malayi",
|
| 61 |
+
"PCR detected Brugia malayi DNA",
|
| 62 |
+
"No serologic (ELISA) or rapid antigen tests performed"
|
| 63 |
+
],
|
| 64 |
+
"management": [
|
| 65 |
+
"Nebulized salbutamol q8h",
|
| 66 |
+
"N-acetylcysteine 400 mg three times a day",
|
| 67 |
+
"Methylprednisolone 16 mg three times a day for 5 days",
|
| 68 |
+
"Albendazole 400 mg single dose",
|
| 69 |
+
"Diethylcarbamazine 350 mg single dose",
|
| 70 |
+
"Medium-chain triglyceride (MCT) diet of 1,500 kcal/day",
|
| 71 |
+
"Admitted to Physical Medicine and Rehabilitation (PMR) department for chest physiotherapy"
|
| 72 |
+
],
|
| 73 |
+
"outcome": [
|
| 74 |
+
"Follow up on day 5",
|
| 75 |
+
"Favorable response",
|
| 76 |
+
"Chylous drainage decreased to 100 mL/24 h",
|
| 77 |
+
"Complaint of shortness of breath subsided",
|
| 78 |
+
"Blood oxygen saturation improved to 99% on 3 L per minute of oxygen",
|
| 79 |
+
"Rhonchi no longer observed on both lung fields",
|
| 80 |
+
"Chest X-ray showed slight decrease in opacification of both lungs"
|
| 81 |
+
]
|
| 82 |
+
}
|
atoms/PMC12871403_atoms.json
ADDED
|
@@ -0,0 +1,116 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"15-year-old female",
|
| 4 |
+
"healthy girl"
|
| 5 |
+
],
|
| 6 |
+
"presentation": [
|
| 7 |
+
"2 years of persistent right anterior knee pain",
|
| 8 |
+
"varus-hyperextension gait pattern",
|
| 9 |
+
"audible clunk during ambulation mimicking knee subluxation",
|
| 10 |
+
"significant functional limitations during ambulation",
|
| 11 |
+
"no longer able to play sports",
|
| 12 |
+
"denied any trauma or identifiable trigger",
|
| 13 |
+
"failed conservative management with physiotherapy",
|
| 14 |
+
"failed conservative management with knee brace",
|
| 15 |
+
"referred to multiple orthopedic surgeons",
|
| 16 |
+
"right squinting patella",
|
| 17 |
+
"right hip internal rotation 85°",
|
| 18 |
+
"right hip external rotation 30°",
|
| 19 |
+
"bimalleolar axis knee flexed 90° 32° external",
|
| 20 |
+
"foot progression angle 0°",
|
| 21 |
+
"varus thrust noted on right side during ambulation",
|
| 22 |
+
"10 to 15° of knee hyperextension noted on right side during ambulation"
|
| 23 |
+
],
|
| 24 |
+
"diagnostics": [
|
| 25 |
+
"Magnetic resonance imaging (MRI) of right knee failed to reveal any ligamentous laxity or intra-articular pathology",
|
| 26 |
+
"Initial plain radiography of right knee revealed normal coronal alignment",
|
| 27 |
+
"Valgus stress radiographs demonstrated a normal right lateral distal femoral angle",
|
| 28 |
+
"CT lower limb rotational profile revealed significantly increased right femoral anteversion 44.4°",
|
| 29 |
+
"CT lower limb rotational profile revealed significantly increased right tibial external torsion 35.2°",
|
| 30 |
+
"EOS revealed increased right femoral torsion 38°",
|
| 31 |
+
"EOS revealed increased right tibial torsion 29°",
|
| 32 |
+
"Thigh foot axis 45°",
|
| 33 |
+
"Hip internal rotation 85°",
|
| 34 |
+
"Hip external rotation 30°",
|
| 35 |
+
"Foot progression angle 0°",
|
| 36 |
+
"Bimalleolar axis knee flexed 90° 32° externally",
|
| 37 |
+
"CT femoral anteversion 44.4°",
|
| 38 |
+
"CT tibial torsion 35.2°",
|
| 39 |
+
"CT TT-TTG distance 15.1 mm",
|
| 40 |
+
"CT trochlear/sulcus angle 151°",
|
| 41 |
+
"EOS femoral torsion pre-op 38°",
|
| 42 |
+
"EOS tibial torsion pre-op 29°",
|
| 43 |
+
"EOS femorotibial rotation pre-op 19°",
|
| 44 |
+
"EOS femur length pre-op 39.8 cm",
|
| 45 |
+
"EOS tibia length pre-op 34.0 cm",
|
| 46 |
+
"EOS functional length pre-op 74.2 cm",
|
| 47 |
+
"EOS anatomical length pre-op 73.8 cm",
|
| 48 |
+
"EOS femoral head diameter pre-op 37 mm",
|
| 49 |
+
"EOS neck length pre-op 50 mm",
|
| 50 |
+
"EOS neck shaft angle pre-op 131°",
|
| 51 |
+
"EOS femoral offset pre-op 38 mm",
|
| 52 |
+
"EOS valgus/varus pre-op Valgus 2°",
|
| 53 |
+
"EOS knee flexion/extension pre-op Extension 7°",
|
| 54 |
+
"EOS HKS pre-op 4°",
|
| 55 |
+
"EOS femoral mechanical angle pre-op 94°",
|
| 56 |
+
"EOS tibial mechanical angle pre-op 93°"
|
| 57 |
+
],
|
| 58 |
+
"management": [
|
| 59 |
+
"physiotherapy undergone",
|
| 60 |
+
"knee brace used",
|
| 61 |
+
"percutaneous torsional osteotomies of the right femur and tibia",
|
| 62 |
+
"distal femoral segment rotated 25˚externally",
|
| 63 |
+
"distal tibial segment internally rotated by 25°",
|
| 64 |
+
"Intramedullary rods inserted into both bones",
|
| 65 |
+
"Postoperative care included pain management",
|
| 66 |
+
"Postoperative care included full weight-bearing",
|
| 67 |
+
"Postoperative care included rehabilitation plan"
|
| 68 |
+
],
|
| 69 |
+
"outcome": [
|
| 70 |
+
"At 2 years postoperatively, right knee pain and subluxation had resolved",
|
| 71 |
+
"patient ambulated with a FPA of 5° external",
|
| 72 |
+
"Right hip IR decreased by 25°",
|
| 73 |
+
"Right hip ER increased by 40°",
|
| 74 |
+
"Bimalleolar axis decreased by 17° externally",
|
| 75 |
+
"Pedi-International Knee Documentation Committee score improved from 73.9/100 to 89/100",
|
| 76 |
+
"Pediatric Outcomes Data Collection Instrument (PODCI) score increased across 5 categories",
|
| 77 |
+
"Functional Activity Questionnaire improved from 28/88 to 23/88",
|
| 78 |
+
"patient reported that she had resumed her functional activities 315 days postsurgery",
|
| 79 |
+
"EOS imaging (425 days postoperatively) revealed a decrease of 15° for right femoral torsion",
|
| 80 |
+
"EOS imaging (425 days postoperatively) revealed a decrease of 13° for external tibial torsion",
|
| 81 |
+
"Postoperative gait analysis was performed 762 days (over 2 years) after surgery",
|
| 82 |
+
"preoperative abnormal right knee varus normalized during stance phase",
|
| 83 |
+
"preoperative abnormal right knee hyperextension normalized during stance phase",
|
| 84 |
+
"preoperative abnormal right knee ER normalized during stance phase",
|
| 85 |
+
"Right hip abduction and knee valgus moments normalized",
|
| 86 |
+
"Postoperative hip internal rotation 60°",
|
| 87 |
+
"Postoperative hip external rotation 70°",
|
| 88 |
+
"Postoperative knee flexion (prone) 145°",
|
| 89 |
+
"Postoperative knee flexion (supine) 145°",
|
| 90 |
+
"Postoperative knee extension 9°",
|
| 91 |
+
"Postoperative Bimalleolar axis knee flexed 90° 15° externally",
|
| 92 |
+
"Postoperative Bimalleolar axis knee extended VICON 18° externally",
|
| 93 |
+
"EOS imaging (425 days postoperatively) revealed normalized femoral version",
|
| 94 |
+
"EOS imaging (425 days postoperatively) revealed decreased right femoral torsion 23°",
|
| 95 |
+
"EOS imaging (425 days postoperatively) revealed decreased right tibial torsion 16°",
|
| 96 |
+
"Postoperative femur length 40.1 cm",
|
| 97 |
+
"Postoperative tibia length 34.2 cm",
|
| 98 |
+
"Postoperative functional length 74.6 cm",
|
| 99 |
+
"Postoperative anatomical length 74.3 cm",
|
| 100 |
+
"Postoperative femoral head diameter 37 mm",
|
| 101 |
+
"Postoperative neck length 49 mm",
|
| 102 |
+
"Postoperative neck shaft angle 133°",
|
| 103 |
+
"Postoperative femoral offset 37 mm",
|
| 104 |
+
"Postoperative valgus/varus Valgus 4°",
|
| 105 |
+
"Postoperative knee flexion/extension Extension 7°",
|
| 106 |
+
"Postoperative HKS 2°",
|
| 107 |
+
"Postoperative femoral mechanical angle 95°",
|
| 108 |
+
"Postoperative tibial mechanical angle 94°",
|
| 109 |
+
"Postoperative PODCI Upper Function 100",
|
| 110 |
+
"Postoperative PODCI Transfer Mobile 100",
|
| 111 |
+
"Postoperative PODCI Sport 85",
|
| 112 |
+
"Postoperative PODCI Comfort 83",
|
| 113 |
+
"Postoperative PODCI Global Function 92",
|
| 114 |
+
"Postoperative PODCI Happiness 90"
|
| 115 |
+
]
|
| 116 |
+
}
|
atoms/PMC12872036_atoms.json
ADDED
|
@@ -0,0 +1,45 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"47-year-old woman",
|
| 4 |
+
"Persistent atrial fibrillation",
|
| 5 |
+
"No major cardiovascular history"
|
| 6 |
+
],
|
| 7 |
+
"presentation": [
|
| 8 |
+
"Scheduled for point-by-point pulmonary vein isolation under general anesthesia",
|
| 9 |
+
"Left-sided ablation completed",
|
| 10 |
+
"Right-sided access initiated",
|
| 11 |
+
"Developed hypotension",
|
| 12 |
+
"Developed tachycardia (130 bpm)",
|
| 13 |
+
"Indicating hypoperfusion"
|
| 14 |
+
],
|
| 15 |
+
"diagnostics": [
|
| 16 |
+
"Emergency coronary angiography performed via right femoral artery access",
|
| 17 |
+
"6 Fr introducer",
|
| 18 |
+
"5 Fr TIG 3.5 diagnostic catheter",
|
| 19 |
+
"No coronary flow (TIMI 0) observed in the mid–LAD artery",
|
| 20 |
+
"6 Fr JL 3.5 guiding catheter used to cannulate left main coronary artery",
|
| 21 |
+
"0.014” × 180 cm Runthrough NS floppy intracoronary guidewire advanced into LAD",
|
| 22 |
+
"TIMI 3 coronary flow",
|
| 23 |
+
"Subsequent echocardiogram revealed global right ventricular hypokinesia",
|
| 24 |
+
"Echocardiogram revealed anterolateral and inferoseptal wall motion abnormalities",
|
| 25 |
+
"Repeat coronary angiography at 24 h ruled out recurrent embolic events or underlying coronary lesions",
|
| 26 |
+
"Cranial CT scan revealed a left parietal cerebrovascular disease"
|
| 27 |
+
],
|
| 28 |
+
"management": [
|
| 29 |
+
"Procedure discontinued before completing right pulmonary vein ablation",
|
| 30 |
+
"Mechanical flushing with saline to ensure complete de-airing",
|
| 31 |
+
"400 mcg of intracoronary adenosine administered",
|
| 32 |
+
"Transferred to coronary care unit",
|
| 33 |
+
"High-dose vasopressors",
|
| 34 |
+
"Inotropes",
|
| 35 |
+
"Intra-aortic balloon pump support",
|
| 36 |
+
"Venoarterial ECMO",
|
| 37 |
+
"ECMO and balloon pump weaning"
|
| 38 |
+
],
|
| 39 |
+
"outcome": [
|
| 40 |
+
"Native cardiac output improved after 48 h",
|
| 41 |
+
"Successful ECMO and balloon pump weaning without complications",
|
| 42 |
+
"Discharged 1 week after the index event",
|
| 43 |
+
"Developed right hemifacial and hemibody hemiplegia"
|
| 44 |
+
]
|
| 45 |
+
}
|
atoms/PMC12875340_atoms.json
ADDED
|
@@ -0,0 +1,41 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Female infant",
|
| 4 |
+
"Gestation: 38 weeks",
|
| 5 |
+
"Delivery: Spontaneous vaginal",
|
| 6 |
+
"Admitted to neonatal intensive care unit"
|
| 7 |
+
],
|
| 8 |
+
"presentation": [
|
| 9 |
+
"Vaginal bulge noticed shortly after birth",
|
| 10 |
+
"Progressive abdominal enlargement on third day of life",
|
| 11 |
+
"Abdominal mass identified by local doctor",
|
| 12 |
+
"Clinical assessment consistent with hydrocolpos",
|
| 13 |
+
"Pediatric surgery consultation confirmed imperforate hymen",
|
| 14 |
+
"Severe hydrocolpos extending above the umbilicus",
|
| 15 |
+
"Severe diaper dermatitis"
|
| 16 |
+
],
|
| 17 |
+
"diagnostics": [
|
| 18 |
+
"CT scan: large homogeneous abdominopelvic cyst",
|
| 19 |
+
"CT scan: cyst compressing surrounding organs",
|
| 20 |
+
"CT scan: cyst extending caudally toward the vagina",
|
| 21 |
+
"CT scan: marked left hydronephrosis",
|
| 22 |
+
"CT scan: mild right hydronephrosis",
|
| 23 |
+
"CT scan: preserved renal function",
|
| 24 |
+
"WBC: 16.5 (×109/L)",
|
| 25 |
+
"Hemoglobin: 15 (g/dL)",
|
| 26 |
+
"Platelets: 423 (×109/L)",
|
| 27 |
+
"GPT / ALT: 15 (U/L)",
|
| 28 |
+
"Urea: 15 (mg/dL)",
|
| 29 |
+
"Creatinine: 0.3 (mg/dL)"
|
| 30 |
+
],
|
| 31 |
+
"management": [
|
| 32 |
+
"Hymenal incision performed",
|
| 33 |
+
"Drainage of turbid uterine secretions"
|
| 34 |
+
],
|
| 35 |
+
"outcome": [
|
| 36 |
+
"Postoperatively, abdominal distension resolved",
|
| 37 |
+
"Hydrocolpos significantly decreased",
|
| 38 |
+
"Clear clinical improvement on follow-up",
|
| 39 |
+
"Repeat ultrasound confirmed complete resolution of fluid collection"
|
| 40 |
+
]
|
| 41 |
+
}
|
atoms/PMC12875659_atoms.json
ADDED
|
@@ -0,0 +1,76 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"33-year-old male at initial presentation",
|
| 4 |
+
"No significant past medical history"
|
| 5 |
+
],
|
| 6 |
+
"presentation": [
|
| 7 |
+
"Right ophthalmalgia",
|
| 8 |
+
"Blurry vision",
|
| 9 |
+
"Sinus congestion",
|
| 10 |
+
"Amelanotic right choroidal lesion measuring 1.04 x 1.15 x 0.31 cm",
|
| 11 |
+
"20/20 vision bilaterally",
|
| 12 |
+
"Full visual fields bilaterally",
|
| 13 |
+
"Enhancing plaque along posterior-lateral wall of right globe on MRI Orbit",
|
| 14 |
+
"Right middle lobe (RML) nodule measuring 0.5 cm on CT Chest",
|
| 15 |
+
"Right upper lobe (RUL) nodule measuring 0.2 cm on CT Chest",
|
| 16 |
+
"Scant atypical cells with neuroendocrine-like nuclear features on right intraophthalmic choroidal biopsy",
|
| 17 |
+
"Non-avid RML nodule on DOTATATE PET",
|
| 18 |
+
"RUL nodule measuring 0.2 cm on DOTATATE PET",
|
| 19 |
+
"Mildly avid left iliac crest lesion measuring 1 cm on DOTATATE PET",
|
| 20 |
+
"Right choroidal FNA read as metastatic carcinoma compatible with pulmonary adenocarcinoma",
|
| 21 |
+
"Histology positive for CK7 and TTF1",
|
| 22 |
+
"Histology negative for PD-L1, thyroglobulin, PAX8, CD3, Melan-A",
|
| 23 |
+
"CK20 weakly focally positive",
|
| 24 |
+
"Synaptophysin highlighted pieces of retina but not the tumor",
|
| 25 |
+
"No actionable mutation in EGFR, KRAS, BRAF, or HER2",
|
| 26 |
+
"ALK, RET, ROS1, NTRK1/3, and MET testing inconclusive due to insufficient sample",
|
| 27 |
+
"Left iliac biopsy read as carcinoma showing CK7 and TTF1 positivity",
|
| 28 |
+
"Mediastinal lymph node (4R) FNA biopsy read as carcinoma showing CK7 and TTF1 positivity",
|
| 29 |
+
"IHC analysis negative for EGFR, ALK, ROS, and BRAF driver mutations",
|
| 30 |
+
"No PD-L1 expression (0%) observed",
|
| 31 |
+
"Multidisciplinary tumor board determination: metastatic adenocarcinoma of unknown primary, most likely pulmonary origin",
|
| 32 |
+
"Rib pain",
|
| 33 |
+
"New lesion in left 4th rib on PET/CT",
|
| 34 |
+
"New lesion in right lower lobe (RLL) on PET/CT",
|
| 35 |
+
"Increase in additional right pulmonary nodules on PET/CT",
|
| 36 |
+
"New left frontal gyrus lesion on MRI Brain",
|
| 37 |
+
"Right optic nerve enhancement on MRI orbit (Day 1123)",
|
| 38 |
+
"Blindness in right eye after initial treatment",
|
| 39 |
+
"20/20 vision in left eye"
|
| 40 |
+
],
|
| 41 |
+
"diagnostics": [
|
| 42 |
+
"Right intraophthalmic choroidal biopsy performed on Day 44",
|
| 43 |
+
"DOTATATE PET performed on Day 64 showing SUV 2.6 and Krenning 1 in right globe mass",
|
| 44 |
+
"Right choroidal fine-needle aspiration (FNA) performed on Day 69",
|
| 45 |
+
"Left iliac biopsy performed on Day 113",
|
| 46 |
+
"Mediastinal lymph node (4R) FNA biopsy performed on Day 114",
|
| 47 |
+
"PET/CT performed on Day 293 showing new lesion in left 4th rib and RLL",
|
| 48 |
+
"MRI Brain performed on Day 324 showing new left frontal gyrus lesion",
|
| 49 |
+
"MRI orbit performed on Day 1123 showing right optic nerve enhancement",
|
| 50 |
+
"Scans as of Day 1563 show no evidence of recurrence"
|
| 51 |
+
],
|
| 52 |
+
"management": [
|
| 53 |
+
"Started carboplatin, paclitaxel, and pembrolizumab on Day 125 for 4 cycles",
|
| 54 |
+
"Pembrolizumab continued as maintenance after cycle 4",
|
| 55 |
+
"Stereotactic radiosurgery (SRS) to right orbit lesion on Day 173 (36 Gy in 4 fractions)",
|
| 56 |
+
"Radiation to left iliac on Day 252 (50 Gy in 5 fractions)",
|
| 57 |
+
"Radiation to RML on Day 252 (50 Gy in 5 fractions)",
|
| 58 |
+
"Radiation to mediastinal nodes on Day 273 (40 Gy in 10 fractions)",
|
| 59 |
+
"Radiation to left chest wall on Day 313 (50 Gy in 5 fractions)",
|
| 60 |
+
"Radiation to left frontal operculum on Day 337 (1 fraction)",
|
| 61 |
+
"Pembrolizumab stopped on Day 315 due to radiographic progression",
|
| 62 |
+
"Started carboplatin, pemetrexed, and bevacizumab on Day 344 for 4 cycles",
|
| 63 |
+
"Pemetrexed and bevacizumab continued as maintenance after cycle 4",
|
| 64 |
+
"Pemetrexed and bevacizumab held after 14 cycles (last dose Day 743) in preparation for cataract removal",
|
| 65 |
+
"One dose of intraocular bevacizumab injection administered for eye pain",
|
| 66 |
+
"Surveillance with MRI Brain and PET imaging every 3 months"
|
| 67 |
+
],
|
| 68 |
+
"outcome": [
|
| 69 |
+
"Clinical and radiographic progression at ribs and lungs as well as intracranial site on Day 293-324",
|
| 70 |
+
"Eye pain completely resolved after intraocular bevacizumab injection",
|
| 71 |
+
"Remained with 20/20 vision in left eye",
|
| 72 |
+
"Maintained employment",
|
| 73 |
+
"Continues with regular follow-up and surveillance imaging every 3 months",
|
| 74 |
+
"No clinical or radiographic evidence of disease progression as of Day 1563"
|
| 75 |
+
]
|
| 76 |
+
}
|
atoms/PMC12875833_atoms.json
ADDED
|
@@ -0,0 +1,86 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"32-year-old woman",
|
| 4 |
+
"10-year history of type 2 diabetes mellitus",
|
| 5 |
+
"History of arterial hypertension"
|
| 6 |
+
],
|
| 7 |
+
"presentation": [
|
| 8 |
+
"15-day history of right facial pain",
|
| 9 |
+
"15-day history of dysphagia",
|
| 10 |
+
"15-day history of intermittent fever",
|
| 11 |
+
"15-day history of progressive right-sided neck swelling",
|
| 12 |
+
"Swelling evolved into tender, erythematous, warm mass extending from mandibular border to thyroid cartilage",
|
| 13 |
+
"Trismus",
|
| 14 |
+
"Increasing discomfort",
|
| 15 |
+
"Worsening dyspnea three days before admission",
|
| 16 |
+
"Pleuritic right-sided chest pain three days before admission",
|
| 17 |
+
"On arrival: febrile (38.5°C)",
|
| 18 |
+
"On arrival: tachycardic (130 bpm)",
|
| 19 |
+
"On arrival: tachypneic (36 breaths/min)",
|
| 20 |
+
"On arrival: hypoxemic (oxygen saturation 84% on room air)",
|
| 21 |
+
"Physical examination: facial asymmetry",
|
| 22 |
+
"Physical examination: multiple dental foci of infection",
|
| 23 |
+
"Physical examination: firm, tender cervical mass involving levels III–IV",
|
| 24 |
+
"Physical examination: overlying erythema and warmth on cervical mass",
|
| 25 |
+
"Respiratory assessment: use of accessory muscles",
|
| 26 |
+
"Respiratory assessment: bilateral basal crackles"
|
| 27 |
+
],
|
| 28 |
+
"diagnostics": [
|
| 29 |
+
"Random blood glucose 356 mg/dL on admission",
|
| 30 |
+
"Glycated hemoglobin (HbA1c) 10.8%",
|
| 31 |
+
"Arterial blood gas PaO2 56 mmHg on room air",
|
| 32 |
+
"Arterial blood gas FiO2 0.21",
|
| 33 |
+
"Arterial blood gas PaCO2 34 mmHg",
|
| 34 |
+
"Arterial blood gas SaO2 84%",
|
| 35 |
+
"Arterial blood gas PaO2/FiO2 ratio 267",
|
| 36 |
+
"Hemoglobin 14.1 g/dL",
|
| 37 |
+
"Platelet count 117 × 103 /mL",
|
| 38 |
+
"White blood cell count 20.9 × 103 /mL",
|
| 39 |
+
"Neutrophils 19.6 × 103 /mL",
|
| 40 |
+
"C-reactive protein 115 mg/L",
|
| 41 |
+
"Total bilirubin 1.2 mg/dL",
|
| 42 |
+
"Lactate dehydrogenase 300 U/L",
|
| 43 |
+
"Serum creatinine 1.3 mg/dL",
|
| 44 |
+
"Procalcitonin 11.6 ng/mL",
|
| 45 |
+
"SOFA score 7",
|
| 46 |
+
"APACHE II score 14",
|
| 47 |
+
"Two sets of blood cultures obtained at admission prior to antimicrobial therapy",
|
| 48 |
+
"Blood cultures remained negative after standard incubation",
|
| 49 |
+
"Microbiological cultures from surgical drainage yielded Klebsiella pneumoniae",
|
| 50 |
+
"Antimicrobial susceptibility testing demonstrated wild-type susceptibility profile",
|
| 51 |
+
"No extended-spectrum β-lactamase production detected",
|
| 52 |
+
"Cervical ultrasonography: thrombosis of the right internal jugular vein",
|
| 53 |
+
"Cervical ultrasonography: 21 mL cervical abscess",
|
| 54 |
+
"Chest computed tomography: multiple peripheral cavitary nodules",
|
| 55 |
+
"Cranial CT: excluded intracranial extension or venous sinus thrombosis"
|
| 56 |
+
],
|
| 57 |
+
"management": [
|
| 58 |
+
"Intensive insulin therapy initiated during hospitalization",
|
| 59 |
+
"Patient intubated and placed on invasive mechanical ventilation",
|
| 60 |
+
"Surgical extraction of infected teeth",
|
| 61 |
+
"Drainage of cervical abscess under general anesthesia",
|
| 62 |
+
"Empiric therapy with imipenem and vancomycin initiated",
|
| 63 |
+
"Vancomycin discontinued after microbiological confirmation",
|
| 64 |
+
"Carbapenem therapy limited to 4 days",
|
| 65 |
+
"Targeted treatment with ceftriaxone and metronidazole",
|
| 66 |
+
"Therapeutic anticoagulation with enoxaparin administered for internal jugular vein thrombosis",
|
| 67 |
+
"Discharged on oral amoxicillin–clavulanate",
|
| 68 |
+
"Anticoagulation planned for a total duration of 3 months"
|
| 69 |
+
],
|
| 70 |
+
"outcome": [
|
| 71 |
+
"Metabolic stabilization without hypoglycemic events",
|
| 72 |
+
"Patient became afebrile and normoxemic",
|
| 73 |
+
"Successfully extubated on day seven",
|
| 74 |
+
"Platelet recovery by day five",
|
| 75 |
+
"Discharged on oral amoxicillin–clavulanate",
|
| 76 |
+
"At 2 weeks postoperatively: partial recanalization of the right internal jugular vein",
|
| 77 |
+
"At 2 weeks postoperatively: near-complete resolution of the cervical abscess",
|
| 78 |
+
"At one-month follow-up chest CT: complete resolution of cavitary pulmonary lesions",
|
| 79 |
+
"Completed 14-day course of intravenous antibiotics followed by 7-day oral regimen",
|
| 80 |
+
"At six-week outpatient evaluation: asymptomatic",
|
| 81 |
+
"At six-week outpatient evaluation: normalized inflammatory markers",
|
| 82 |
+
"At six-week outpatient evaluation: no evidence of recurrent infection, thrombosis, or respiratory impairment",
|
| 83 |
+
"Fully returned to baseline functional status",
|
| 84 |
+
"Overall prognosis was favorable"
|
| 85 |
+
]
|
| 86 |
+
}
|
atoms/PMC12875838_atoms.json
ADDED
|
@@ -0,0 +1,49 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"65-year-old woman",
|
| 4 |
+
"Newly diagnosed with CVID",
|
| 5 |
+
"Trough immunoglobulin G [IgG], 235 mg/dL"
|
| 6 |
+
],
|
| 7 |
+
"presentation": [
|
| 8 |
+
"Presented in emergency department with nerve pain",
|
| 9 |
+
"Presented in emergency department with severe itching",
|
| 10 |
+
"Presented in emergency department with rash",
|
| 11 |
+
"Presented in emergency department with tachycardia",
|
| 12 |
+
"Presented in emergency department with hypertension",
|
| 13 |
+
"Diagnosed with red man syndrome",
|
| 14 |
+
"Experienced severe neuropathy within 2 h post-treatment",
|
| 15 |
+
"Neuropathy described as burning/pins-and-needles sensation in the extremities",
|
| 16 |
+
"Experienced muscle twitching",
|
| 17 |
+
"Neuropathy and muscle twitching lasted for several days post-treatment",
|
| 18 |
+
"Admitted to intensive care unit for bilateral pneumonia",
|
| 19 |
+
"Admitted to intensive care unit for sepsis",
|
| 20 |
+
"Did not report experiencing AEs of edema",
|
| 21 |
+
"Did not report experiencing AEs of headache",
|
| 22 |
+
"Did not report experiencing AEs of fatigue",
|
| 23 |
+
"Reported mild nausea",
|
| 24 |
+
"Reported mild fatigue",
|
| 25 |
+
"No symptoms of neuropathy reported after SCIG dose with C1-INH pretreatment"
|
| 26 |
+
],
|
| 27 |
+
"diagnostics": [
|
| 28 |
+
"Trough immunoglobulin G [IgG], 235 mg/dL"
|
| 29 |
+
],
|
| 30 |
+
"management": [
|
| 31 |
+
"Began treatment with 35-g weight-based dose of immune globulin infusion (human), 10% (Gammagard Liquid)",
|
| 32 |
+
"Switched to SCIG (Cuvitru) 10 g once weekly",
|
| 33 |
+
"Health care provider petitioned insurance company for approval of trial of off-label C1-INH replacement therapy",
|
| 34 |
+
"Letter of medical necessity not approved initially",
|
| 35 |
+
"Admitted to intensive care unit",
|
| 36 |
+
"Second request for coverage of trial of C1-INH replacement therapy approved by insurance provider",
|
| 37 |
+
"Single-dose rhC1-INH (Ruconest) 4200 U administered as intravenous injection over approximately 5 min",
|
| 38 |
+
"rhC1-INH administered at 1 h prior to SCIG 1 g on Day 1",
|
| 39 |
+
"SCIG dose 1 g administered on Day 1",
|
| 40 |
+
"SCIG 3 g administered on Days 2 and 3",
|
| 41 |
+
"At-home routine rhC1-INH 4200 U pretreatment (prophylaxis) 1 h prior to SCIG administration",
|
| 42 |
+
"Tolerating recommended dose of SCIG 20 g once weekly with C1-INH pretreatment"
|
| 43 |
+
],
|
| 44 |
+
"outcome": [
|
| 45 |
+
"Neuropathy and muscle twitching lasted for several days post-treatment",
|
| 46 |
+
"Currently tolerating the recommended dose of SCIG 20 g once weekly without the debilitating neuropathy",
|
| 47 |
+
"Currently tolerating the recommended dose of SCIG 20 g once weekly without other AEs previously experienced with SCIG alone"
|
| 48 |
+
]
|
| 49 |
+
}
|
atoms/PMC12875844_atoms.json
ADDED
|
@@ -0,0 +1,54 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"34-year-old male patient",
|
| 4 |
+
"Medically healthy",
|
| 5 |
+
"No systemic disease",
|
| 6 |
+
"No syndromic features commonly associated with multiple supernumerary teeth"
|
| 7 |
+
],
|
| 8 |
+
"presentation": [
|
| 9 |
+
"Presented seeking correction of malocclusion and improvement of dental esthetics",
|
| 10 |
+
"Intraoral clinical examination revealed presence of four bilaterally symmetrical maxillary lateral incisors",
|
| 11 |
+
"Occlusal analysis demonstrated anterior open bite",
|
| 12 |
+
"Occlusal analysis demonstrated posterior crossbite involving the premolar region",
|
| 13 |
+
"Moderate crowding observed in the maxillary arch",
|
| 14 |
+
"Mandibular arch exhibited mild crowding",
|
| 15 |
+
"Lateral cephalometric radiograph obtained"
|
| 16 |
+
],
|
| 17 |
+
"diagnostics": [
|
| 18 |
+
"Panoramic radiographic evaluation confirmed presence of supernumerary maxillary lateral incisors with independent crowns",
|
| 19 |
+
"Panoramic radiographic evaluation confirmed fully developed roots",
|
| 20 |
+
"Panoramic radiographic evaluation excluded dental anomalies such as gemination or fusion"
|
| 21 |
+
],
|
| 22 |
+
"management": [
|
| 23 |
+
"Orthodontic treatment initiated",
|
| 24 |
+
"Combined approach of transverse expansion and comprehensive fixed mechanotherapy",
|
| 25 |
+
"W-arch appliance placed in the maxilla",
|
| 26 |
+
"Full-arch bonding performed in both arches",
|
| 27 |
+
"0.022-in. MBT prescription brackets placed",
|
| 28 |
+
"Supernumerary maxillary lateral incisors located adjacent to canines extracted",
|
| 29 |
+
"Sequential archwire progression consisting of 0.012-in. nickel–titanium",
|
| 30 |
+
"Sequential archwire progression consisting of 0.016-in. nickel–titanium",
|
| 31 |
+
"Sequential archwire progression consisting of 0.018-in. stainless steel",
|
| 32 |
+
"Sequential archwire progression consisting of 0.016 × 0.022-in. nickel–titanium",
|
| 33 |
+
"Sequential archwire progression consisting of 0.017 × 0.025-in. stainless steel",
|
| 34 |
+
"Space closure performed using sliding mechanics on 0.017 × 0.025-in. stainless steel archwires",
|
| 35 |
+
"Space closure performed using elastomeric chains",
|
| 36 |
+
"Bilateral Class III intermaxillary elastics employed",
|
| 37 |
+
"Retention provided using vacuum‐formed Essix retainers",
|
| 38 |
+
"Retainers fabricated from 0.7‐mm thermoplastic material",
|
| 39 |
+
"Retainers worn full-time for first 4 months",
|
| 40 |
+
"Retainers worn at nighttime thereafter"
|
| 41 |
+
],
|
| 42 |
+
"outcome": [
|
| 43 |
+
"After 18 months of active orthodontic treatment, satisfactory alignment of both arches achieved",
|
| 44 |
+
"Marked improvement in smile esthetics observed",
|
| 45 |
+
"Anterior open bite successfully resolved",
|
| 46 |
+
"Stable bilateral Class I canine relationship established",
|
| 47 |
+
"At 3-month posttreatment follow-up, occlusion remained stable",
|
| 48 |
+
"At 3-month posttreatment follow-up, transverse correction maintained",
|
| 49 |
+
"At 3-month posttreatment follow-up, dental arches well-aligned",
|
| 50 |
+
"Patient referred for esthetic rehabilitation",
|
| 51 |
+
"Patient referred for veneer or laminate restorations for anterior teeth",
|
| 52 |
+
"Patient referred for prosthetic replacement of missing posterior molars"
|
| 53 |
+
]
|
| 54 |
+
}
|
atoms/PMC12875846_atoms.json
ADDED
|
@@ -0,0 +1,72 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Male preterm neonate",
|
| 4 |
+
"34 + 5 weeks of gestation",
|
| 5 |
+
"Bi‐chorionic bi‐amniotic twin pregnancy",
|
| 6 |
+
"Mother 41 years old",
|
| 7 |
+
"Mother no history of diabetes or hypertension",
|
| 8 |
+
"Delivery performed by cesarean section",
|
| 9 |
+
"Delivery indication third‐trimester bleeding",
|
| 10 |
+
"Birth weight 2030 g"
|
| 11 |
+
],
|
| 12 |
+
"presentation": [
|
| 13 |
+
"Day 7 of life erythematous plaques right inguinal region 4 cm × 3 cm",
|
| 14 |
+
"Day 7 of life erythematous plaques scrotum 1.5 × 2 cm",
|
| 15 |
+
"Progression to necrotic plaques with central ulceration and detachment",
|
| 16 |
+
"Plaque surrounded by erythematous halo",
|
| 17 |
+
"Infant remained afebrile",
|
| 18 |
+
"Infant normocardic",
|
| 19 |
+
"Infant hemodynamically stable"
|
| 20 |
+
],
|
| 21 |
+
"diagnostics": [
|
| 22 |
+
"Platelets 62 × 103/mm3",
|
| 23 |
+
"White blood cells 11 × 103/mm3",
|
| 24 |
+
"Neutrophils 5 × 103/mm3",
|
| 25 |
+
"Lymphocytes 4.3 × 103/mm3",
|
| 26 |
+
"C‐reactive protein negative",
|
| 27 |
+
"Ultrasound scrotum and soft tissue infiltration of right thigh",
|
| 28 |
+
"Ultrasound scrotum and soft tissue no abscess formation",
|
| 29 |
+
"Doppler study did not reveal thrombosis",
|
| 30 |
+
"Absence of crepitus",
|
| 31 |
+
"Absence of bullae",
|
| 32 |
+
"Absence of systemic toxicity",
|
| 33 |
+
"Absence of radiological signs of fascial gas",
|
| 34 |
+
"Ultrasound no fascial thickening",
|
| 35 |
+
"Ultrasound no fluid collections",
|
| 36 |
+
"Ultrasound no subcutaneous gas",
|
| 37 |
+
"Culture of cutaneous lesion Klebsiella pneumoniae sensitive to imipenem and amikacin",
|
| 38 |
+
"Culture of cutaneous lesion Enterococcus faecium sensitive to vancomycin",
|
| 39 |
+
"Blood cultures isolated Enterococcus faecium",
|
| 40 |
+
"Urine cultures sterile",
|
| 41 |
+
"TORCH screening normal",
|
| 42 |
+
"Immunoglobulin levels (IgG, IgA, IgM) normal",
|
| 43 |
+
"Oxidative burst testing (DHR) normal",
|
| 44 |
+
"CD4/CD8 lymphocyte subsets normal",
|
| 45 |
+
"CH50 complement assay normal"
|
| 46 |
+
],
|
| 47 |
+
"management": [
|
| 48 |
+
"Admitted for presumed early‐onset neonatal bacterial infection",
|
| 49 |
+
"Received cefotaxime IV for 7 days",
|
| 50 |
+
"Received gentamicin IV for 2 days",
|
| 51 |
+
"Empirical antimicrobial therapy with ceftazidime and amikacin initiated",
|
| 52 |
+
"Antimicrobial regimen combining ceftazidime and amikacin continued",
|
| 53 |
+
"Addition of vancomycin to antimicrobial regimen",
|
| 54 |
+
"Completed 14‐day course of ceftazidime",
|
| 55 |
+
"Completed 3‐day course of amikacin",
|
| 56 |
+
"Completed 10‐day course of vancomycin",
|
| 57 |
+
"Daily wound care performed",
|
| 58 |
+
"Daily dressing changes performed"
|
| 59 |
+
],
|
| 60 |
+
"outcome": [
|
| 61 |
+
"Favorable clinical evolution",
|
| 62 |
+
"Normalization of platelet count",
|
| 63 |
+
"Progressive wound healing",
|
| 64 |
+
"At four‐week follow‐up lesions healed leaving small residual scar",
|
| 65 |
+
"At 1 year lesions showed complete resolution",
|
| 66 |
+
"At 1 year minor residual scar persisted",
|
| 67 |
+
"Child remained clinically well",
|
| 68 |
+
"Normal development",
|
| 69 |
+
"Normal growth",
|
| 70 |
+
"No recurrent infections"
|
| 71 |
+
]
|
| 72 |
+
}
|
atoms/PMC12876038_atoms.json
ADDED
|
@@ -0,0 +1,72 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"37-year-old woman",
|
| 4 |
+
"Demographics: Alhada Armed Forces Hospital, Saudi Arabia",
|
| 5 |
+
"Past medical history: Diabetes mellitus (DM)",
|
| 6 |
+
"Past medical history: Helicobacter pylori infection",
|
| 7 |
+
"Past medical history: Hemorrhoids",
|
| 8 |
+
"No family history of a similar hematologic disorder",
|
| 9 |
+
"DM controlled with insulin therapy",
|
| 10 |
+
"Previously received clarithromycin and amoxicillin for H. pylori eradication",
|
| 11 |
+
"Previously treated with intravenous (IV) iron for iron deficiency anemia"
|
| 12 |
+
],
|
| 13 |
+
"presentation": [
|
| 14 |
+
"Complaints of menorrhagia",
|
| 15 |
+
"Complaints of fatigue",
|
| 16 |
+
"Complaints of extensive bruising",
|
| 17 |
+
"Persistence of symptoms",
|
| 18 |
+
"Severe thrombocytopenia",
|
| 19 |
+
"Subarachnoid hemorrhage (SAH)",
|
| 20 |
+
"Tonic-clonic seizure",
|
| 21 |
+
"Rectal bleeding (20 days post-splenectomy)"
|
| 22 |
+
],
|
| 23 |
+
"diagnostics": [
|
| 24 |
+
"Bone marrow biopsy: megakaryocytic hyperplasia",
|
| 25 |
+
"Bone marrow biopsy: thrombocytopenia consistent with peripheral platelet destruction",
|
| 26 |
+
"Diagnosis: ITP",
|
| 27 |
+
"Antinuclear antibody (ANA) test: positive",
|
| 28 |
+
"Did not meet the full classification criteria for systemic lupus erythematosus (SLE)",
|
| 29 |
+
"Platelet count < 4 × 10^9/L",
|
| 30 |
+
"Platelet count < 10 × 10^9/L (after rituximab trial 7 days)",
|
| 31 |
+
"Platelet count < 10 × 10^9/L (after romiplostim and rituximab course 10 days)",
|
| 32 |
+
"Platelet count: 2 × 10^9/L (after azathioprine trial)",
|
| 33 |
+
"Platelet count: 14 × 10^9/L (at SAH event)",
|
| 34 |
+
"Platelet count: 200–300 × 10^9/L (immediately after splenectomy)",
|
| 35 |
+
"Platelet count: 15 × 10^9/L (20 days after splenectomy)",
|
| 36 |
+
"Complete blood count (CBC) platelet count: 14 × 10^9/L (pre-avatrombopag)",
|
| 37 |
+
"Complete blood count (CBC) platelet count: 72 × 10^9/L (after 9 days avatrombopag)",
|
| 38 |
+
"Nuclear scan: performed to rule out an accessory spleen"
|
| 39 |
+
],
|
| 40 |
+
"management": [
|
| 41 |
+
"High-dose dexamethasone",
|
| 42 |
+
"Intravenous immunoglobulin (IVIG)",
|
| 43 |
+
"Romiplostim 500 mcg",
|
| 44 |
+
"Romiplostim increased to 750 mcg (10 mcg/kg)",
|
| 45 |
+
"Rituximab 625 mg each (four doses)",
|
| 46 |
+
"Eltrombopag 25 mg daily",
|
| 47 |
+
"Eltrombopag increased to 50 mg daily",
|
| 48 |
+
"Combination therapy rituximab trial 7 days",
|
| 49 |
+
"Combination therapy romiplostim and rituximab (10 days total)",
|
| 50 |
+
"Azathioprine 100 mg daily",
|
| 51 |
+
"Dapsone 100 mg daily",
|
| 52 |
+
"Cyclosporine 50 mg daily",
|
| 53 |
+
"Vincristine 1 mg",
|
| 54 |
+
"Open splenectomy planned",
|
| 55 |
+
"Platelet transfusion (six platelet units)",
|
| 56 |
+
"IVIG 40 g",
|
| 57 |
+
"Tranexamic acid 1500 mg IV",
|
| 58 |
+
"High-dose methylprednisolone 1000 mg IV once daily for two days",
|
| 59 |
+
"Open splenectomy successfully performed",
|
| 60 |
+
"Oral prednisolone 20 mg daily",
|
| 61 |
+
"Avatrombopag 20 mg daily"
|
| 62 |
+
],
|
| 63 |
+
"outcome": [
|
| 64 |
+
"Combination therapy discontinued due to lack of efficacy",
|
| 65 |
+
"Combination therapy discontinued due to lack of efficacy (romiplostim and rituximab)",
|
| 66 |
+
"Azathioprine discontinued due to persistent thrombocytopenia",
|
| 67 |
+
"Prednisolone gradually tapered and discontinued",
|
| 68 |
+
"Outpatient follow-up: no new bleeding symptoms or adverse effects",
|
| 69 |
+
"Stable platelet counts without bleeding episodes at latest follow-up",
|
| 70 |
+
"Remains clinically stable on weekly avatrombopag regimen"
|
| 71 |
+
]
|
| 72 |
+
}
|
atoms/PMC12876632_atoms.json
ADDED
|
@@ -0,0 +1,60 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Woman in early 40s",
|
| 4 |
+
"Presented December 2024",
|
| 5 |
+
"Beijing Shunyi District Maternal and Child Health Hospital",
|
| 6 |
+
"2-month history of menstrual irregularities",
|
| 7 |
+
"Laparoscopic myomectomy (2011)",
|
| 8 |
+
"Cesarean section (2012)",
|
| 9 |
+
"Cesarean section (2017)",
|
| 10 |
+
"Completed family planning",
|
| 11 |
+
"Requested definitive therapy"
|
| 12 |
+
],
|
| 13 |
+
"presentation": [
|
| 14 |
+
"Palpable pelvic mass",
|
| 15 |
+
"Myoma-like mass in left vaginal fornix",
|
| 16 |
+
"Irregular uterine enlargement",
|
| 17 |
+
"Broad ligament nodularity (8.0 × 7.0 cm)",
|
| 18 |
+
"Mirena IUD properly positioned",
|
| 19 |
+
"Extensive sigmoid adhesions",
|
| 20 |
+
"8-cm left broad ligament myoma extending to pelvic sidewall",
|
| 21 |
+
"Lobulated presacral mass (15 × 12 × 9 cm)",
|
| 22 |
+
"Dense rectal adhesions"
|
| 23 |
+
],
|
| 24 |
+
"diagnostics": [
|
| 25 |
+
"Transvaginal ultrasound revealed multiple masses",
|
| 26 |
+
"9.5 ×7.5 × 7.2-cm hypoechoic mass in posterior cervical lip",
|
| 27 |
+
"11.4 × 8.5 × 7.3-cm inhomogeneous hypoechoic lesion in right pelvis",
|
| 28 |
+
"7.5 × 6.1-cm mass on left side of uterus",
|
| 29 |
+
"Endometrial thickening (4.9 cm)",
|
| 30 |
+
"Color Doppler flow imaging indicated internal vascularity",
|
| 31 |
+
"Resistance index of 0.5",
|
| 32 |
+
"Serum tumor markers within normal ranges",
|
| 33 |
+
"Pelvic MRI demonstrated numerous leiomyomas affecting uterus",
|
| 34 |
+
"Pelvic MRI demonstrated numerous leiomyomas affecting cervix",
|
| 35 |
+
"Pelvic MRI demonstrated numerous leiomyomas affecting bilateral broad ligaments",
|
| 36 |
+
"Largest lesion in right broad ligament (149 × 59.5 ×71.5 mm)",
|
| 37 |
+
"T1 hypointense signal",
|
| 38 |
+
"Heterogeneous T2 hypointensity with internal hyperintense foci",
|
| 39 |
+
"Secondary cervical canal stenosis",
|
| 40 |
+
"Rectal compression",
|
| 41 |
+
"Minimal pelvic fluid",
|
| 42 |
+
"Gross examination revealed 8-cm broad ligament myoma",
|
| 43 |
+
"Three mesenteric leiomyomas (largest 15 × 12 × 9 cm)",
|
| 44 |
+
"Total resected specimen weight 4600 g",
|
| 45 |
+
"Histopathology demonstrated benign leiomyomatosis across all resected specimens",
|
| 46 |
+
"Diagnosis of LPD confirmed on histopathology"
|
| 47 |
+
],
|
| 48 |
+
"management": [
|
| 49 |
+
"Total laparoscopic hysterectomy",
|
| 50 |
+
"Bilateral salpingectomy",
|
| 51 |
+
"Additional mesenteric nodules excised during adhesiolysis"
|
| 52 |
+
],
|
| 53 |
+
"outcome": [
|
| 54 |
+
"Patient remained well during postoperative period",
|
| 55 |
+
"Discharged on day 7",
|
| 56 |
+
"No recurrence observed at 1-month postoperative follow-up",
|
| 57 |
+
"No recurrence observed at 3-month postoperative follow-up",
|
| 58 |
+
"No recurrence observed at 6-month postoperative follow-up"
|
| 59 |
+
]
|
| 60 |
+
}
|
atoms/PMC12881196_atoms.json
ADDED
|
@@ -0,0 +1,52 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"75-year-old man",
|
| 4 |
+
"history of CCS",
|
| 5 |
+
"history of stable ischemic heart disease, diagnosed 20 years ago",
|
| 6 |
+
"underwent CAG 20 years ago",
|
| 7 |
+
"treated with aspirin as antithrombotic therapy",
|
| 8 |
+
"developed intolerance to aspirin, experiencing respiratory and dermatologic reactions, including rash and pruritus",
|
| 9 |
+
"recurrence of hypersensitivity reactions to aspirin 2 years before the current event that was non-severe",
|
| 10 |
+
"did not report a history of asthma or nasal polyps",
|
| 11 |
+
"experienced episodes of allergic rhinitis",
|
| 12 |
+
"reported experiencing dyspnea, potentially triggered by previous diclofenac ingestion"
|
| 13 |
+
],
|
| 14 |
+
"presentation": [
|
| 15 |
+
"increase in the frequency of angina episodes during the recent few months",
|
| 16 |
+
"reported experiencing dyspnea"
|
| 17 |
+
],
|
| 18 |
+
"diagnostics": [
|
| 19 |
+
"Laboratory data obtained on admission",
|
| 20 |
+
"White blood cell 4.7 × 10^9 cells/L",
|
| 21 |
+
"Hemoglobin 14.3 g/dL",
|
| 22 |
+
"Platelet's count 161 × 10^9 cells/L",
|
| 23 |
+
"Sodium 140 mEq/L",
|
| 24 |
+
"Potassium 3.7 mEq/L",
|
| 25 |
+
"Calcium 9 mEq/L",
|
| 26 |
+
"Phosphorus 2.8 mg/dL",
|
| 27 |
+
"Magnesium 1.9 mg/dL",
|
| 28 |
+
"Creatinine 1 mg/dL",
|
| 29 |
+
"considerable stenosis in the LAD",
|
| 30 |
+
"stenosis in the RCA"
|
| 31 |
+
],
|
| 32 |
+
"management": [
|
| 33 |
+
"Hospitalized for coronary angiography",
|
| 34 |
+
"pharmacotherapy consultation was conducted to evaluate the patient's suitability for aspirin desensitization",
|
| 35 |
+
"aspirin desensitization protocol implemented",
|
| 36 |
+
"final dose of aspirin (ASA) reached 325 mg",
|
| 37 |
+
"desensitization protocol, conducted over 6 h",
|
| 38 |
+
"doses of 25 mg or more were administered by cutting 100 mg non-enteric coated tablets",
|
| 39 |
+
"CAG and PCI were performed",
|
| 40 |
+
"underwent ad hoc PCI on LM-LAD & RCA",
|
| 41 |
+
"treated with aspirin and clopidogrel as antithrombotic therapy",
|
| 42 |
+
"dual antiplatelet therapy (DAPT) with aspirin 80 mg daily and clopidogrel 75 mg daily for 6 months",
|
| 43 |
+
"proton pump inhibitor (PPI) prescribed",
|
| 44 |
+
"high-intensity statin prescribed",
|
| 45 |
+
"beta-blocker prescribed",
|
| 46 |
+
"advised to avoid taking unnecessary medications, including NSAIDs"
|
| 47 |
+
],
|
| 48 |
+
"outcome": [
|
| 49 |
+
"patient successfully tolerated the 325 mg aspirin dose on the first day",
|
| 50 |
+
"scheduled for a follow-up in the following weeks"
|
| 51 |
+
]
|
| 52 |
+
}
|
atoms/PMC12881202_atoms.json
ADDED
|
@@ -0,0 +1,100 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"53-year-old male",
|
| 4 |
+
"6-year history of maintenance hemodialysis",
|
| 5 |
+
"Anticoagulant therapy limited to low-molecular-weight heparin (LMWH) administered during hemodialysis sessions",
|
| 6 |
+
"Nadroparin calcium 4100 IU administered during hemodialysis session on November 28, 2024",
|
| 7 |
+
"9 years earlier: proteinuria and elevated serum creatinine",
|
| 8 |
+
"Diagnosed with chronic glomerulonephritis 9 years earlier, without renal biopsy",
|
| 9 |
+
"Stage 5 chronic kidney disease",
|
| 10 |
+
"Well-controlled hypertension for 8 years",
|
| 11 |
+
"Left forearm arteriovenous fistula placed in December 2017",
|
| 12 |
+
"No history of drug allergies",
|
| 13 |
+
"No history of tobacco use",
|
| 14 |
+
"No history of alcohol consumption",
|
| 15 |
+
"No family history of similar conditions",
|
| 16 |
+
"Social and psychological functioning intact"
|
| 17 |
+
],
|
| 18 |
+
"presentation": [
|
| 19 |
+
"Presented to emergency department with acute left flank pain lasting for 3 h on November 29, 2024",
|
| 20 |
+
"No history of trauma",
|
| 21 |
+
"No symptoms of nausea, vomiting, or diarrhea",
|
| 22 |
+
"Temperature 36.6°C",
|
| 23 |
+
"Pulse 90 beats per minute",
|
| 24 |
+
"Respiratory rate 20 breaths per minute",
|
| 25 |
+
"Blood pressure 121/105 mmHg",
|
| 26 |
+
"Left lumbar percussion tenderness",
|
| 27 |
+
"Otherwise physical examination unremarkable",
|
| 28 |
+
"Urgently hospitalized on November 29, 2024",
|
| 29 |
+
"By third day of hospitalization, acute left flank pain and tachycardia progressed",
|
| 30 |
+
"Heart rate up to 124 beats per minute by third day",
|
| 31 |
+
"Hemoglobin level decreased to 54 g/L by third day"
|
| 32 |
+
],
|
| 33 |
+
"diagnostics": [
|
| 34 |
+
"Hemoglobin level 102 g/L on day of admission",
|
| 35 |
+
"Platelet count 146 × 10^9/L on day of admission",
|
| 36 |
+
"Contrast-enhanced CT on April 7, 2024: bilateral renal atrophy with multiple cysts; no definite hemorrhage",
|
| 37 |
+
"Contrast-enhanced CT on November 29, 2024: irregular mass in left renal region, no enhancement at lesion site",
|
| 38 |
+
"Contrast-enhanced CT on November 29, 2024: significant perirenal fluid accumulation and thickening of renal fascia",
|
| 39 |
+
"Contrast-enhanced CT on November 29, 2024: right kidney showed signs of atrophy and multiple calcifications",
|
| 40 |
+
"Renal angiography on day of admission: no definite high-flow source of hemorrhage identified",
|
| 41 |
+
"Renal angiography on day of admission: subtle contrast pooling in an upper-pole branch suggested possible slow bleeding",
|
| 42 |
+
"Serum glutamyl pyruvate transaminase no significant abnormalities throughout hospitalization",
|
| 43 |
+
"Total bilirubin no significant abnormalities throughout hospitalization",
|
| 44 |
+
"Thrombin time (TT) no significant abnormalities throughout hospitalization",
|
| 45 |
+
"Prothrombin time (PT) no significant abnormalities throughout hospitalization",
|
| 46 |
+
"Thromboelastography (TEG) not performed",
|
| 47 |
+
"Left kidney weight 50 g",
|
| 48 |
+
"Left kidney measured 7.4 × 3.9 × 4.1 cm",
|
| 49 |
+
"Renal capsule completely intact and smooth, without any fissures or tear marks",
|
| 50 |
+
"Renal parenchyma thinned (0.5–1.2 cm thick)",
|
| 51 |
+
"Multiple small cortical cysts observed in renal parenchyma",
|
| 52 |
+
"No aneurysms or thrombi present in vessels",
|
| 53 |
+
"Dark red, hemispherical blood clots found (9.4 × 6.9 × 6.7 cm) completely separated from the kidney, located outside the renal capsule",
|
| 54 |
+
"Multiple perirenal fat masses demonstrated infiltrative hemorrhage",
|
| 55 |
+
"Microscopic examination: diffuse tubular atrophy",
|
| 56 |
+
"Microscopic examination: no evidence of necrosis or vasculitic changes",
|
| 57 |
+
"Microscopic examination: cortical cyst had an intact wall without rupture or hemorrhage",
|
| 58 |
+
"Microscopic examination: small arteries within renal tissue exhibited wall thickening and fibrosis",
|
| 59 |
+
"Microscopic examination: perirenal fat contained extensive fresh hemorrhage dispersed among adipocytes",
|
| 60 |
+
"Microscopic examination: blood clot composed predominantly of densely packed red blood cells with fibrin"
|
| 61 |
+
],
|
| 62 |
+
"management": [
|
| 63 |
+
"Bed rest",
|
| 64 |
+
"Hemostatic therapy",
|
| 65 |
+
"Anti-inflammatory treatment",
|
| 66 |
+
"Nutritional support",
|
| 67 |
+
"Renal angiography under local anesthesia on day of admission",
|
| 68 |
+
"Left selective renal artery embolization (SRAE) on day of admission",
|
| 69 |
+
"Microcatheter advanced into a second-order superior branch",
|
| 70 |
+
"Two 2 × 6 mm coils (0.018-in. system) deployed in second-order superior branch",
|
| 71 |
+
"One 3 × 6 mm coil deployed in proximal main left renal artery",
|
| 72 |
+
"One 3 × 12 mm coil deployed in proximal main left renal artery",
|
| 73 |
+
"Additional embolization with 1000-μm gelatin sponge particles in proximal main left renal artery",
|
| 74 |
+
"Emergency left nephrectomy under general anesthesia on Day 3",
|
| 75 |
+
"Evacuation of perirenal hematoma during surgery",
|
| 76 |
+
"Complete resection of left kidney and surrounding fatty tissue",
|
| 77 |
+
"Red blood cell transfusion: 2 units on hospital day 3",
|
| 78 |
+
"Red blood cell transfusion: 2 units on hospital day 4",
|
| 79 |
+
"Red blood cell transfusion: 1 unit on hospital day 7",
|
| 80 |
+
"Total 5 units of packed red blood cells received during hospitalization",
|
| 81 |
+
"Anticoagulation during hemodialysis switched to nafamostat mesylate 150 mg per session after bleeding diagnosis",
|
| 82 |
+
"Routine hemodialysis three times a week continued after discharge",
|
| 83 |
+
"LMWH (nadroparin calcium 4100 IU) reintroduced for anticoagulation during each hemodialysis session on POD 71 (11/02/2025)"
|
| 84 |
+
],
|
| 85 |
+
"outcome": [
|
| 86 |
+
"Discharged from hospital on Day 10",
|
| 87 |
+
"Hemoglobin level 74 g/L on Day 10",
|
| 88 |
+
"No abdominal pain reported on Day 10",
|
| 89 |
+
"Physical examination indicated stable vital signs and satisfactory healing of surgical wound on Day 10",
|
| 90 |
+
"Postoperative ICU monitoring following nephrectomy",
|
| 91 |
+
"Follow-up CT at POD 37 confirmed no residual hematoma",
|
| 92 |
+
"LMWH resumed at full standard dose without step-wise up-titration",
|
| 93 |
+
"No recurrent bleeding occurred during more than 5 months of follow-up",
|
| 94 |
+
"Hemoglobin level 109 g/L at latest follow-up (approximately 7 months after surgery)",
|
| 95 |
+
"No discomfort reported at latest follow-up (approximately 7 months after surgery)",
|
| 96 |
+
"Patient reported no clinical evidence of ongoing bleeding at time of LMWH reintroduction",
|
| 97 |
+
"Stable hemoglobin levels without further transfusion at time of LMWH reintroduction",
|
| 98 |
+
"Complete healing of surgical wound at time of LMWH reintroduction"
|
| 99 |
+
]
|
| 100 |
+
}
|
atoms/PMC12881697_atoms.json
ADDED
|
@@ -0,0 +1,80 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"46-year-old female",
|
| 4 |
+
"from Uttar Pradesh, India",
|
| 5 |
+
"no history of substance abuse",
|
| 6 |
+
"no comorbidities"
|
| 7 |
+
],
|
| 8 |
+
"presentation": [
|
| 9 |
+
"gradually progressive dysphagia to solid foods over 4 months",
|
| 10 |
+
"no difficulty in swallowing liquids",
|
| 11 |
+
"burning sensation over chest during swallowing",
|
| 12 |
+
"abdomen soft, nontender",
|
| 13 |
+
"no organomegaly",
|
| 14 |
+
"no supraclavicular node palpable",
|
| 15 |
+
"chest auscultation no abnormal sounds",
|
| 16 |
+
"swelling in left supraclavicular fossa on May 10, 2021",
|
| 17 |
+
"Grade 2 odynophagia",
|
| 18 |
+
"Grade 1 dysphagia",
|
| 19 |
+
"Grade 1 skin reaction",
|
| 20 |
+
"Grade 1 dysphagia without odynophagia or weight loss"
|
| 21 |
+
],
|
| 22 |
+
"diagnostics": [
|
| 23 |
+
"upper gastrointestinal endoscopy on January 26, 2019 revealed ulcero-proliferative growth in lower third of esophagus",
|
| 24 |
+
"ulcerative growth beginning 30 cm from upper central incisors",
|
| 25 |
+
"endoscope could not be negotiated beyond lesion",
|
| 26 |
+
"biopsy confirmed moderately differentiated squamous cell carcinoma",
|
| 27 |
+
"PET-CT demonstrated FDG-avid thickening of esophageal wall from inferior edge of D7–D9 vertebrae",
|
| 28 |
+
"GE junction appearing tumor-free on PET-CT",
|
| 29 |
+
"FDG-avid 8-mm subcarinal node",
|
| 30 |
+
"FDG-avid 5-mm left paraesophageal nodule",
|
| 31 |
+
"right level II cervical lymph node 9 × 6 mm non-FDG-avid",
|
| 32 |
+
"ultrasound-guided FNAC of right cervical node confirmed reactive node",
|
| 33 |
+
"histopathology revealed residual viable, poorly differentiated squamous cell carcinoma without necrosis",
|
| 34 |
+
"tumor infiltrated muscularis propria",
|
| 35 |
+
"tumor extended into adventitia",
|
| 36 |
+
"evidence of lymphovascular invasion",
|
| 37 |
+
"evidence of perineural invasion",
|
| 38 |
+
"32 dissected lymph nodes, two metastatic",
|
| 39 |
+
"one metastatic node in aortopulmonary window",
|
| 40 |
+
"one metastatic node in lower paraesophageal region",
|
| 41 |
+
"metastatic nodes without extranodal extension",
|
| 42 |
+
"proximal resection margin 4 cm",
|
| 43 |
+
"distal resection margin 5.5 cm",
|
| 44 |
+
"circumferential resection margin 0.7 cm from nearest firm area",
|
| 45 |
+
"final staging ypT2N1 based on AJCC 8th edition",
|
| 46 |
+
"FNAC left supraclavicular fossa confirmed metastatic squamous cell carcinoma",
|
| 47 |
+
"PET-CT revealed FDG-avid left supraclavicular fossa lymph node 2.1 × 2.8 cm",
|
| 48 |
+
"left supraclavicular fossa lymph node SUVmax 11.6",
|
| 49 |
+
"FDG-avid subcarinal mediastinal node 7 × 8 mm",
|
| 50 |
+
"subcarinal mediastinal node SUVmax 6.38",
|
| 51 |
+
"PET-CT 3 months post-treatment showed complete metabolic response",
|
| 52 |
+
"follow-up PET-CT on March 28, 2024 showed FDG-avid irregular soft tissue lesion posterior cardiac/peri-aortic region 50 × 27 × 57 mm",
|
| 53 |
+
"FDG-avid posterior cardiac/peri-aortic region lesion SUVmax 22.53",
|
| 54 |
+
"FDG-avid pre-carinal node SUVmax 4.31",
|
| 55 |
+
"three small lung nodules maximum 6 mm with nil to low FDG uptake",
|
| 56 |
+
"EBUS-TBNA of subaortic and subcarinal nodes confirmed metastatic squamous cell carcinoma",
|
| 57 |
+
"follow-up PET-CT on September 18, 2024 showed complete metabolic and significant morphologic response",
|
| 58 |
+
"lung nodules remained stable and non-FDG avid",
|
| 59 |
+
"UGIE showed normal study"
|
| 60 |
+
],
|
| 61 |
+
"management": [
|
| 62 |
+
"three cycles of neoadjuvant chemotherapy with paclitaxel and cisplatin administered every 3 weeks between February 28 and April 13, 2019",
|
| 63 |
+
"open transthoracic esophagectomy with mediastinal lymphadenectomy on June 1, 2019",
|
| 64 |
+
"left supraclavicular fossa nodal clearance on June 8, 2021",
|
| 65 |
+
"radiotherapy 45 Gy in 25 fractions to SCF",
|
| 66 |
+
"radiotherapy 50.4 Gy in 28 fractions to mediastinal nodal region",
|
| 67 |
+
"concurrent chemotherapy five cycles of weekly paclitaxel and carboplatin completed on September 17, 2021",
|
| 68 |
+
"two additional cycles of consolidative chemotherapy",
|
| 69 |
+
"re-irradiation 50.4 Gy in 28 fractions over 5.5 weeks",
|
| 70 |
+
"concurrent weekly paclitaxel and carboplatin six cycles completed on June 19, 2024"
|
| 71 |
+
],
|
| 72 |
+
"outcome": [
|
| 73 |
+
"remained disease-free until May 2021",
|
| 74 |
+
"resumed regular diet with improved swallowing",
|
| 75 |
+
"kept under close follow-up with 3-monthly contrast enhanced computed tomography of thorax and abdomen",
|
| 76 |
+
"kept under close follow-up with annual PET-CT and UGIE",
|
| 77 |
+
"tolerated treatment well",
|
| 78 |
+
"follow-up PET-CT on September 18, 2024 showed complete metabolic and significant morphologic response"
|
| 79 |
+
]
|
| 80 |
+
}
|
atoms/PMC12881888_atoms.json
ADDED
|
@@ -0,0 +1,73 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"80-year-old woman",
|
| 4 |
+
"Cardiovascular comorbidities",
|
| 5 |
+
"Atrial fibrillation status post-His-ablation with pacemaker",
|
| 6 |
+
"Hypertension",
|
| 7 |
+
"Hyperlipidaemia",
|
| 8 |
+
"Previous transitory ischemic attack (TIA)",
|
| 9 |
+
"Fitzpatrick skin type II",
|
| 10 |
+
"Multiple BCCs treated on face, scalp, and trunk",
|
| 11 |
+
"2004 unsuccessful surgical removal of BCC on right cheek and nasal dorsum",
|
| 12 |
+
"2004 PDR contact brachytherapy for BCC",
|
| 13 |
+
"2012 nasal tip lesion treated with cryotherapy",
|
| 14 |
+
"2018 surgical excision of BCC on nasal tip with clear margins",
|
| 15 |
+
"2022 treated with topical fluorouracil for recurrent sores",
|
| 16 |
+
"2024 Cholecystectomy for cholecystitis"
|
| 17 |
+
],
|
| 18 |
+
"presentation": [
|
| 19 |
+
"Referred for evaluation of a nasal tip lesion",
|
| 20 |
+
"Symptoms persisted with crusting and ulceration from nasal ala to tip",
|
| 21 |
+
"August 2023 Biopsy of left nasal ala revealed an infiltrative BCC",
|
| 22 |
+
"February 2025 BCC on nose measured approximately 20 mm",
|
| 23 |
+
"February 2025 BCC on nose appeared bulky and indurated",
|
| 24 |
+
"2024 Liver lesion detected on follow-up after cholecystectomy",
|
| 25 |
+
"2024 Abdominal leiomyosarcoma diagnosed",
|
| 26 |
+
"Tumour inoperable",
|
| 27 |
+
"Lesion occupying right liver lobe",
|
| 28 |
+
"Satellite lesions observed",
|
| 29 |
+
"Metastases limited to right lobe",
|
| 30 |
+
"Enlarged lymph nodes observed in hepatoduodenal ligament",
|
| 31 |
+
"Lung lesions observed",
|
| 32 |
+
"Skeletal metastases observed",
|
| 33 |
+
"July 2025 Nasal tip appeared smooth and soft with slightly atrophic skin",
|
| 34 |
+
"July 2025 No signs of residual tumour observed on nasal tip"
|
| 35 |
+
],
|
| 36 |
+
"diagnostics": [
|
| 37 |
+
"2014 biopsy review showed superficial and focally infiltrative BCC with actinic keratosis",
|
| 38 |
+
"2014 biopsy initially reported only actinic keratosis",
|
| 39 |
+
"August 2023 biopsy (left nasal ala): infiltrative BCC",
|
| 40 |
+
"2024 biopsy (liver lesion): confirmed abdominal leiomyosarcoma",
|
| 41 |
+
"NGS (Oncomine Childhood Cancer Assay) on leiomyosarcoma: MDM2 amplification (CNV253)",
|
| 42 |
+
"July 2025 imaging: stable disease",
|
| 43 |
+
"July 2025 imaging: lesion occupying right liver lobe",
|
| 44 |
+
"July 2025 imaging: satellite lesions",
|
| 45 |
+
"July 2025 imaging: metastases limited to right lobe",
|
| 46 |
+
"July 2025 imaging: enlarged lymph nodes in hepatoduodenal ligament",
|
| 47 |
+
"July 2025 imaging: lung lesions",
|
| 48 |
+
"July 2025 imaging: skeletal metastases"
|
| 49 |
+
],
|
| 50 |
+
"management": [
|
| 51 |
+
"2004 PDR contact brachytherapy",
|
| 52 |
+
"2012 Cryotherapy",
|
| 53 |
+
"2018 Surgical excision of BCC",
|
| 54 |
+
"2022 Topical fluorouracil",
|
| 55 |
+
"2023 Referred for MMS",
|
| 56 |
+
"2023 Intervention postponed due to other health problems",
|
| 57 |
+
"2024 Cholecystectomy",
|
| 58 |
+
"Pazopanib discontinued due to liver toxicity",
|
| 59 |
+
"Liposomal doxorubicin failed to control disease progression",
|
| 60 |
+
"February 2025 Eribulin mesylate (70% reduced dose) for metastatic leiomyosarcoma",
|
| 61 |
+
"Summer 2025 Eribulin treatment paused",
|
| 62 |
+
"Recommendation: Contact brachytherapy for BCC after completion or pause in oncological treatment",
|
| 63 |
+
"Decision: Surgery for BCC deemed inappropriate",
|
| 64 |
+
"Side effects treated: fatigue, diarrhoea, non-febrile neutropenia, elevated liver enzymes (grade 1-2)"
|
| 65 |
+
],
|
| 66 |
+
"outcome": [
|
| 67 |
+
"July 2025 Eribulin treatment revealed stable disease",
|
| 68 |
+
"Patient remained active and walked daily during treatment period",
|
| 69 |
+
"July 2025 dermatological evaluation: BCC completely disappeared clinically and dermoscopically",
|
| 70 |
+
"July 2025 nasal tip appeared smooth and soft with slightly atrophic skin",
|
| 71 |
+
"Follow-up visit 4 months later: nose showed no signs of recurrence"
|
| 72 |
+
]
|
| 73 |
+
}
|
atoms/PMC12882434_atoms.json
ADDED
|
@@ -0,0 +1,111 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Case 1: 72-year-old man.",
|
| 4 |
+
"Case 1: 169 cm tall.",
|
| 5 |
+
"Case 1: 65 kg.",
|
| 6 |
+
"Case 1: Previously in good health.",
|
| 7 |
+
"Case 1: Did not regularly engage in strenuous exercise.",
|
| 8 |
+
"Case 1: High-intensity physical labor 1 week prior to symptom onset.",
|
| 9 |
+
"Case 1: House renovation work involving lifting and moving of heavy objects.",
|
| 10 |
+
"Case 1: 3 months before admission developed mild asthenia.",
|
| 11 |
+
"Case 1: 3 months before admission developed palpitations.",
|
| 12 |
+
"Case 1: 3 months before admission developed non-pitting edema of the limbs.",
|
| 13 |
+
"Case 1: Symptoms persisted since onset.",
|
| 14 |
+
"Case 2: 52-year-old man.",
|
| 15 |
+
"Case 2: Water and electricity engineering.",
|
| 16 |
+
"Case 2: 169 cm tall.",
|
| 17 |
+
"Case 2: 74 kg.",
|
| 18 |
+
"Case 2: Previously in good health.",
|
| 19 |
+
"Case 2: Rarely engaged in strenuous exercise at work or in daily life.",
|
| 20 |
+
"Case 2: Short-term high-intensity physical labor 1 month prior to symptom onset.",
|
| 21 |
+
"Case 2: Continuous moving for relocation purposes over 1 week."
|
| 22 |
+
],
|
| 23 |
+
"presentation": [
|
| 24 |
+
"Case 1: Denied nausea.",
|
| 25 |
+
"Case 1: Denied vomiting.",
|
| 26 |
+
"Case 1: Denied tea-colored urine.",
|
| 27 |
+
"Case 1: Denied myalgia.",
|
| 28 |
+
"Case 1: Denied chest pain.",
|
| 29 |
+
"Case 1: Denied other symptoms.",
|
| 30 |
+
"Case 1: Vital signs within normal limits.",
|
| 31 |
+
"Case 1: Physical examination revealed mild limb swelling.",
|
| 32 |
+
"Case 1: Physical examination without other abnormalities.",
|
| 33 |
+
"Case 2: Presented with bilateral lower limb edema.",
|
| 34 |
+
"Case 2: Presented with asthenia.",
|
| 35 |
+
"Case 2: Presented with palpitations.",
|
| 36 |
+
"Case 2: Symptoms persisted for 1 month.",
|
| 37 |
+
"Case 2: Denied nausea.",
|
| 38 |
+
"Case 2: Denied vomiting.",
|
| 39 |
+
"Case 2: Denied tea-colored urine.",
|
| 40 |
+
"Case 2: Denied myalgia.",
|
| 41 |
+
"Case 2: Denied chest pain.",
|
| 42 |
+
"Case 2: Denied other symptoms.",
|
| 43 |
+
"Case 2: Symptoms did not improve during cardiac support.",
|
| 44 |
+
"Case 2: Limb swelling and palpitations gradually resolved."
|
| 45 |
+
],
|
| 46 |
+
"diagnostics": [
|
| 47 |
+
"Case 1: Local hospital CK level 750.56 U/L.",
|
| 48 |
+
"Case 1: Local hospital CK-MB level 39.99 U/L.",
|
| 49 |
+
"Case 1: Local hospital LDH level 336.24 U/L.",
|
| 50 |
+
"Case 1: Local hospital CK reference range 26–174 U/L.",
|
| 51 |
+
"Case 1: Local hospital CK-MB reference range 0–40 U/L.",
|
| 52 |
+
"Case 1: Local hospital LDH reference range 120–250 U/L.",
|
| 53 |
+
"Case 1: Center admission CK substantial increases.",
|
| 54 |
+
"Case 1: Center admission Mb substantial increases.",
|
| 55 |
+
"Case 1: Center admission CK-MB slight increases.",
|
| 56 |
+
"Case 1: Center admission LDH slight increases.",
|
| 57 |
+
"Case 1: Center admission ALT slight increases.",
|
| 58 |
+
"Case 1: Center admission AST slight increases.",
|
| 59 |
+
"Case 1: Center admission Cardiac troponin unremarkable.",
|
| 60 |
+
"Case 1: Center admission Renal function unremarkable.",
|
| 61 |
+
"Case 1: Center admission Coagulation studies unremarkable.",
|
| 62 |
+
"Case 1: Center admission Electrocardiography unremarkable.",
|
| 63 |
+
"Case 1: Center admission Echocardiography unremarkable.",
|
| 64 |
+
"Case 1: Center admission Antinuclear antibody testing unremarkable.",
|
| 65 |
+
"Case 1: Center admission Myositis antibody testing unremarkable.",
|
| 66 |
+
"Case 1: Center admission Electromyography unremarkable.",
|
| 67 |
+
"Case 1: Center admission Muscle magnetic resonance imaging unremarkable.",
|
| 68 |
+
"Case 2: Local hospital CK level 2266.0 U/L.",
|
| 69 |
+
"Case 2: Local hospital CK-MB level 73.0 U/L.",
|
| 70 |
+
"Case 2: Local hospital LDH level 294.0 U/L.",
|
| 71 |
+
"Case 2: Local hospital CK level increased to 2950 U/L.",
|
| 72 |
+
"Case 2: Center admission CK level 1936.8 U/L.",
|
| 73 |
+
"Case 2: Center admission CK-MB level 37.0 U/L.",
|
| 74 |
+
"Case 2: Center admission LDH level 288.0 U/L.",
|
| 75 |
+
"Case 2: Center admission Cardiac troponin unremarkable.",
|
| 76 |
+
"Case 2: Center admission Renal function unremarkable.",
|
| 77 |
+
"Case 2: Center admission Coagulation studies unremarkable.",
|
| 78 |
+
"Case 2: Center admission Electrocardiography unremarkable.",
|
| 79 |
+
"Case 2: Center admission Echocardiography unremarkable.",
|
| 80 |
+
"Case 2: Center admission Electromyography unremarkable.",
|
| 81 |
+
"Case 2: Center admission Antinuclear antibody testing unremarkable."
|
| 82 |
+
],
|
| 83 |
+
"management": [
|
| 84 |
+
"Case 1: Local hospital received methylprednisolone 40 mg/day.",
|
| 85 |
+
"Case 1: Local hospital discharged despite persistent symptoms.",
|
| 86 |
+
"Case 1: Center received aggressive fluid replacement.",
|
| 87 |
+
"Case 1: Center fluid replacement volume 1500 mL daily.",
|
| 88 |
+
"Case 1: Center fluid replacement rate approximately 200 mL/h.",
|
| 89 |
+
"Case 1: Center high water intake encouraged.",
|
| 90 |
+
"Case 2: Local hospital received myocardial-nourishing therapy.",
|
| 91 |
+
"Case 2: Local hospital treatment consisted of cardiac support.",
|
| 92 |
+
"Case 2: Center received adequate fluid replacement therapy.",
|
| 93 |
+
"Case 2: Center fluid replacement volume 1500 mL daily.",
|
| 94 |
+
"Case 2: Center fluid replacement rate approximately 200 mL/h.",
|
| 95 |
+
"Case 2: Center high water intake encouraged."
|
| 96 |
+
],
|
| 97 |
+
"outcome": [
|
| 98 |
+
"Case 1: Limb swelling gradually resolved.",
|
| 99 |
+
"Case 1: CK levels slow but steady decline.",
|
| 100 |
+
"Case 1: Telephone follow-up at 1 month after discharge confirmed substantial improvement in limb swelling.",
|
| 101 |
+
"Case 1: Telephone follow-up at 3 months after discharge confirmed substantial improvement in limb swelling.",
|
| 102 |
+
"Case 1: Diagnosed with ER.",
|
| 103 |
+
"Case 2: CK level gradually decreased to 1500 U/L.",
|
| 104 |
+
"Case 2: CK levels declined gradually but at a slow rate.",
|
| 105 |
+
"Case 2: Limb swelling gradually resolved.",
|
| 106 |
+
"Case 2: Palpitations gradually resolved.",
|
| 107 |
+
"Case 2: Telephone follow-up at 1 month after discharge confirmed full recovery.",
|
| 108 |
+
"Case 2: Telephone follow-up at 3 months after discharge confirmed full recovery.",
|
| 109 |
+
"Case 2: Diagnosed with ER."
|
| 110 |
+
]
|
| 111 |
+
}
|
atoms/PMC12882586_atoms.json
ADDED
|
@@ -0,0 +1,59 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"3-month-old female Asian infant",
|
| 4 |
+
"15-day history of respiratory distress",
|
| 5 |
+
"Family history unremarkable",
|
| 6 |
+
"Perinatal history unremarkable",
|
| 7 |
+
"Height 58 cm",
|
| 8 |
+
"Weight 5.2 kg"
|
| 9 |
+
],
|
| 10 |
+
"presentation": [
|
| 11 |
+
"Cyanosis",
|
| 12 |
+
"Neck retractions",
|
| 13 |
+
"Tachypnea",
|
| 14 |
+
"Irritability",
|
| 15 |
+
"Low arterial oxygen saturation (PO2 85%)",
|
| 16 |
+
"Decreased breath sounds on posterior right side",
|
| 17 |
+
"Dullness over right posterior chest wall",
|
| 18 |
+
"Temperature 37.5 °C",
|
| 19 |
+
"Pulse rate 120/minute",
|
| 20 |
+
"Respiratory rate 45/minute"
|
| 21 |
+
],
|
| 22 |
+
"diagnostics": [
|
| 23 |
+
"Laboratory results within normal limits",
|
| 24 |
+
"Chest CT: large, well-defined cystic mass in posterior mediastinum",
|
| 25 |
+
"Chest CT: mass extending from right to left side",
|
| 26 |
+
"Chest CT: mass extending from upper mediastinum down to diaphragm",
|
| 27 |
+
"Chest CT: mass measuring approximately 8.5 cm × 7.5 cm",
|
| 28 |
+
"Sagittal contrast enhanced CT: well-defined, large, oval-shaped cystic lesion",
|
| 29 |
+
"Sagittal contrast enhanced CT: homogeneous fluid density",
|
| 30 |
+
"Sagittal contrast enhanced CT: lesion located in posterior mediastinum",
|
| 31 |
+
"Sagittal contrast enhanced CT: lesion closely associated with the esophagus",
|
| 32 |
+
"Coronal views: lesion vertically from thoracic inlet down to diaphragm",
|
| 33 |
+
"Coronal views: retrocardiac and paravertebral location",
|
| 34 |
+
"Axial CT sections: cystic structure occupying posterior mediastinum",
|
| 35 |
+
"Histopathological examination: enteric duplication cyst"
|
| 36 |
+
],
|
| 37 |
+
"management": [
|
| 38 |
+
"Stabilized using ventilator in pediatric intensive care unit",
|
| 39 |
+
"Supplemental oxygen 4–5 L/minute",
|
| 40 |
+
"Right retropleural thoracotomy performed",
|
| 41 |
+
"Mass identified extending from right thoracic cavity across midline toward left hemithorax",
|
| 42 |
+
"Mass closely adherent to posterior aspect of esophagus",
|
| 43 |
+
"No direct luminal communication between cyst and esophagus observed intraoperatively",
|
| 44 |
+
"Cyst shared common muscular wall with esophagus",
|
| 45 |
+
"Separation of cyst from esophageal wall without injury to esophageal mucosa",
|
| 46 |
+
"Intraoperative assessment confirmed integrity of esophagus post-resection",
|
| 47 |
+
"No leak evident"
|
| 48 |
+
],
|
| 49 |
+
"outcome": [
|
| 50 |
+
"1 day after operation: transferred to recovery room",
|
| 51 |
+
"Oxygen saturation normalized",
|
| 52 |
+
"No need of mechanical ventilation",
|
| 53 |
+
"Postoperative course uneventful",
|
| 54 |
+
"Gradual improvement in respiratory function",
|
| 55 |
+
"Gradual improvement in overall clinical condition",
|
| 56 |
+
"Discharged in stable condition",
|
| 57 |
+
"Follow-up after 3 months: demonstrated good health"
|
| 58 |
+
]
|
| 59 |
+
}
|
atoms/PMC12883056_atoms.json
ADDED
|
@@ -0,0 +1,50 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"6-year-old girl",
|
| 4 |
+
"5-day history of spontaneous, intermittent epistaxis",
|
| 5 |
+
"Anterior nasal packing at peripheral health center"
|
| 6 |
+
],
|
| 7 |
+
"presentation": [
|
| 8 |
+
"Bleeding intensified following packing",
|
| 9 |
+
"Bleeding became profuse and soaking packs",
|
| 10 |
+
"Oropharyngeal bleeding",
|
| 11 |
+
"Lethargic on arrival to emergency department",
|
| 12 |
+
"Blood-soaked nasal gauze secured to columella",
|
| 13 |
+
"Clots around nares",
|
| 14 |
+
"Nasopharyngoscopy demonstrated extensive mucosal lacerations involving inferior turbinate",
|
| 15 |
+
"Nasopharyngoscopy demonstrated extensive mucosal lacerations involving nasal floor",
|
| 16 |
+
"Nasopharyngoscopy demonstrated extensive mucosal lacerations involving nasopharyngeal roof",
|
| 17 |
+
"Nasopharyngoscopy demonstrated extensive mucosal lacerations involving posterior wall",
|
| 18 |
+
"Nasopharyngoscopy demonstrated active bleeding",
|
| 19 |
+
"Traumatic injuries observed on soft palate",
|
| 20 |
+
"Traumatic injuries observed on left posterior tonsillar pillar"
|
| 21 |
+
],
|
| 22 |
+
"diagnostics": [
|
| 23 |
+
"Full blood count revealed severe anemia",
|
| 24 |
+
"Full blood count revealed thrombocytopenia",
|
| 25 |
+
"Full blood count revealed leucocytosis",
|
| 26 |
+
"Subsequent investigations confirmed B-cell ALL"
|
| 27 |
+
],
|
| 28 |
+
"management": [
|
| 29 |
+
"Examination under anesthesia",
|
| 30 |
+
"Blood clots evacuated through irrigation",
|
| 31 |
+
"Hemostasis achieved through gauze compression",
|
| 32 |
+
"Hemostasis achieved through suturing",
|
| 33 |
+
"Hemostasis achieved through electrocautery",
|
| 34 |
+
"Anterior nasal packing performed",
|
| 35 |
+
"Posterior nasal packing performed",
|
| 36 |
+
"Received two units of blood",
|
| 37 |
+
"Stabilized before transfer",
|
| 38 |
+
"Transfer to pediatric oncology ward",
|
| 39 |
+
"Appropriate therapy initiated for B-cell ALL",
|
| 40 |
+
"Multiple transfusions received",
|
| 41 |
+
"Chemotherapy received"
|
| 42 |
+
],
|
| 43 |
+
"outcome": [
|
| 44 |
+
"Condition progressively deteriorated",
|
| 45 |
+
"Recurrent vomiting",
|
| 46 |
+
"Uncontrolled gastrointestinal bleeding",
|
| 47 |
+
"Recurrent nasal bleeding",
|
| 48 |
+
"Death"
|
| 49 |
+
]
|
| 50 |
+
}
|
atoms/PMC12883664_atoms.json
ADDED
|
@@ -0,0 +1,104 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Patient is a man in his 50s.",
|
| 4 |
+
"Patient denied alcohol use.",
|
| 5 |
+
"Patient denied tobacco use.",
|
| 6 |
+
"Patient was not taking any chronic medications.",
|
| 7 |
+
"Patient was newly diagnosed with HIV.",
|
| 8 |
+
"No prior measurements of kidney function were available before this presentation."
|
| 9 |
+
],
|
| 10 |
+
"presentation": [
|
| 11 |
+
"Patient presented with 1-week history of worsening dyspnea.",
|
| 12 |
+
"Patient presented with 1-week history of fever.",
|
| 13 |
+
"Patient presented with 1-week history of cough.",
|
| 14 |
+
"Patient presented with 1-week history of bilateral lower limb weakness.",
|
| 15 |
+
"Patient was in severe respiratory distress.",
|
| 16 |
+
"Patient required intubation.",
|
| 17 |
+
"Patient required mechanical ventilation.",
|
| 18 |
+
"Blood pressure was 108/93 mmHg.",
|
| 19 |
+
"Pulse rate was 138 beats per minute.",
|
| 20 |
+
"Patient was apyrexial.",
|
| 21 |
+
"Bilateral diffuse crackles were heard on auscultation.",
|
| 22 |
+
"Heart sounds were normal.",
|
| 23 |
+
"Apex beat was mildly laterally displaced.",
|
| 24 |
+
"Following extubation, patient was alert and fully oriented to time, place, and person.",
|
| 25 |
+
"Power was 0/5 in bilateral hip flexion and knee extension.",
|
| 26 |
+
"Plantar and dorsiflexion power was 3/5 bilaterally.",
|
| 27 |
+
"Upper limb power was normal.",
|
| 28 |
+
"Patient had absent reflexes.",
|
| 29 |
+
"Patient had reduced tone in both lower limbs.",
|
| 30 |
+
"Sensation in upper and lower limbs remained intact.",
|
| 31 |
+
"Patient had normal bladder and bowel function.",
|
| 32 |
+
"Abdominal examination was normal.",
|
| 33 |
+
"No bone tenderness was present.",
|
| 34 |
+
"Urine dipsticks showed 4+ protein without blood.",
|
| 35 |
+
"Urine protein excretion was 8.16 g/L."
|
| 36 |
+
],
|
| 37 |
+
"diagnostics": [
|
| 38 |
+
"Respiratory viral panel testing was positive for rhinovirus.",
|
| 39 |
+
"Respiratory viral panel testing was positive for adenovirus.",
|
| 40 |
+
"GeneXpert testing for Mycobacterium tuberculosis was negative.",
|
| 41 |
+
"Sodium was 125 mmol/L.",
|
| 42 |
+
"Potassium was 8.4 mmol/L.",
|
| 43 |
+
"Urea was 18.1 mmol/L.",
|
| 44 |
+
"Creatinine was 593 μmol/L.",
|
| 45 |
+
"eGFR was 8 mL/min per 1.73 m2.",
|
| 46 |
+
"Total protein was 59 g/L.",
|
| 47 |
+
"Albumin was 36 g/L.",
|
| 48 |
+
"Calcium was 2.32 mmol/L.",
|
| 49 |
+
"Magnesium was 1.17 mmol/L.",
|
| 50 |
+
"Phosphate was 3.07 mmol/L.",
|
| 51 |
+
"Alanine transaminase was 45 U/L.",
|
| 52 |
+
"Leucocyte count was 12.74 × 10^9/L.",
|
| 53 |
+
"Hemoglobin was 9.4 g/dL.",
|
| 54 |
+
"Platelets were 294 × 10^9/L.",
|
| 55 |
+
"C-reactive protein was 80 mg/L.",
|
| 56 |
+
"Creatine kinase was 2321 U/L.",
|
| 57 |
+
"CD4 count was 321 cells/μL.",
|
| 58 |
+
"Urine protein-to-creatinine ratio could not be determined due to laboratory error.",
|
| 59 |
+
"Patient became anuric.",
|
| 60 |
+
"Kidney ultrasound showed normal renal sizes.",
|
| 61 |
+
"Kidney ultrasound showed no evidence of obstruction.",
|
| 62 |
+
"Kidney biopsy yielded a total of 20 glomeruli.",
|
| 63 |
+
"Five glomeruli were examined on light microscopy.",
|
| 64 |
+
"One glomerulus was globally sclerosed.",
|
| 65 |
+
"Fifteen glomeruli were examined on electron microscopy.",
|
| 66 |
+
"Periodic acid–Schiff stain revealed negative tubular casts with fracture planes and multinucleated giant cells.",
|
| 67 |
+
"Congo red staining was negative for amyloid deposition.",
|
| 68 |
+
"Electron microscopy demonstrated flocculent to granular electron-dense material along the subendothelial regions of the glomerular basement membranes.",
|
| 69 |
+
"Direct immunofluorescence confirmed lambda light chain restriction predominantly within the myeloma casts.",
|
| 70 |
+
"Serum-free lambda light chains were 1540 mg/L.",
|
| 71 |
+
"Serum-free kappa light chains were 19.6 mg/L.",
|
| 72 |
+
"Kappa-to-lambda ratio was 0.01.",
|
| 73 |
+
"Serum protein electrophoresis demonstrated immune paresis with a monoclonal peak.",
|
| 74 |
+
"Immunofixation revealed two free lambda monoclonal proteins.",
|
| 75 |
+
"Bone marrow aspirate demonstrated atypical plasma cells.",
|
| 76 |
+
"Bone marrow plasma cells included large and multinucleated forms.",
|
| 77 |
+
"Immunohistochemical staining with CD138 was positive in some plasma cells.",
|
| 78 |
+
"MUM1 stain was positive in all plasma cells.",
|
| 79 |
+
"Plasma cells were kappa-negative and lambda-positive.",
|
| 80 |
+
"Plasma cells comprised approximately 20% of all nucleated marrow cells.",
|
| 81 |
+
"FISH analysis found no high-risk chromosomal changes associated with MM.",
|
| 82 |
+
"Whole-spine MRI revealed lower lumbar degenerative changes.",
|
| 83 |
+
"Whole-spine MRI showed no evidence of a plasmacytoma.",
|
| 84 |
+
"Lumbar puncture revealed clear and acellular cerebrospinal fluid.",
|
| 85 |
+
"Cerebrospinal fluid protein was 2.9 g/L.",
|
| 86 |
+
"Cerebrospinal fluid glucose was 2.9 mmol/L.",
|
| 87 |
+
"Nerve conduction studies showed symmetrical axonal neuropathy.",
|
| 88 |
+
"Nerve biopsy was planned but not performed."
|
| 89 |
+
],
|
| 90 |
+
"management": [
|
| 91 |
+
"Patient was referred to the intensive care unit.",
|
| 92 |
+
"Patient required mechanical ventilation for 6 days.",
|
| 93 |
+
"Hemodialysis was commenced for refractory hyperkalemia and pulmonary edema.",
|
| 94 |
+
"Patient received acute hemodialysis support for 2 weeks.",
|
| 95 |
+
"Kidney biopsy was performed.",
|
| 96 |
+
"Whole-spine magnetic resonance imaging was performed.",
|
| 97 |
+
"Lumbar puncture was performed.",
|
| 98 |
+
"Nerve biopsy was planned."
|
| 99 |
+
],
|
| 100 |
+
"outcome": [
|
| 101 |
+
"Patient failed to show renal recovery following 2 weeks of acute hemodialysis support.",
|
| 102 |
+
"Patient passed away before the nerve biopsy could be performed."
|
| 103 |
+
]
|
| 104 |
+
}
|
atoms/PMC12884002_atoms.json
ADDED
|
@@ -0,0 +1,112 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"46-year-old male",
|
| 4 |
+
"electrical technician",
|
| 5 |
+
"previously healthy",
|
| 6 |
+
"no known history of tuberculosis contact",
|
| 7 |
+
"no family or occupational exposure to TB",
|
| 8 |
+
"no history of animal contact"
|
| 9 |
+
],
|
| 10 |
+
"presentation": [
|
| 11 |
+
"insidious onset of high-grade continuous fever",
|
| 12 |
+
"chills and rigors",
|
| 13 |
+
"unresponsive to paracetamol",
|
| 14 |
+
"productive cough",
|
| 15 |
+
"significant headache",
|
| 16 |
+
"arthralgia",
|
| 17 |
+
"denied abdominal pain",
|
| 18 |
+
"denied urinary symptoms",
|
| 19 |
+
"denied cellulitis",
|
| 20 |
+
"denied seizures",
|
| 21 |
+
"denied loss of appetite",
|
| 22 |
+
"low grade fever and headache on further care",
|
| 23 |
+
"blood pressure of 100/60 mmHg",
|
| 24 |
+
"pulse rate of 96 beats per minute",
|
| 25 |
+
"conscious with a Glasgow Coma Scale (GCS) of 15/15",
|
| 26 |
+
"neck stiffness",
|
| 27 |
+
"positive Kernig’s and Brudzinski’s sign",
|
| 28 |
+
"other neurological findings were normal",
|
| 29 |
+
"bilateral rhonchi on respiratory examination",
|
| 30 |
+
"cardiovascular and abdominal examination findings were unremarkable",
|
| 31 |
+
"recurrence of fever lasting 2 weeks",
|
| 32 |
+
"generalized body aches",
|
| 33 |
+
"intermittent altered consciousness",
|
| 34 |
+
"involuntary movements of the bilateral upper limbs",
|
| 35 |
+
"severe imbalance",
|
| 36 |
+
"difficulty ambulating",
|
| 37 |
+
"marked hypertonia in all limbs",
|
| 38 |
+
"myoclonic jerks in bilateral upper limbs",
|
| 39 |
+
"exaggerated deep tendon reflexes in all four limbs",
|
| 40 |
+
"positive jaw jerk",
|
| 41 |
+
"All other cranial nerve examinations were unremarkable"
|
| 42 |
+
],
|
| 43 |
+
"diagnostics": [
|
| 44 |
+
"white cell count of 22.54 × 10^9/L",
|
| 45 |
+
"neutrophil predominance (18.62 × 10^9/L)",
|
| 46 |
+
"C‐reactive protein (CRP) level of 32.87 mg/L",
|
| 47 |
+
"erythrocyte sedimentation rate (ESR) of 124 mm/h",
|
| 48 |
+
"serum creatinine level was 0.84 mg/dL",
|
| 49 |
+
"granulocytes 250 cells/mm3",
|
| 50 |
+
"lymphocytes 12 cells/mm3",
|
| 51 |
+
"raised protein (132 mg/dL) in CSF",
|
| 52 |
+
"glucose level of 54 mg/dL in CSF",
|
| 53 |
+
"random blood sugar of 130 mg/dL",
|
| 54 |
+
"sodium levels peaking at 153 mmol/L",
|
| 55 |
+
"aspartate transaminase level of 19.9 U/L",
|
| 56 |
+
"alanine transaminase 15.5 U/L",
|
| 57 |
+
"alkaline phosphatase 66.2 U/L",
|
| 58 |
+
"gamma glutamyl transferase 20.3 U/L",
|
| 59 |
+
"albumin level was 3.8 g/dL",
|
| 60 |
+
"Total bilirubin was measured at 0.79 mg/dL",
|
| 61 |
+
"direct bilirubin at 0.34 mg/dL",
|
| 62 |
+
"indirect bilirubin at 0.46 mg/dL",
|
| 63 |
+
"blood, urine, and CSF cultures yielded no microbial growth",
|
| 64 |
+
"noncontrast and contrast‐enhanced CT scans of the brain were unremarkable",
|
| 65 |
+
"white cell count of 7.45 × 10^9/L on repeat",
|
| 66 |
+
"neutrophils 60.0% on repeat",
|
| 67 |
+
"lymphocytes 25.1% on repeat",
|
| 68 |
+
"ESR was 94 mm/h on repeat",
|
| 69 |
+
"CRP of 7.0 mg/L on repeat",
|
| 70 |
+
"CSF 7 lymphocytes per mm3 on repeat",
|
| 71 |
+
"no polymorphs in repeat CSF",
|
| 72 |
+
"protein level of 134 mg/dL in repeat CSF",
|
| 73 |
+
"electroencephalogram (EEG) was normal",
|
| 74 |
+
"MRI spine demonstrated features of infective spondylitis involving the thoracic vertebrae",
|
| 75 |
+
"vertebral body marrow edema on MRI spine",
|
| 76 |
+
"spinal canal narrowing at the T5 level causing spinal cord compression",
|
| 77 |
+
"associated myelopathic signal changes on MRI spine",
|
| 78 |
+
"MRI spine showed early syrinx formation",
|
| 79 |
+
"MRI brain demonstrated basal meningeal enhancement suggestive of chronic inflammatory changes",
|
| 80 |
+
"MRI brain images were not available for inclusion in this report",
|
| 81 |
+
"chest radiograph was unremarkable",
|
| 82 |
+
"peripheral blood smear and full blood count were unremarkable",
|
| 83 |
+
"no lymphadenopathy observed",
|
| 84 |
+
"normal serum calcium levels",
|
| 85 |
+
"negative serological testing for HIV",
|
| 86 |
+
"tuberculosis PCR of the CSF was positive",
|
| 87 |
+
"T2–T6 vertebral body involvement on MRI spine (Table)",
|
| 88 |
+
"T5 level causing spinal cord compression on MRI spine (Text)"
|
| 89 |
+
],
|
| 90 |
+
"management": [
|
| 91 |
+
"empirically treated with intravenous antibiotics (ceftriaxone, vancomycin, and meropenem)",
|
| 92 |
+
"patient was discharged",
|
| 93 |
+
"advised to continue outpatient physiotherapy",
|
| 94 |
+
"regular follow‐ups in medicine and cardiology clinics",
|
| 95 |
+
"initiated anti‐TB therapy with a fixed‐dose, WHO‐recommended first‐line regimen (Category I: HRZE)",
|
| 96 |
+
"adjunct corticosteroids (prednisolone 30 mg daily)",
|
| 97 |
+
"vitamin B6 supplementation",
|
| 98 |
+
"alendronate",
|
| 99 |
+
"calcium lactate",
|
| 100 |
+
"referred to neurosurgery and orthopedics for further management",
|
| 101 |
+
"decompressive surgery was deferred",
|
| 102 |
+
"plan to continue anti‐TB treatments for 12 months"
|
| 103 |
+
],
|
| 104 |
+
"outcome": [
|
| 105 |
+
"developed some neurological impairments while on the hospital stay",
|
| 106 |
+
"limb weakness",
|
| 107 |
+
"hypertonia",
|
| 108 |
+
"exaggerated tendon reflexes",
|
| 109 |
+
"clinical improvement following targeted therapy and multidisciplinary care",
|
| 110 |
+
"subsequently discharged"
|
| 111 |
+
]
|
| 112 |
+
}
|
atoms/PMC12884671_atoms.json
ADDED
|
@@ -0,0 +1,54 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"22-year-old man",
|
| 4 |
+
"wire injury",
|
| 5 |
+
"removed wire himself before presentation"
|
| 6 |
+
],
|
| 7 |
+
"presentation": [
|
| 8 |
+
"vision loss in right eye for 2 h",
|
| 9 |
+
"uncorrected visual acuity of 20/400 in right eye",
|
| 10 |
+
"intraocular pressure of 3.2 mmHg in right eye",
|
| 11 |
+
"full-thickness penetration wound approximately 2 mm in length in middle of lower eyelid",
|
| 12 |
+
"conjunctival laceration at corresponding site",
|
| 13 |
+
"scleral laceration at corresponding site",
|
| 14 |
+
"cornea appeared transparent",
|
| 15 |
+
"lens appeared transparent",
|
| 16 |
+
"traumatic vitreous hemorrhage present",
|
| 17 |
+
"no obvious abnormalities in superior retina",
|
| 18 |
+
"choroidal elevation evident in inferior and temporal peripheral areas",
|
| 19 |
+
"8-mm full-thickness scleral laceration identified at inferior corneoscleral limbus during procedure",
|
| 20 |
+
"scleral laceration extending approximately 7 mm posteriorly"
|
| 21 |
+
],
|
| 22 |
+
"diagnostics": [
|
| 23 |
+
"no IOFB identified",
|
| 24 |
+
"B-scan ultrasonography one week after emergency surgery showed persistent vitreous hemorrhage in right eye",
|
| 25 |
+
"B-scan ultrasonography one week after emergency surgery showed suspected posterior scleral rupture",
|
| 26 |
+
"fundus examination one week after emergency surgery revealed dense preretinal hemorrhage",
|
| 27 |
+
"fundus examination one week after emergency surgery revealed chorioretinal laceration",
|
| 28 |
+
"long chorioretinal wound extending from inferior posterior pole to equator observed during second procedure",
|
| 29 |
+
"chorioretinal wound reaching deeply toward retrobulbar sclera",
|
| 30 |
+
"B-scan ultrasonography one week after vitrectomy repeated",
|
| 31 |
+
"fundus examination one week after vitrectomy repeated",
|
| 32 |
+
"retinal wound had healed one week after vitrectomy",
|
| 33 |
+
"retrobulbar hematoma persisted one week after vitrectomy"
|
| 34 |
+
],
|
| 35 |
+
"management": [
|
| 36 |
+
"initial debridement and suturing under local anesthesia",
|
| 37 |
+
"routine postoperative treatment to prevent infection, reduce inflammation, and control bleeding",
|
| 38 |
+
"25-gauge vitrectomy to remove vitreous hemorrhage",
|
| 39 |
+
"25-gauge vitrectomy to repair retinal damage",
|
| 40 |
+
"hemorrhage and vitreous surrounding wound completely removed during second procedure",
|
| 41 |
+
"hemorrhage within wound preserved to provide self-tissue tamponade during second procedure",
|
| 42 |
+
"laser photocoagulation applied around wound during second procedure",
|
| 43 |
+
"eye filled with air at end of second procedure"
|
| 44 |
+
],
|
| 45 |
+
"outcome": [
|
| 46 |
+
"intraocular pressure gradually normalized after initial surgery",
|
| 47 |
+
"best-corrected visual acuity of injured eye was 20/25 at 3 months after hospital discharge",
|
| 48 |
+
"intraocular pressure normal at 3 months after hospital discharge",
|
| 49 |
+
"retina flat at 3 months after hospital discharge",
|
| 50 |
+
"posterior wound closed at 3 months after hospital discharge",
|
| 51 |
+
"B-scan ultrasonography at 3 months showed complete resolution of retrobulbar hematoma",
|
| 52 |
+
"optical coherence tomography at 3 months revealed no abnormalities in macular area"
|
| 53 |
+
]
|
| 54 |
+
}
|
atoms/PMC12885676_atoms.json
ADDED
|
@@ -0,0 +1,48 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"58-year-old male",
|
| 4 |
+
"Known history of advanced GEJ adenocarcinoma",
|
| 5 |
+
"Peritoneal seeding diagnosed January 2023",
|
| 6 |
+
"Received first- and second-line palliative systemic therapy at another institution",
|
| 7 |
+
"Fully covered SEMS placed across GEJ in July 2023",
|
| 8 |
+
"Received palliative third-line trastuzumab deruxtecan for 3 months",
|
| 9 |
+
"Received palliative fourth-line nivolumab initiated 2 weeks prior to current presentation"
|
| 10 |
+
],
|
| 11 |
+
"presentation": [
|
| 12 |
+
"Presented to secondary hospital with acute chest pain and dyspnea",
|
| 13 |
+
"Appeared acutely ill upon arrival at emergency department",
|
| 14 |
+
"Hypotension despite prior fluid resuscitation and vasopressor support",
|
| 15 |
+
"Blood pressure 73/51 mm Hg",
|
| 16 |
+
"Heart rate 97 beats/min while receiving norepinephrine"
|
| 17 |
+
],
|
| 18 |
+
"diagnostics": [
|
| 19 |
+
"White blood cell count 14,550/μL",
|
| 20 |
+
"C-reactive protein 18.65 mg/dL",
|
| 21 |
+
"Procalcitonin 3.81 ng/mL",
|
| 22 |
+
"Creatine kinase 21 U/L",
|
| 23 |
+
"Creatine kinase-MB 0.549 ng/mL",
|
| 24 |
+
"High-sensitivity troponin T 25 ng/L",
|
| 25 |
+
"Electrocardiogram revealed diffuse ST-segment elevations in the precordial leads",
|
| 26 |
+
"Chest radiography did not reveal definitive evidence of free air around the cardiac silhouette",
|
| 27 |
+
"Computed tomography of the chest demonstrated multiple air pockets within the pericardial space",
|
| 28 |
+
"Computed tomography of the chest demonstrated small to moderate pericardial effusion",
|
| 29 |
+
"Computed tomography of the chest identified direct communication between GEJ stent and pericardial cavity",
|
| 30 |
+
"Transthoracic echocardiography confirmed the presence of pericardial effusion",
|
| 31 |
+
"Transthoracic echocardiography showed no signs of hemodynamic compromise",
|
| 32 |
+
"Transthoracic echocardiography showed no regional wall motion abnormalities",
|
| 33 |
+
"Transthoracic echocardiography showed preserved left ventricular systolic function",
|
| 34 |
+
"Patient diagnosed with pneumopericardium with pericarditis"
|
| 35 |
+
],
|
| 36 |
+
"management": [
|
| 37 |
+
"Received norepinephrine for vasopressor support",
|
| 38 |
+
"Empirical broad-spectrum antibiotics initiated",
|
| 39 |
+
"Pericardiocentesis not performed",
|
| 40 |
+
"Stent repositioning or removal deferred",
|
| 41 |
+
"Conservative management pursued"
|
| 42 |
+
],
|
| 43 |
+
"outcome": [
|
| 44 |
+
"Follow-up CT imaging showed stable findings",
|
| 45 |
+
"Clinical status gradually declined due to disease progression",
|
| 46 |
+
"Patient died 1.5 months after presentation"
|
| 47 |
+
]
|
| 48 |
+
}
|
atoms/PMC12886187_atoms.json
ADDED
|
@@ -0,0 +1,59 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"67-year-old female",
|
| 4 |
+
"good systemic health",
|
| 5 |
+
"no known allergies",
|
| 6 |
+
"nonsmoker",
|
| 7 |
+
"reported no parafunctional habits",
|
| 8 |
+
"never undergone orthodontic treatments",
|
| 9 |
+
"never undergone bleaching treatments"
|
| 10 |
+
],
|
| 11 |
+
"presentation": [
|
| 12 |
+
"chief concern was progressive apical migration of gingival margin",
|
| 13 |
+
"chief concern was increasing sensitivity",
|
| 14 |
+
"RT1 gingival recessions affecting Teeth #26, #27, and #28",
|
| 15 |
+
"mandibular right canine and premolars",
|
| 16 |
+
"area exhibited reduced keratinized tissue",
|
| 17 |
+
"area exhibited shallow vestibule",
|
| 18 |
+
"mild dentin hypersensitivity",
|
| 19 |
+
"Probing depths ranged from 1–3 mm",
|
| 20 |
+
"no bleeding on probing",
|
| 21 |
+
"Tooth vitality tests were positive",
|
| 22 |
+
"localized cervical defect noted on buccal aspect of mandibular right first premolar (Tooth #28)",
|
| 23 |
+
"patient discomfort during oral hygiene"
|
| 24 |
+
],
|
| 25 |
+
"diagnostics": [
|
| 26 |
+
"Probing depths ranged from 1–3 mm",
|
| 27 |
+
"no bleeding on probing",
|
| 28 |
+
"Tooth vitality tests were positive",
|
| 29 |
+
"X‐rays revealed hard, irregular resorptive surface",
|
| 30 |
+
"periapical radiograph confirmed superficial radiolucency at the cervical third of Tooth #28",
|
| 31 |
+
"lesion confined to the coronal third",
|
| 32 |
+
"no pulpal involvement",
|
| 33 |
+
"no periapical pathology"
|
| 34 |
+
],
|
| 35 |
+
"management": [
|
| 36 |
+
"combined periodontal–restorative approach planned",
|
| 37 |
+
"Surgical access achieved through partial‐thickness flap extending from canine to second premolar",
|
| 38 |
+
"Minor osteoplasty performed on the buccal plate",
|
| 39 |
+
"cervical defect sealed using composite resin",
|
| 40 |
+
"Free gingival graft (FGG) placed to increase keratinized tissue",
|
| 41 |
+
"Local anesthesia administered (2% xylocaine with 1:100,000 epinephrine)",
|
| 42 |
+
"FGG of approximately 2 mm‐thickness harvested from the palate",
|
| 43 |
+
"donor site sutured with horizontal compressive mattress stitches",
|
| 44 |
+
"graft secured using horizontal periosteal mattress suture",
|
| 45 |
+
"buccal mucosal flap repositioned and sutured apically to graft",
|
| 46 |
+
"Postoperative discomfort managed with ibuprofen 600 mg twice daily for 2 days",
|
| 47 |
+
"instructed to avoid mechanical trauma and refrain from toothbrushing in surgical area for first 2 weeks",
|
| 48 |
+
"Chemical plaque control maintained with 0.12% chlorhexidine mouthrinse used three times daily for 1 min",
|
| 49 |
+
"Palatal sutures removed after 7 days",
|
| 50 |
+
"sutures at recipient site removed at 14 days postoperatively",
|
| 51 |
+
"patient provided oral and written informed consent for treatment"
|
| 52 |
+
],
|
| 53 |
+
"outcome": [
|
| 54 |
+
"Postoperative symptoms were within normal limits",
|
| 55 |
+
"initial healing progressed uneventfully",
|
| 56 |
+
"Follow‐up appointments scheduled at 1, 3, 6, and 12 months",
|
| 57 |
+
"Healing maturation and soft‐tissue stability assessed at each visit"
|
| 58 |
+
]
|
| 59 |
+
}
|
atoms/PMC12886194_atoms.json
ADDED
|
@@ -0,0 +1,102 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Female infant",
|
| 4 |
+
"Asymmetrically SGA infant",
|
| 5 |
+
"Birth weight 2696 g",
|
| 6 |
+
"Birth head circumference 33 cm",
|
| 7 |
+
"Birth length 46.5 cm",
|
| 8 |
+
"Born to young primigravida mother",
|
| 9 |
+
"Gestational age 40+1 week",
|
| 10 |
+
"Apgar score 9 at 1 min of life",
|
| 11 |
+
"Apgar score 9 at 5 min of life",
|
| 12 |
+
"No family history of endocrine disorders",
|
| 13 |
+
"Parents non-consanguineous",
|
| 14 |
+
"Mother denied smoking",
|
| 15 |
+
"Maternal serologies unremarkable"
|
| 16 |
+
],
|
| 17 |
+
"presentation": [
|
| 18 |
+
"At 9 h of life, developed symptomatic hypoglycaemia",
|
| 19 |
+
"Capillary blood glucose 2.2 mmol/L at 9 h of life",
|
| 20 |
+
"Hypothermia 34.9°C at 9 h of life",
|
| 21 |
+
"Lethargic at 9 h of life",
|
| 22 |
+
"Recurrent episodes of hypoglycaemia (capillary glucose < 3.0 mmol/L)",
|
| 23 |
+
"Glucose nadir 1.6 mmol/L on attempting to wean off GIR",
|
| 24 |
+
"Occasional hypothermic episodes",
|
| 25 |
+
"On day 9 of life, developed clay-colored stools",
|
| 26 |
+
"Physical examination was unremarkable initially",
|
| 27 |
+
"Fundoscopic examination revealed bilateral optic disc hypoplasia",
|
| 28 |
+
"Orbit images showed hypoplasia of the right optic nerve and chiasm"
|
| 29 |
+
],
|
| 30 |
+
"diagnostics": [
|
| 31 |
+
"Cranial ultrasound scan on day 13 of life was unremarkable",
|
| 32 |
+
"Fetal scans did not reveal any stigmata related to SOD",
|
| 33 |
+
"Critical blood done on day 12 of life",
|
| 34 |
+
"Plasma glucose 1.6 mmol/L on day 12 of life",
|
| 35 |
+
"Cortisol < 28 nmol/L on day 12 of life",
|
| 36 |
+
"Growth hormone 1.4 μg/L on day 12 of life",
|
| 37 |
+
"Insulin Undetectable on day 12 of life",
|
| 38 |
+
"Ketones 0.0 mmol/L on day 12 of life",
|
| 39 |
+
"Thyroid stimulating hormone 4.54 mIU/L on day 12 of life",
|
| 40 |
+
"Free thyroxine (T4) 6.9 pmol/L on day 12 of life",
|
| 41 |
+
"Estradiol (E2) < 88 pmol/L on day 12 of life",
|
| 42 |
+
"Luteinizing Hormone (LH) 0.2 IU/L on day 12 of life",
|
| 43 |
+
"Follicle stimulation hormone (FSH) 1.8 IU/L on day 12 of life",
|
| 44 |
+
"Progesterone 1.9 nmol/L on day 12 of life",
|
| 45 |
+
"Serum sodium 126 mmol/L on day 12 of life",
|
| 46 |
+
"Serum potassium 4.7 mmol/L on day 12 of life",
|
| 47 |
+
"Serum chloride 97 mmol/L on day 12 of life",
|
| 48 |
+
"Serum bicarbonate 20 mmol/L on day 12 of life",
|
| 49 |
+
"Serum creatinine 29 μmol/L on day 12 of life",
|
| 50 |
+
"Serum urea 1.8 mmol/L on day 12 of life",
|
| 51 |
+
"Liver function test done on day 9 of life",
|
| 52 |
+
"Albumin 30 g/L on day 9 of life",
|
| 53 |
+
"Gamma-glutamyl transferase 528 U/L on day 9 of life",
|
| 54 |
+
"Aspartate transaminase 29 U/L on day 9 of life",
|
| 55 |
+
"Bilirubin direct 25 μmol/L on day 9 of life",
|
| 56 |
+
"Alanine transaminase 12 U/L on day 9 of life",
|
| 57 |
+
"Alkaline phosphatase 229 U/L on day 9 of life",
|
| 58 |
+
"Total protein 55 g/L on day 9 of life",
|
| 59 |
+
"Total bilirubin 242 μmol/L on day 9 of life",
|
| 60 |
+
"Cytomegalovirus infection investigation returned negative",
|
| 61 |
+
"Hepatobiliary system scan returned normal",
|
| 62 |
+
"Urinalysis returned unremarkable",
|
| 63 |
+
"MRI of the brain revealed ectopic neurohypophysis in the floor of the 3rd ventricle floor-hypothalamus and adenohypophysis in the pituitary fossa",
|
| 64 |
+
"Fundoscopic examination revealed bilateral optic disc hypoplasia"
|
| 65 |
+
],
|
| 66 |
+
"management": [
|
| 67 |
+
"Buccal glucose gel application",
|
| 68 |
+
"Milk feeds",
|
| 69 |
+
"Intravenous glucose infusion",
|
| 70 |
+
"Glucose infusion rate 5.5 mg/kg/min by day 10",
|
| 71 |
+
"Feed volume 189 mL/kg/day by day 10",
|
| 72 |
+
"Antibiotics administered",
|
| 73 |
+
"Antibiotics discontinued after 48 h",
|
| 74 |
+
"Glucocorticoid replacement initiated on day 13 of life",
|
| 75 |
+
"Levothyroxine replacement initiated on day 13 of life",
|
| 76 |
+
"Parents educated on stress dose adjustments during illness",
|
| 77 |
+
"Written instructions to increase hydrocortisone during sick days",
|
| 78 |
+
"Follow-up with ophthalmologist",
|
| 79 |
+
"Hydrocortisone replacement",
|
| 80 |
+
"Levothyroxine replacement",
|
| 81 |
+
"Recombinant human growth hormone (rhGH)",
|
| 82 |
+
"Thyroid function tests repeated every 3 months on follow up visits",
|
| 83 |
+
"Regular pediatric endocrine outpatient reviews"
|
| 84 |
+
],
|
| 85 |
+
"outcome": [
|
| 86 |
+
"Hyponatremia self-corrected to Na 133 mmol/L within 24 h",
|
| 87 |
+
"Resolution of hypoglycaemia within 2 days of treatment",
|
| 88 |
+
"One further episode of hypoglycemia on day 14 of life",
|
| 89 |
+
"Nil subsequent hypoglycemic episodes thereafter",
|
| 90 |
+
"Thyroxine (T4) normalized in 4 days",
|
| 91 |
+
"Discharged home on day 21 of life",
|
| 92 |
+
"Discharged weight 2645 g",
|
| 93 |
+
"Day 46 of life, weight 3700 g",
|
| 94 |
+
"Weight gain 28 g/day over the last 30 days",
|
| 95 |
+
"Follow-up at 1 year 7 months of age, weight 8700 g",
|
| 96 |
+
"Follow-up at 1 year 7 months of age, length 70 cm",
|
| 97 |
+
"Able to walk independently at 1 year 7 months of age",
|
| 98 |
+
"Able to call papa and mama at 1 year 7 months of age",
|
| 99 |
+
"Parents reporting able to play and navigate environment without overt visual difficulty",
|
| 100 |
+
"Ophthalmologist advised for continued visual development monitoring"
|
| 101 |
+
]
|
| 102 |
+
}
|
atoms/PMC12886303_atoms.json
ADDED
|
@@ -0,0 +1,62 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Patient had previous emergency C-section.",
|
| 4 |
+
"Patient had family member recently go through stoma bag experience.",
|
| 5 |
+
"GP suggested trying birth control assuming cause might be endometriosis.",
|
| 6 |
+
"Patient used prescribed pain and anti-inflammatory medication to cope with symptoms.",
|
| 7 |
+
"Patient did regular strength training beforehand."
|
| 8 |
+
],
|
| 9 |
+
"presentation": [
|
| 10 |
+
"Symptoms would flare up mainly around the time of period.",
|
| 11 |
+
"Patient was bedbound for the first two days of each cycle.",
|
| 12 |
+
"Patient had strong IBS-like symptoms.",
|
| 13 |
+
"Patient felt very nauseous on first day post-op.",
|
| 14 |
+
"Patient felt lightheaded on first day post-op.",
|
| 15 |
+
"Patient struggled to sip water on first day post-op.",
|
| 16 |
+
"Patient struggled to chew gum on first day post-op.",
|
| 17 |
+
"MRI pelvis demonstrated heterogenous T2 hyperintense mass.",
|
| 18 |
+
"Mass appeared irregularly walled.",
|
| 19 |
+
"Mass had small peripheral low signal rim.",
|
| 20 |
+
"Mass lay immediately anterior to uterus.",
|
| 21 |
+
"Mass lay superior to bladder.",
|
| 22 |
+
"No definite connection identified to adjacent uterus.",
|
| 23 |
+
"CT abdomen and pelvis demonstrated broad plane of contact with caecum.",
|
| 24 |
+
"CT abdomen and pelvis demonstrated minor contact with adjacent small bowel loops.",
|
| 25 |
+
"CT abdomen and pelvis demonstrated no evidence of invasion into adjacent structures.",
|
| 26 |
+
"Colonoscopy demonstrated normal appearing ileocecal valve.",
|
| 27 |
+
"Colonoscopy demonstrated normal appearing terminal ileum.",
|
| 28 |
+
"Colonoscopy demonstrated external mass indenting into caecal pole.",
|
| 29 |
+
"Biopsy showed mucosa easily lifted from hard lesion underlying it."
|
| 30 |
+
],
|
| 31 |
+
"diagnostics": [
|
| 32 |
+
"MRI pelvis demonstrated heterogenous T2 hyperintense mass which appeared irregularly walled with a small peripheral low signal rim.",
|
| 33 |
+
"CT abdomen and pelvis demonstrated broad plane of contact with the caecum and minor contact with adjacent small bowel loops.",
|
| 34 |
+
"Colonoscopy to the caecum demonstrated a normal appearing ileocecal valve and terminal ileum.",
|
| 35 |
+
"Colonoscopy demonstrated evidence of an external mass indenting into the caecal pole.",
|
| 36 |
+
"Biopsy showed mucosa easily lifted from a hard lesion underlying it.",
|
| 37 |
+
"Post-operative histological analysis revealed a caecal intramuscular epidermoid cyst.",
|
| 38 |
+
"No features of malignancy identified.",
|
| 39 |
+
"Proximal and distal resection margins were unremarkable."
|
| 40 |
+
],
|
| 41 |
+
"management": [
|
| 42 |
+
"Patient underwent robotic-assisted right hemicolectomy.",
|
| 43 |
+
"Surgery included intracorporeal anastomosis.",
|
| 44 |
+
"Patient was positioned supine.",
|
| 45 |
+
"Initial 4-cm Pfannenstiel incision was made.",
|
| 46 |
+
"Small Alexis retractor with cap was placed.",
|
| 47 |
+
"10-mm Airseal assistant port inserted.",
|
| 48 |
+
"Three 8-mm ports were used.",
|
| 49 |
+
"12-mm camera port was used.",
|
| 50 |
+
"Patient followed Enhanced Recovery After Surgery protocol.",
|
| 51 |
+
"Patient discharged home on day four.",
|
| 52 |
+
"Patient will continue on B12 monitoring and replacement as required with GP."
|
| 53 |
+
],
|
| 54 |
+
"outcome": [
|
| 55 |
+
"Discharged home on day four without any post-op complications.",
|
| 56 |
+
"At outpatient review 4 weeks post-op, patient was clinically well.",
|
| 57 |
+
"Wounds were healed at 4 weeks post-op.",
|
| 58 |
+
"Routine bloods were normal at 4 weeks post-op.",
|
| 59 |
+
"Patient's pain and IBS-like symptoms have completely disappeared since surgery.",
|
| 60 |
+
"Patient was able to go to the gym on day one of period since surgery."
|
| 61 |
+
]
|
| 62 |
+
}
|
atoms/PMC12886739_atoms.json
ADDED
|
@@ -0,0 +1,76 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Woman in her mid-30s",
|
| 4 |
+
"Admitted to hospital in mid-2024",
|
| 5 |
+
"Medical history included hypertension",
|
| 6 |
+
"Medical history included intellectual disability",
|
| 7 |
+
"Medical history included seizures",
|
| 8 |
+
"Admitted to Urology Department in 2012",
|
| 9 |
+
"5-year history of bilateral renal space-occupying lesions",
|
| 10 |
+
"Abdominal CT showed marked enlargement of both kidneys",
|
| 11 |
+
"Kidneys largely replaced by fat-containing masses with vascular components",
|
| 12 |
+
"Underwent selective renal artery embolization",
|
| 13 |
+
"Underwent left nephron-sparing tumor enucleation",
|
| 14 |
+
"Admitted to Gynecology Department in February 2023",
|
| 15 |
+
"Irregular vaginal bleeding lasting more than 3 months",
|
| 16 |
+
"MRI showed marked uterine enlargement with multiple masses",
|
| 17 |
+
"Underwent laparoscopic hysterectomy",
|
| 18 |
+
"Underwent bilateral salpingectomy",
|
| 19 |
+
"Gross examination identified two myomatous nodules measuring 0.5–5 cm in diameter",
|
| 20 |
+
"Microscopic spindle cell proliferation observed",
|
| 21 |
+
"Immunohistochemical analysis positive for α-smooth muscle actin (α-SMA)",
|
| 22 |
+
"Immunohistochemical analysis positive for high-molecular-weight caldesmon (H-caldesmon)",
|
| 23 |
+
"Immunohistochemical analysis partial positivity for desmin",
|
| 24 |
+
"Genetic testing confirmed three pathogenic variants in the TSC2 gene",
|
| 25 |
+
"Variant c.2742 + 1G>A",
|
| 26 |
+
"Variant c.774 + 2T>C",
|
| 27 |
+
"Variant p.L1394Afs*19"
|
| 28 |
+
],
|
| 29 |
+
"presentation": [
|
| 30 |
+
"2-week history of progressive dyspnea",
|
| 31 |
+
"2-week history of chest tightness",
|
| 32 |
+
"Intermittent right flank pain",
|
| 33 |
+
"Denied smoking",
|
| 34 |
+
"Denied alcohol consumption",
|
| 35 |
+
"Denied long-term medication use",
|
| 36 |
+
"Denied fever",
|
| 37 |
+
"Denied hemoptysis",
|
| 38 |
+
"Denied chest pain",
|
| 39 |
+
"Oxygen saturation 88% on room air",
|
| 40 |
+
"Blood pressure 139/97 mmHg",
|
| 41 |
+
"Heart rate 115 beats/min",
|
| 42 |
+
"Respiratory rate 24 breaths/min",
|
| 43 |
+
"Crackles in the lung fields",
|
| 44 |
+
"Decreased breath sounds over the right lung",
|
| 45 |
+
"Reddish, shiny, papular, and plaque-like lesions on the nose",
|
| 46 |
+
"Ungual fibromas observed on the fingers and toes",
|
| 47 |
+
"Chest CT revealed a large right pleural effusion",
|
| 48 |
+
"Chest CT revealed numerous bilateral thin-walled pulmonary cysts and nodules",
|
| 49 |
+
"Brain CT revealed patchy hypodense lesions in the left frontal and parietal lobes",
|
| 50 |
+
"Brain CT revealed multiple calcified densities along the bilateral lateral ventricles",
|
| 51 |
+
"Abdominal CT demonstrated bilateral renal AML with hemorrhage and hematoma formation in the right renal lesion",
|
| 52 |
+
"Thoracentesis yielded a hemorrhagic exudative effusion",
|
| 53 |
+
"Cytological examination showed no tumor cells",
|
| 54 |
+
"Total nucleated cell count of pleural effusion 2164/µL",
|
| 55 |
+
"Red blood cell count of pleural effusion 220,000/µL",
|
| 56 |
+
"Total protein level of pleural effusion 45.6 g/L",
|
| 57 |
+
"Lactate dehydrogenase (LDH) level of pleural effusion 516 mmol/L",
|
| 58 |
+
"Glucose level of pleural effusion 5.54 mmol/L",
|
| 59 |
+
"Adenosine deaminase (ADA) level of pleural effusion 8 units/L",
|
| 60 |
+
"Lung biopsy not performed because the patient declined the procedure"
|
| 61 |
+
],
|
| 62 |
+
"diagnostics": [],
|
| 63 |
+
"management": [
|
| 64 |
+
"Selective renal artery embolization",
|
| 65 |
+
"Left nephron-sparing tumor enucleation",
|
| 66 |
+
"Laparoscopic hysterectomy",
|
| 67 |
+
"Bilateral salpingectomy",
|
| 68 |
+
"Potential benefits of mammalian target of rapamycin (mTOR) inhibitor therapy discussed",
|
| 69 |
+
"Patient declined pharmacological treatment",
|
| 70 |
+
"Opted for conservative, symptom-focused management",
|
| 71 |
+
"Discharged with plans for outpatient supportive care"
|
| 72 |
+
],
|
| 73 |
+
"outcome": [
|
| 74 |
+
"Telephone follow-up revealed that the patient died approximately 6 months after discharge"
|
| 75 |
+
]
|
| 76 |
+
}
|
atoms/PMC12887256_atoms.json
ADDED
|
@@ -0,0 +1,66 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"70-year-old male",
|
| 4 |
+
"Fall at home 12 hours prior to arrival",
|
| 5 |
+
"No history of head trauma",
|
| 6 |
+
"No history of seizure",
|
| 7 |
+
"No history of previous stroke",
|
| 8 |
+
"No history of systemic long-standing illness",
|
| 9 |
+
"Not receiving antithrombotic drugs",
|
| 10 |
+
"Not receiving vasoactive drugs"
|
| 11 |
+
],
|
| 12 |
+
"presentation": [
|
| 13 |
+
"Arrived at emergency room 12 hours after fall",
|
| 14 |
+
"Awake on arrival",
|
| 15 |
+
"Complained of dizziness",
|
| 16 |
+
"Complained of occasional inability to focus eyes",
|
| 17 |
+
"Alert and oriented on admission",
|
| 18 |
+
"Cooperative with examination",
|
| 19 |
+
"GCS E4V5M5 (14/15)",
|
| 20 |
+
"Blood pressure 130/80 mmHg",
|
| 21 |
+
"Pulse 82 bpm",
|
| 22 |
+
"Sensory functions intact",
|
| 23 |
+
"Coordination and reflexes intact",
|
| 24 |
+
"Motor strength intact",
|
| 25 |
+
"Slow rhythmic conjugate horizontal gaze movement alternating left to right (ping pong gazing)",
|
| 26 |
+
"Pupillary light reflexes intact",
|
| 27 |
+
"No visual field defects observed",
|
| 28 |
+
"Fundoscopic examination normal",
|
| 29 |
+
"Slit lamp examination normal",
|
| 30 |
+
"Vertical saccades restricted",
|
| 31 |
+
"Smooth pursuit movements restricted",
|
| 32 |
+
"Vertical eye movements performed with Doll's eye maneuver"
|
| 33 |
+
],
|
| 34 |
+
"diagnostics": [
|
| 35 |
+
"Noncontrast cranial CT scan did not reveal acute pathology",
|
| 36 |
+
"MRI performed 2 hours after CT",
|
| 37 |
+
"Bilateral hyperintensities at paramedian thalami on DWI",
|
| 38 |
+
"Bilateral hyperintensities at paramedian thalami on FLAIR",
|
| 39 |
+
"Bilateral hyperintensities at rostral midbrain on DWI",
|
| 40 |
+
"Bilateral hyperintensities at rostral midbrain on FLAIR",
|
| 41 |
+
"MRA performed 6 hours after admission",
|
| 42 |
+
"Filling defect in single branch of artery growing out of P1 segment of right posterior cerebral artery",
|
| 43 |
+
"Basic blood tests noncontributory",
|
| 44 |
+
"Metabolic panel noncontributory",
|
| 45 |
+
"Coagulation profile noncontributory",
|
| 46 |
+
"Vasculitis screening noncontributory",
|
| 47 |
+
"Infectious serologies noncontributory",
|
| 48 |
+
"ECG normal",
|
| 49 |
+
"Transthoracic echocardiography normal",
|
| 50 |
+
"24-hour Holter monitoring normal",
|
| 51 |
+
"Follow-up MRI at 3 months showed change in lacunar infarct in thalami and midbrain",
|
| 52 |
+
"Follow-up MRI at 3 months showed postischemic gliosis"
|
| 53 |
+
],
|
| 54 |
+
"management": [
|
| 55 |
+
"Treated with dual antiplatelet therapy",
|
| 56 |
+
"Aspirin 75 mg once daily",
|
| 57 |
+
"Clopidogrel 75 mg once daily",
|
| 58 |
+
"Supportive therapies administered"
|
| 59 |
+
],
|
| 60 |
+
"outcome": [
|
| 61 |
+
"Ping pong gaze subsided in subsequent week",
|
| 62 |
+
"Ping pong gaze subsided approximately 8 days after starting medication",
|
| 63 |
+
"Follow-up MRI at 3 months showed change in lacunar infarct",
|
| 64 |
+
"Follow-up MRI at 3 months showed postischemic gliosis"
|
| 65 |
+
]
|
| 66 |
+
}
|
atoms/PMC12888404_atoms.json
ADDED
|
@@ -0,0 +1,68 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"52-year-old woman",
|
| 4 |
+
"breast cancer treated with toremifene",
|
| 5 |
+
"toremifene treatment concluded in 2021",
|
| 6 |
+
"no family history for IBD",
|
| 7 |
+
"no medical history of any digestive system disease"
|
| 8 |
+
],
|
| 9 |
+
"presentation": [
|
| 10 |
+
"loose stool for 1 month in November 2022"
|
| 11 |
+
],
|
| 12 |
+
"diagnostics": [
|
| 13 |
+
"colonoscopy found bulging mass in the terminal ileum",
|
| 14 |
+
"colonoscopy found colitis",
|
| 15 |
+
"colonoscopy found hemorrhoids",
|
| 16 |
+
"hemoglobin 85 g/L",
|
| 17 |
+
"CRP 18 mg/L",
|
| 18 |
+
"ESR 86 mm/H",
|
| 19 |
+
"positive fecal occult blood test",
|
| 20 |
+
"negative tumor markers",
|
| 21 |
+
"negative serum protein electrophoresis",
|
| 22 |
+
"negative hepatitis virus",
|
| 23 |
+
"negative stool smear",
|
| 24 |
+
"negative stool culture",
|
| 25 |
+
"negative quantitative EBV",
|
| 26 |
+
"negative quantitative cytomegalovirus",
|
| 27 |
+
"negative syphilis binomial",
|
| 28 |
+
"negative HIV antibody",
|
| 29 |
+
"negative T-SPOT.TB",
|
| 30 |
+
"negative PPD",
|
| 31 |
+
"normal renal function",
|
| 32 |
+
"normal blood glucose",
|
| 33 |
+
"negative antinuclear antibody",
|
| 34 |
+
"negative anti-double-stranded DNA antibody",
|
| 35 |
+
"negative ANCA binomial",
|
| 36 |
+
"negative HLA-B27",
|
| 37 |
+
"negative TPMT gene test",
|
| 38 |
+
"colonoscopy identified large, branched mucosal bulge with congestion and edema in the terminal ileum",
|
| 39 |
+
"colonoscopy identified diffuse basal cell carcinomas or aphthous ulcers throughout the colorectum",
|
| 40 |
+
"endoscopic ultrasonography characterized ileal mass as moderately echogenic lesion within the lamina propria",
|
| 41 |
+
"endoscopic ultrasonography measured ileal mass 12.32×19.07 mm",
|
| 42 |
+
"CTE confirmed inflammatory involvement of the terminal ileum and right colon",
|
| 43 |
+
"histopathology revealed chronic active inflammation with patchy inflammatory infiltrates",
|
| 44 |
+
"MRI showed no significant abnormalities in the anal canal",
|
| 45 |
+
"MRI detected osteitis condensans ilii",
|
| 46 |
+
"CTE indicated irregular soft tissue in the terminal ileum",
|
| 47 |
+
"pathological biopsy indicated chronic active inflammation in the mucosa of the terminal ileum and cecum",
|
| 48 |
+
"pathological biopsy indicated chronic inflammatory changes in ascending and transverse colon",
|
| 49 |
+
"pathological biopsy indicated no overt lesions in descending colon, sigmoid colon, and rectum",
|
| 50 |
+
"terminal ileal mass biopsy characterized as inflammatory granulomatous tissue"
|
| 51 |
+
],
|
| 52 |
+
"management": [
|
| 53 |
+
"initially treated with mesalazine",
|
| 54 |
+
"initially treated with Compound Glutamine Enteric-coated Capsules",
|
| 55 |
+
"initially treated with traditional Chinese medicine Shen Ling Bai Zhu San",
|
| 56 |
+
"initially treated with supportive care",
|
| 57 |
+
"received 3 courses of Ustekinumab",
|
| 58 |
+
"underwent hybrid endoscopic submucosal dissection for FP mass resection"
|
| 59 |
+
],
|
| 60 |
+
"outcome": [
|
| 61 |
+
"symptoms resolved after 3 courses of Ustekinumab",
|
| 62 |
+
"inflammatory markers normalized",
|
| 63 |
+
"CTE indicated reduced intestinal inflammation",
|
| 64 |
+
"follow-up colonoscopy showed complete resolution of intestinal ulcers",
|
| 65 |
+
"final pathology confirmed diagnosis of a filiform polyp",
|
| 66 |
+
"patient remains in remission with no recurrence"
|
| 67 |
+
]
|
| 68 |
+
}
|
atoms/PMC12890575_atoms.json
ADDED
|
@@ -0,0 +1,87 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"26-year-old male",
|
| 4 |
+
"No previous illness",
|
| 5 |
+
"Worked as a cleaner in a public lavatory",
|
| 6 |
+
"Hobby of river fishing",
|
| 7 |
+
"History of kratom use"
|
| 8 |
+
],
|
| 9 |
+
"presentation": [
|
| 10 |
+
"Three-day history of sharp, pleuritic pain over the right hypochondrium",
|
| 11 |
+
"Fever and dyspnea for 2 weeks",
|
| 12 |
+
"No cough",
|
| 13 |
+
"No diarrhea",
|
| 14 |
+
"Patient was alert but dehydrated",
|
| 15 |
+
"Heart rate, 139 beats/min",
|
| 16 |
+
"Blood pressure, 120/80 mmHg",
|
| 17 |
+
"Respiratory rate, 28 breaths/min",
|
| 18 |
+
"SpO2, 93% on room air",
|
| 19 |
+
"Temperature, 37.6°C",
|
| 20 |
+
"Reduced breath sounds in the right lower lung zone",
|
| 21 |
+
"Tender hepatomegaly",
|
| 22 |
+
"No peritonism",
|
| 23 |
+
"No splenomegaly",
|
| 24 |
+
"No lymphadenopathy"
|
| 25 |
+
],
|
| 26 |
+
"diagnostics": [
|
| 27 |
+
"White blood cell count, 8.09 ×10^9/L",
|
| 28 |
+
"Hemoglobin, 10.3 ×10^9/L",
|
| 29 |
+
"Microcytic hypochromic anemia",
|
| 30 |
+
"C-reactive protein, 267 mg/L",
|
| 31 |
+
"Alkaline phosphatase, 262 U/L",
|
| 32 |
+
"Alanine transaminase, 121 U/L",
|
| 33 |
+
"Aspartate transaminase, 165 U/L",
|
| 34 |
+
"Bilirubin, 20 mmol/L",
|
| 35 |
+
"Albumin, 24 g/L",
|
| 36 |
+
"International normalized ratio, 2.88",
|
| 37 |
+
"Prothrombin time, 36.7 s",
|
| 38 |
+
"Activated partial thromboplastin time, 44.7 s",
|
| 39 |
+
"Sodium, 125 mmol/L",
|
| 40 |
+
"Creatinine, 71 μmol/L",
|
| 41 |
+
"Urea, 6.7 mmol/L",
|
| 42 |
+
"Potassium, 4.9 mmol/L",
|
| 43 |
+
"Total protein, 64 g/L",
|
| 44 |
+
"Globulin, 40 g/L",
|
| 45 |
+
"Fasting blood glucose, 5.5 mmol/L",
|
| 46 |
+
"Chest radiograph showed a lenticular heterogeneous opacity on the right lower zone",
|
| 47 |
+
"Hepatobiliary ultrasonography showed a partially liquefied liver abscess",
|
| 48 |
+
"Human immunodeficiency virus antigen/antibody, negative",
|
| 49 |
+
"Hepatitis B surface antigen, negative",
|
| 50 |
+
"Anti-hepatitis C virus, negative",
|
| 51 |
+
"Computed tomography revealed a ruptured right liver abscess",
|
| 52 |
+
"Computed tomography revealed infra-diaphragmatic intrathoracic extension",
|
| 53 |
+
"Computed tomography revealed right lung empyema",
|
| 54 |
+
"Computed tomography revealed inferior vena cava thrombosis",
|
| 55 |
+
"Computed tomography revealed right hepatic vein thrombosis",
|
| 56 |
+
"Computed tomography revealed right pulmonary embolism",
|
| 57 |
+
"Computed tomography revealed a small ill-defined lytic lesion at T1 vertebra",
|
| 58 |
+
"Amoebiasis serology IgG positive",
|
| 59 |
+
"Stool cultures negative for ova and cysts",
|
| 60 |
+
"Pus sample positive for Entamoeba histolytica on polymerase chain reaction",
|
| 61 |
+
"Pus sample positive for giardiasis on polymerase chain reaction",
|
| 62 |
+
"Pus sample bacterial culture and sensitivity showed no growth",
|
| 63 |
+
"Mycobacterium tuberculosis direct smear microscopy negative",
|
| 64 |
+
"Mycobacterium tuberculosis culture negative",
|
| 65 |
+
"Mycobacterium tuberculosis PCR negative",
|
| 66 |
+
"Melioidosis serology negative",
|
| 67 |
+
"Sputum culture and sensitivity showed no pathogen isolated",
|
| 68 |
+
"Blood culture and sensitivity showed no growth",
|
| 69 |
+
"16 S PCR showed no bacteria detected"
|
| 70 |
+
],
|
| 71 |
+
"management": [
|
| 72 |
+
"Intravenous ceftriaxone 2 g once daily",
|
| 73 |
+
"Intravenous metronidazole 500 mg three times daily",
|
| 74 |
+
"Intravenous ceftriaxone switched to ceftazidime 2 g three times daily",
|
| 75 |
+
"Oral amoxicillin/clavulanic acid 625 mg three times daily for 6 weeks",
|
| 76 |
+
"Insertion of a percutaneous pigtail thoracostomy catheter for drainage of right lung empyema",
|
| 77 |
+
"Warfarin commenced for the treatment of venous thromboembolism",
|
| 78 |
+
"Oral paromomycin 500 mg three times daily for 1 week",
|
| 79 |
+
"Right video-assisted thoracoscopy surgery for visualization and repair of bronchopleural fistula",
|
| 80 |
+
"Warfarin switched to rivaroxaban 20 mg once daily for 6 months"
|
| 81 |
+
],
|
| 82 |
+
"outcome": [
|
| 83 |
+
"Pigtail thoracostomy drainage showed continuous persistent air leakage after 1 week",
|
| 84 |
+
"Repeat CT thorax and abdomen 2 months after completing treatment demonstrated a significant reduction in size of the right lateral intrathoracic and liver abscess",
|
| 85 |
+
"Three monthly follow-ups were arranged"
|
| 86 |
+
]
|
| 87 |
+
}
|
atoms/PMC12891435_atoms.json
ADDED
|
@@ -0,0 +1,42 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"75-year-old woman",
|
| 4 |
+
"Diagnosed with Schamberg's disease approximately 10 years previously",
|
| 5 |
+
"Hyperlipidemia",
|
| 6 |
+
"Taking rosuvastatin for hyperlipidemia for more than a year",
|
| 7 |
+
"Purpuric symptoms present for several years before taking rosuvastatin"
|
| 8 |
+
],
|
| 9 |
+
"presentation": [
|
| 10 |
+
"Scattered tiny purpuric rashes",
|
| 11 |
+
"Pigmented spots",
|
| 12 |
+
"Edematous macular pigmentation on the dorsal Achilles tendon area of the left leg",
|
| 13 |
+
"Fading pale pigmentation spots on the margin of the pigmented lesion",
|
| 14 |
+
"Inflammatory reaction subsided after rinsing the mouth with ozonated water"
|
| 15 |
+
],
|
| 16 |
+
"diagnostics": [
|
| 17 |
+
"Total cholesterol 221 mg/dL",
|
| 18 |
+
"Low-density lipoprotein (LDL) normal range value",
|
| 19 |
+
"Skin biopsies obtained from edematous macular pigmentation on the dorsal Achilles tendon area of the left leg",
|
| 20 |
+
"Skin biopsies obtained from fading pale pigmentation spots on the margin of the pigmented lesion without laser treatment",
|
| 21 |
+
"Hematoxylin–eosin staining performed",
|
| 22 |
+
"Berlin blue staining performed",
|
| 23 |
+
"Extensive pigmentation observed in the upper dermis",
|
| 24 |
+
"No granuloma reaction, including giant cells",
|
| 25 |
+
"No perivascular lymphocytic infiltrates",
|
| 26 |
+
"Edema, dilation, capillary vessel distribution, and endothelial cell swelling exhibited",
|
| 27 |
+
"Extensive hemosiderin deposits confirmed in the upper dermis",
|
| 28 |
+
"Scattered Berlin blue–positive pigments observed in faded areas",
|
| 29 |
+
"No lymphocytic infiltration around the blood vessels in faded areas"
|
| 30 |
+
],
|
| 31 |
+
"management": [
|
| 32 |
+
"Treated with mixture of topical steroids and moisturizers",
|
| 33 |
+
"Rinsing the mouth with ozonated water",
|
| 34 |
+
"High‐power short‐pulse Ruby laser treatment several times"
|
| 35 |
+
],
|
| 36 |
+
"outcome": [
|
| 37 |
+
"Without any improvement after topical steroids and moisturizers",
|
| 38 |
+
"Desired effect was not achieved with high‐power short‐pulse Ruby laser",
|
| 39 |
+
"Original disease cured by rinsing the mouth with ozonated water",
|
| 40 |
+
"Tissue difference between peripheral improved pigmented lesion and edematous hyperpigmented area was the amount of deposited hemosiderin"
|
| 41 |
+
]
|
| 42 |
+
}
|
atoms/PMC12892171_atoms.json
ADDED
|
@@ -0,0 +1,77 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"34-year-old woman",
|
| 4 |
+
"Diagnosed with PWS (genetically confirmed)",
|
| 5 |
+
"Grade II obesity",
|
| 6 |
+
"Sleep apnea",
|
| 7 |
+
"Generalized muscle hypotonia",
|
| 8 |
+
"Acromicria",
|
| 9 |
+
"Compulsive eating behavior",
|
| 10 |
+
"Intellectual disability",
|
| 11 |
+
"Characteristic behavioral phenotype, including frequent mood swings and episodes of heteroaggressiveness"
|
| 12 |
+
],
|
| 13 |
+
"presentation": [
|
| 14 |
+
"Reasonable level of comprehension",
|
| 15 |
+
"Good interaction with clinician",
|
| 16 |
+
"Resistant to some verbal instructions",
|
| 17 |
+
"Labial hypotonia",
|
| 18 |
+
"Lingual hypotonia",
|
| 19 |
+
"Mouth breathing",
|
| 20 |
+
"Atypical swallowing",
|
| 21 |
+
"Class II malocclusion",
|
| 22 |
+
"Poor oral hygiene",
|
| 23 |
+
"Generalized dental wear",
|
| 24 |
+
"Dental wear attributed to attrition due to bruxism",
|
| 25 |
+
"Dental wear was asymptomatic",
|
| 26 |
+
"Self-perceived pain (2 years later)",
|
| 27 |
+
"Pain attributed to pulp exposure"
|
| 28 |
+
],
|
| 29 |
+
"diagnostics": [
|
| 30 |
+
"Multiple carious lesions identified (teeth 17, 18, 26, 28, 37, 38, 46, 47, and 48)",
|
| 31 |
+
"Missing teeth (16, 27, and 36)",
|
| 32 |
+
"Root canal treatment proposed for pulp exposure",
|
| 33 |
+
"General anesthesia planned for treatment sessions",
|
| 34 |
+
"Manual pre-instrumentation with K-files",
|
| 35 |
+
"Rotary instrumentation using ProTaper system",
|
| 36 |
+
"Canal obturation with Thermafil system (warm gutta-percha technique)",
|
| 37 |
+
"Impressions of both arches taken using silicone",
|
| 38 |
+
"Registration of intermaxillary relationship",
|
| 39 |
+
"Two complete acrylic dentures designed (upper and lower)",
|
| 40 |
+
"Metal reinforcement in dentures in area of maximum occlusal contact",
|
| 41 |
+
"Substantial bone atrophy observed (edentulous areas) after six years",
|
| 42 |
+
"Progressive loss of coronal structures of remaining teeth after six years",
|
| 43 |
+
"Dental wear confirmed not exclusively due to attrition from bruxism after six years"
|
| 44 |
+
],
|
| 45 |
+
"management": [
|
| 46 |
+
"Postpone restorative procedures (initial visit)",
|
| 47 |
+
"Provide preventive recommendations (oral hygiene and dietary counseling)",
|
| 48 |
+
"Propose fabrication of protective splints",
|
| 49 |
+
"Option deemed unfeasible by family",
|
| 50 |
+
"Root canal treatment proposed (2 years later)",
|
| 51 |
+
"Two hospital-based treatment sessions under general anesthesia planned",
|
| 52 |
+
"Extractions of teeth 17, 18, 46, 47, and 48 performed",
|
| 53 |
+
"Root canal treatments performed on teeth 11, 12, 13, 14, 15, 21, 22, 23, 24, and 25",
|
| 54 |
+
"Extractions of teeth 26, 28, 37, and 38 performed",
|
| 55 |
+
"Root canal treatments performed on teeth 34, 35, 44, and 45",
|
| 56 |
+
"Pharmacological treatment with risperidone",
|
| 57 |
+
"Pharmacological treatment with paroxetine",
|
| 58 |
+
"Pharmacological treatment with topiramate",
|
| 59 |
+
"Patient tolerated wax trial",
|
| 60 |
+
"Patient tolerated fitting of definitive dentures",
|
| 61 |
+
"Prostheses designed as protective splints against dental attrition",
|
| 62 |
+
"Anterior region restored lost vertical dimension",
|
| 63 |
+
"Buccal surfaces of acrylic teeth extended beyond gingival sulcus",
|
| 64 |
+
"Patient instructed in oral hygiene techniques",
|
| 65 |
+
"Supervised brushing",
|
| 66 |
+
"Use of fluoride and chlorhexidine mouthwashes prescribed",
|
| 67 |
+
"Annual follow-up visits scheduled",
|
| 68 |
+
"Dentures relined in dental office",
|
| 69 |
+
"Dentures used regularly without pharmacological sedation"
|
| 70 |
+
],
|
| 71 |
+
"outcome": [
|
| 72 |
+
"Patient continued to use the dentures regularly",
|
| 73 |
+
"Dentures relined in the dental office without the need for pharmacological sedation",
|
| 74 |
+
"Substantial bone atrophy observed, particularly in the edentulous areas",
|
| 75 |
+
"Progressive loss of the coronal structures of the remaining teeth"
|
| 76 |
+
]
|
| 77 |
+
}
|
atoms/PMC12895833_atoms.json
ADDED
|
@@ -0,0 +1,93 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"31-year-old female",
|
| 4 |
+
"G2P1",
|
| 5 |
+
"Approximately five weeks postpartum",
|
| 6 |
+
"Healthy status reported at presentation",
|
| 7 |
+
"Denied trauma",
|
| 8 |
+
"Denied fever",
|
| 9 |
+
"Denied chills",
|
| 10 |
+
"Denied paresthesia",
|
| 11 |
+
"Denied focal weakness"
|
| 12 |
+
],
|
| 13 |
+
"presentation": [
|
| 14 |
+
"Pain and swelling of the left hand",
|
| 15 |
+
"Pain and swelling worsened next day after cast",
|
| 16 |
+
"Temperature 36.5 degrees Celsius",
|
| 17 |
+
"Blood pressure 157/72 mmHg",
|
| 18 |
+
"Pulse 55 beats/min",
|
| 19 |
+
"Oxygen saturation 96% on room air",
|
| 20 |
+
"Awake, alert, and in no acute distress",
|
| 21 |
+
"Swelling of the left upper extremity",
|
| 22 |
+
"Ecchymosis of the left upper extremity",
|
| 23 |
+
"Firmness of the forearm consistent with a hematoma",
|
| 24 |
+
"Tenderness on dorsiflexion of the fingers",
|
| 25 |
+
"Paresthesia to light touch",
|
| 26 |
+
"Smaller hematoma noted on the right hand",
|
| 27 |
+
"Compartments non-tense",
|
| 28 |
+
"Radial pulses 2+",
|
| 29 |
+
"Capillary refill less than 3 s",
|
| 30 |
+
"Range of motion of the digits preserved",
|
| 31 |
+
"Intact abduction, adduction, flexion, extension, and thumb opposition",
|
| 32 |
+
"Sensory and motor function of radial, median, and ulnar nerves grossly intact",
|
| 33 |
+
"No deformity present",
|
| 34 |
+
"No crepitus present",
|
| 35 |
+
"No erythema present",
|
| 36 |
+
"No warmth present",
|
| 37 |
+
"Initial diagnosis of tendinitis",
|
| 38 |
+
"Volar cast placed"
|
| 39 |
+
],
|
| 40 |
+
"diagnostics": [
|
| 41 |
+
"Ultrasound showed subcutaneous edema of left forearm and hand",
|
| 42 |
+
"Computed tomography venography showed diffuse hypodense subcutaneous and fascial edema of left forearm",
|
| 43 |
+
"Computed tomography venography showed mild muscular enlargement",
|
| 44 |
+
"Computed tomography venography showed loss of normal fascial definition",
|
| 45 |
+
"Computed tomography venography excluded venous thrombosis",
|
| 46 |
+
"Hemoglobin 12.5 g/dL",
|
| 47 |
+
"Partial thromboplastin time 86.9 s",
|
| 48 |
+
"International normalized ratio 1.00",
|
| 49 |
+
"Creatine phosphokinase 87 U/L",
|
| 50 |
+
"C-reactive protein 0.40 mg/dL",
|
| 51 |
+
"Factor VIII activity 1.5%",
|
| 52 |
+
"Mixing study demonstrated no correction",
|
| 53 |
+
"Factor VIII inhibitor titer 16 Bethesda units",
|
| 54 |
+
"Lupus anticoagulant testing negative",
|
| 55 |
+
"Von Willebrand factor antigen 110%",
|
| 56 |
+
"Von Willebrand factor activity 130%",
|
| 57 |
+
"Immunoglobulins within normal limits",
|
| 58 |
+
"Antinuclear antibody negative",
|
| 59 |
+
"Anti-double-stranded DNA negative",
|
| 60 |
+
"Diagnosis confirmed as acquired hemophilia A"
|
| 61 |
+
],
|
| 62 |
+
"management": [
|
| 63 |
+
"Admitted to medical intensive care unit",
|
| 64 |
+
"Treated with bypassing hemostatic therapy",
|
| 65 |
+
"Recombinant factor VIIa administered",
|
| 66 |
+
"Factor VIII concentrate administered",
|
| 67 |
+
"Tranexamic acid 1 g four times daily",
|
| 68 |
+
"Hydrocortisone 100 mg three times daily",
|
| 69 |
+
"Rituximab 600 mg administered",
|
| 70 |
+
"Single dose emicizumab administered",
|
| 71 |
+
"Orthopedic intervention not required",
|
| 72 |
+
"Tranexamic acid dose decreased during hospitalization",
|
| 73 |
+
"Steroids tapered during hospitalization",
|
| 74 |
+
"No further need for emicizumab",
|
| 75 |
+
"Discharged on prednisone",
|
| 76 |
+
"Discharged on tranexamic acid",
|
| 77 |
+
"Discharged on esomeprazole",
|
| 78 |
+
"Instructions for outpatient monitoring of complete blood count",
|
| 79 |
+
"Instructions for outpatient monitoring of chemistries",
|
| 80 |
+
"Instructions for outpatient monitoring of coagulation studies"
|
| 81 |
+
],
|
| 82 |
+
"outcome": [
|
| 83 |
+
"Factor VIII activity increased from 1.5% to 15% after emicizumab",
|
| 84 |
+
"Serial factor VIII activity levels remained below 10% during first week of hospitalization",
|
| 85 |
+
"Factor VIII activity increased to 58.8% by hospital day 12",
|
| 86 |
+
"Factor VIII activity increased to 147.2% by hospital day 26",
|
| 87 |
+
"Factor VIII activity remained within normal range at outpatient follow-up",
|
| 88 |
+
"Thromboelastography and PTT demonstrated interval improvement toward institutional reference ranges",
|
| 89 |
+
"Discrete serial TEG numeric parameters not available for reporting",
|
| 90 |
+
"Demonstrated improvement in swelling, pain, and function of the affected hand",
|
| 91 |
+
"21-day hospitalization"
|
| 92 |
+
]
|
| 93 |
+
}
|
atoms/PMC12898139_atoms.json
ADDED
|
@@ -0,0 +1,83 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Patient is a 60-year-old male.",
|
| 4 |
+
"Hypertension had been treated with telmisartan and hydrochlorothiazide for four years.",
|
| 5 |
+
"Patient reported an average blood pressure of 130/85 mmHg before admission.",
|
| 6 |
+
"Patient had a history of gallstones and kidney stones.",
|
| 7 |
+
"Patient had no previous history of seizures or sudden fits.",
|
| 8 |
+
"Patient had smoked approximately 25 cigarettes daily for at least 40 years."
|
| 9 |
+
],
|
| 10 |
+
"presentation": [
|
| 11 |
+
"Sudden loss of consciousness with tonic-clonic seizures prompted ambulance transport to a neurology department.",
|
| 12 |
+
"Right-sided limb weakness and speech difficulties followed the initial episode.",
|
| 13 |
+
"On admission, the patient was conscious but unresponsive and reacted only to strong stimuli.",
|
| 14 |
+
"Admission examination showed right upper-limb paresis and slight movement of the right lower limb.",
|
| 15 |
+
"Admission NIHSS score was 19 and modified Rankin scale score was 5.",
|
| 16 |
+
"There was no chest pain or dyspnea on admission; heart rate and blood pressure were normal.",
|
| 17 |
+
"During early hospitalization, blood pressure ranged from 90/70 to 150/90 mmHg and heart rate from 54 to 72 beats/min.",
|
| 18 |
+
"On the day after admission, a second episode of sudden loss of consciousness occurred with a generalized tonic-clonic seizure."
|
| 19 |
+
],
|
| 20 |
+
"diagnostics": [
|
| 21 |
+
"Admission electrolytes, hemoglobin, troponin, coagulation parameters, creatinine, glucose, and C-reactive protein were reported as normal.",
|
| 22 |
+
"Admission total cholesterol was 191 mg/dL and triglycerides were 152 mg/dL.",
|
| 23 |
+
"Urine testing indicated signs of a urinary tract infection.",
|
| 24 |
+
"Initial head CT showed no bleeding and subtle blurring of the left insular band.",
|
| 25 |
+
"Initial head CT ASPECTS was 9/10; the ventricular system was not displaced or dilated.",
|
| 26 |
+
"Initial cervical and cerebral CTA showed left common carotid artery occlusion just beyond its origin and poor contrast filling of the left internal carotid artery.",
|
| 27 |
+
"Initial CTA showed patent right common and internal carotid arteries, vertebral arteries, basilar artery, and anterior, middle, and posterior cerebral arteries, without significant stenosis.",
|
| 28 |
+
"Initial cervical and cerebral CTA showed no aneurysms or obvious signs of aortic dissection.",
|
| 29 |
+
"Brain MRI showed two mildly DWI-hyperintense foci, up to 5 mm, in the left frontal and parietal regions.",
|
| 30 |
+
"The left parietal focus had no FLAIR signal change and was hypointense on ADC maps.",
|
| 31 |
+
"The left frontal focus was hyperintense on FLAIR and ADC maps.",
|
| 32 |
+
"Brain MRI showed several T2- and FLAIR-hyperintense foci, up to 4 mm, in bilateral subcortical white matter.",
|
| 33 |
+
"Initial ECG showed sinus rhythm without other abnormalities.",
|
| 34 |
+
"EEG was reported as normal, with posterior alpha activity at 8 Hz and amplitude up to 30 microvolts; activation procedures did not change the recording.",
|
| 35 |
+
"After the second seizure, C-reactive protein was 112 mg/L.",
|
| 36 |
+
"After the second seizure, D-dimer was reported as 7.44 micrograms/L.",
|
| 37 |
+
"Echocardiography showed left ventricular wall hypertrophy and an ascending aorta measuring up to 6.5 cm with a visible dissection channel.",
|
| 38 |
+
"Echocardiography showed severe aortic regurgitation and pericardial effusion up to 1 cm behind the right ventricle.",
|
| 39 |
+
"Echocardiography showed impaired left ventricular diastolic function with preserved contractility.",
|
| 40 |
+
"Subsequent thoracic and abdominal CTA showed a dilated thoracic aorta with dissection extending from just above the aortic bulb to the origin of the left renal artery.",
|
| 41 |
+
"Subsequent CTA showed dissection involving the brachiocephalic trunk and proximal right common carotid artery, which had not been visible on the initial cervical and cerebral CTA.",
|
| 42 |
+
"Subsequent CTA showed signs of proximal left common carotid artery dissection and suspected significant left subclavian artery stenosis.",
|
| 43 |
+
"Subsequent CTA showed proximal celiac trunk dissection with otherwise preserved contrast filling and signs of superior mesenteric artery dissection.",
|
| 44 |
+
"Subsequent CTA raised suspicion of proximal left renal artery dissection; the renal arteries appeared to fill from the same channel.",
|
| 45 |
+
"Subsequent CTA showed no dissection below the renal artery branches or in the common, external, or internal iliac arteries.",
|
| 46 |
+
"CTA aortic dimensions were 59 mm at the bulb, 53 mm in the ascending aorta, 43 mm at the arch, and 44 mm in the descending aorta.",
|
| 47 |
+
"CTA aortic dimensions were 36 mm at the celiac trunk outlet, 28 mm at the renal arteries, and 20 mm before the bifurcation.",
|
| 48 |
+
"Subsequent CTA showed trace pericardial fluid and pleural fluid up to 20 mm on the left and 5 mm on the right.",
|
| 49 |
+
"Subsequent CTA showed no obvious central pulmonary embolism or pulmonary trunk dilation.",
|
| 50 |
+
"Postoperative long-term ECG identified atrial fibrillation and second- and third-degree atrioventricular block."
|
| 51 |
+
],
|
| 52 |
+
"management": [
|
| 53 |
+
"After initial neurological recovery to NIHSS 0, oral aspirin 75 mg and clopidogrel 75 mg were administered.",
|
| 54 |
+
"Initial inpatient treatment included atorvastatin 40 mg once daily, prophylactic low-molecular-weight heparin at a reported dosage of 0.04 g/0.4 mL, and intravenous fluids.",
|
| 55 |
+
"Initial inpatient antihypertensive treatment included amlodipine 5 mg and telmisartan 80 mg once daily.",
|
| 56 |
+
"The second seizure was treated with intravenous diazepam 10 mg followed by oral valproate 300 mg.",
|
| 57 |
+
"Urgent cardiac surgical consultation led to transfer for immediate surgery.",
|
| 58 |
+
"Bentall surgery was performed under extracorporeal circulation with hypothermia at 30 degrees Celsius.",
|
| 59 |
+
"A conduit and an SJM 27 mm mechanical aortic valve prosthesis were implanted.",
|
| 60 |
+
"Postoperative circulatory support required intravenous catecholamines for four days.",
|
| 61 |
+
"Continuous renal replacement therapy was provided for acute postoperative renal failure.",
|
| 62 |
+
"The chest tube was maintained for up to six postoperative days because of an air leak.",
|
| 63 |
+
"Postoperative medications included intravenous adrenaline, dobutamine, noradrenaline, fluids, and furosemide.",
|
| 64 |
+
"Postoperative care included analgesics, cefazolin followed by ceftriaxone for perioperative prophylaxis, and low-molecular-weight heparin.",
|
| 65 |
+
"A VVIR pacing system was implanted after atrial fibrillation and atrioventricular block were identified.",
|
| 66 |
+
"Warfarin was started after bleeding risk decreased, with INR monitoring.",
|
| 67 |
+
"No antiepileptic treatment was given during the cardiothoracic surgery admission.",
|
| 68 |
+
"During one-year follow-up, medications included oral warfarin, atorvastatin, zofenopril, torasemide, empagliflozin, and pantoprazole.",
|
| 69 |
+
"Follow-up included regular cardiothoracic surgery outpatient visits."
|
| 70 |
+
],
|
| 71 |
+
"outcome": [
|
| 72 |
+
"Within one hour of admission, the patient became responsive, followed instructions, and was oriented to person, place, and time.",
|
| 73 |
+
"On re-examination within the first hour, there were no meningeal signs, cranial nerve deficits, limb weakness, or pathological pyramidal signs; coordination was normal and walking was unassisted.",
|
| 74 |
+
"NIHSS and modified Rankin scale scores improved to 0 within the first hour.",
|
| 75 |
+
"The patient regained consciousness after treatment of the second seizure, with no further seizures reported.",
|
| 76 |
+
"At transfer from neurology, the patient was conscious without focal deficits, with NIHSS and modified Rankin scale scores of 0, blood pressure 90/70 mmHg, heart rate 80 beats/min, and oxygen saturation above 90%.",
|
| 77 |
+
"The postoperative course was complicated by acute renal failure and a chest-tube air leak.",
|
| 78 |
+
"The patient was discharged home 16 days after surgery in good condition, with stable circulatory and respiratory function and a pacemaker-supported rhythm.",
|
| 79 |
+
"There were no neurological symptoms at postoperative discharge.",
|
| 80 |
+
"No further seizures occurred during the cardiothoracic surgery admission despite receiving no antiepileptic treatment.",
|
| 81 |
+
"At one-year follow-up, the patient remained seizure-free and fully independent without residual neurological symptoms."
|
| 82 |
+
]
|
| 83 |
+
}
|
atoms/PMC12898264_atoms.json
ADDED
|
@@ -0,0 +1,79 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"69-year-old male",
|
| 4 |
+
"History of nasal cavity melanoma treated with surgical resection 16 years prior",
|
| 5 |
+
"History of dementia",
|
| 6 |
+
"Diagnosis of vasovagal syncope managed conservatively",
|
| 7 |
+
"No history of recent trauma",
|
| 8 |
+
"No prior thromboembolic events",
|
| 9 |
+
"Not receiving vasoactive agents at presentation",
|
| 10 |
+
"Not receiving anticoagulants at presentation",
|
| 11 |
+
"Not receiving antiplatelet therapy at presentation"
|
| 12 |
+
],
|
| 13 |
+
"presentation": [
|
| 14 |
+
"Presented in April 2025",
|
| 15 |
+
"Acute swelling in the left lower extremity",
|
| 16 |
+
"Pain in the left lower extremity",
|
| 17 |
+
"Hemodynamically stable",
|
| 18 |
+
"Diffuse pitting edema on physical examination",
|
| 19 |
+
"Tenderness on physical examination",
|
| 20 |
+
"No skin discoloration on physical examination",
|
| 21 |
+
"Peripheral pulses preserved",
|
| 22 |
+
"No cardiopulmonary symptoms"
|
| 23 |
+
],
|
| 24 |
+
"diagnostics": [
|
| 25 |
+
"Hemoglobin level 11.0 g/dL",
|
| 26 |
+
"D-dimer level 10,881 ng/mL",
|
| 27 |
+
"International normalized ratio 1.21",
|
| 28 |
+
"Platelet count within normal limits",
|
| 29 |
+
"Activated partial thromboplastin time within normal limits",
|
| 30 |
+
"CT angiography showed compression of the left common iliac vein by the overlying right CIA",
|
| 31 |
+
"CT angiography showed approximately 73.33% luminal stenosis of the left common iliac vein",
|
| 32 |
+
"CT angiography showed extensive iliofemoral DVT involving the left CIV, EIV, and CFV",
|
| 33 |
+
"CT angiography showed extension of DVT to the popliteal vein",
|
| 34 |
+
"CT angiography identified a non-enhancing, low-attenuation lesion (3.5 × 2.5 cm) adjacent to the proximal left iliac vessels",
|
| 35 |
+
"CT angiography suspected the lesion to be a hematoma associated with iliac vein rupture",
|
| 36 |
+
"CT angiography observed pulmonary thromboembolism in the subsegmental pulmonary artery of the right lower lobe",
|
| 37 |
+
"Contrast-enhanced CT showed no evidence of active bleeding or definite iliac vein rupture",
|
| 38 |
+
"D-dimer level decreased to 1032 ng/mL within 4 days of anticoagulation",
|
| 39 |
+
"D-dimer level increased to 2047 ng/mL one week later",
|
| 40 |
+
"Hemoglobin level decreased to 9.6 g/dL one week later",
|
| 41 |
+
"Follow-up CT angiography demonstrated persistent extensive DVT involving the left CIV, EIV, and CFV",
|
| 42 |
+
"Follow-up CT angiography showed partial improvement of femoral and popliteal vein thrombosis",
|
| 43 |
+
"Follow-up CT angiography showed the iliac hematoma increased in size to 4.5 × 3.2 cm",
|
| 44 |
+
"Follow-up CT angiography showed an enhancing focus within the hematoma on the arterial phase",
|
| 45 |
+
"Pelvic arteriography showed no definite contrast extravasation",
|
| 46 |
+
"Pelvic arteriography showed no pseudoaneurysm",
|
| 47 |
+
"Doppler ultrasonography revealed a hematoma without evidence of active bleeding",
|
| 48 |
+
"Initial venography demonstrated extensive DVT involving the left CIV to CFV",
|
| 49 |
+
"Initial venography showed partial thrombosis of the superficial femoral vein and popliteal veins",
|
| 50 |
+
"Post-thrombectomy venography revealed no evidence of contrast extravasation",
|
| 51 |
+
"Final venography showed restored antegrade flow through the left femoral vein to the stented left iliac vein segment",
|
| 52 |
+
"Final venography showed no residual filling defects",
|
| 53 |
+
"Final venography showed no contrast extravasation",
|
| 54 |
+
"Follow-up Doppler ultrasonography at filter removal showed no interval change in size of the lesion",
|
| 55 |
+
"Follow-up Doppler ultrasonography at filter removal showed decreased echogenicity of the lesion",
|
| 56 |
+
"Contrast-enhanced CT at 3-month follow-up demonstrated complete resolution of DVT",
|
| 57 |
+
"Contrast-enhanced CT at 3-month follow-up demonstrated sustained stent patency",
|
| 58 |
+
"Contrast-enhanced CT at 3-month follow-up demonstrated resolved pulmonary thromboembolism",
|
| 59 |
+
"Contrast-enhanced CT at 3-month follow-up demonstrated marked decrease in the size of the resolving hematoma",
|
| 60 |
+
"D-dimer level normalized at 7-month follow-up"
|
| 61 |
+
],
|
| 62 |
+
"management": [
|
| 63 |
+
"Placement of an inferior vena cava (IVC) filter after admission",
|
| 64 |
+
"Conservative management with low-molecular-weight heparin (Enoxaparin, 80 mg twice daily)",
|
| 65 |
+
"Rheolytic thrombectomy using the AngioJet system from the left femoral vein to the CIV",
|
| 66 |
+
"Rheolytic thrombectomy performed without recombinant tissue plasminogen activator",
|
| 67 |
+
"Limited aspiration thrombectomy for residual thrombus using an 8-fr guiding catheter",
|
| 68 |
+
"Pre-dilatation of the left CIV using a 12-mm balloon",
|
| 69 |
+
"Deployment of a 12-mm × 100-mm self-expanding venous stent (Venovo) across the stenotic segment",
|
| 70 |
+
"Removal of the IVC filter six days after the intervention",
|
| 71 |
+
"Anticoagulation therapy with rivaroxaban prescribed at 15 mg twice daily for 2 weeks",
|
| 72 |
+
"Anticoagulation therapy with rivaroxaban prescribed at 20 mg once daily for 3 months"
|
| 73 |
+
],
|
| 74 |
+
"outcome": [
|
| 75 |
+
"Patient discharged two days after intervention",
|
| 76 |
+
"Swelling of the left leg completely improved at 3-month follow-up",
|
| 77 |
+
"Patient remained asymptomatic for 7 months"
|
| 78 |
+
]
|
| 79 |
+
}
|
atoms/PMC12910172_atoms.json
ADDED
|
@@ -0,0 +1,77 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"Patient is a 15-year-old female.",
|
| 4 |
+
"Diagnosed with T1D at age 11.",
|
| 5 |
+
"History of DKA.",
|
| 6 |
+
"Pattern of recurrent DKA episodes.",
|
| 7 |
+
"Residing in foster placement with several other children and an infant in care.",
|
| 8 |
+
"Due to commence grade 10 in the autumn.",
|
| 9 |
+
"History of multiple suicidal attempts.",
|
| 10 |
+
"Suicidal attempts through withholding insulin resulting in DKA.",
|
| 11 |
+
"Suicidal attempts through administering excessive insulin.",
|
| 12 |
+
"Established diagnosis of attention deficit hyperactivity disorder.",
|
| 13 |
+
"Established diagnosis of unspecified anxiety/mood disorder.",
|
| 14 |
+
"Previously used insulin pump without a passcode.",
|
| 15 |
+
"Glycemic outcomes suboptimal during period of pump use without passcode."
|
| 16 |
+
],
|
| 17 |
+
"presentation": [
|
| 18 |
+
"Admitted to child and adolescent psychiatry.",
|
| 19 |
+
"Admission following suicidal attempt by deliberate insulin overdose.",
|
| 20 |
+
"Insulin overdose delivered through Tandem X2 insulin pump with Control IQ algorithm.",
|
| 21 |
+
"Tru Steel infusion set used.",
|
| 22 |
+
"Pump programmed to deliver concentrated insulin lispro (U200).",
|
| 23 |
+
"Used Dexcom G7 continuous glucose monitor.",
|
| 24 |
+
"Acute psychosocial stressors present.",
|
| 25 |
+
"Remained an inpatient for 16 days."
|
| 26 |
+
],
|
| 27 |
+
"diagnostics": [
|
| 28 |
+
"Electrocardiogram was normal.",
|
| 29 |
+
"HbA1c 8.5%.",
|
| 30 |
+
"Mild high anion gap metabolic acidosis.",
|
| 31 |
+
"Anion gap 14 mmol/L.",
|
| 32 |
+
"Bicarbonate 21 mmol/L.",
|
| 33 |
+
"Reduced ferritin.",
|
| 34 |
+
"Reduced serum iron.",
|
| 35 |
+
"Isolated elevations of alkaline phosphatase.",
|
| 36 |
+
"Isolated elevations of vitamin B12.",
|
| 37 |
+
"Complete blood count unremarkable.",
|
| 38 |
+
"Thyroid function test unremarkable.",
|
| 39 |
+
"CRP unremarkable.",
|
| 40 |
+
"Vitamin D unremarkable.",
|
| 41 |
+
"Folate unremarkable.",
|
| 42 |
+
"Screen for Child Anxiety Related Emotional Disorders (SCARED) score 53.",
|
| 43 |
+
"Social anxiety and panic symptoms most pronounced on SCARED.",
|
| 44 |
+
"Beck Depression Inventory–II (BDI‐II) score 35.",
|
| 45 |
+
"BDI‐II score consistent with severe depressive symptoms."
|
| 46 |
+
],
|
| 47 |
+
"management": [
|
| 48 |
+
"Targeted adjustments implemented to optimize glycemic stability.",
|
| 49 |
+
"Pump adjusted basal rate from 0.95 to 1.05 U/h mid‐day.",
|
| 50 |
+
"ISF adjusted from 1:4 to 1:3.5.",
|
| 51 |
+
"Bolus passcode lock added.",
|
| 52 |
+
"High-glucose alarm maintained.",
|
| 53 |
+
"Passcode‐protected pump reissued.",
|
| 54 |
+
"Passcode‐protected bolus implemented.",
|
| 55 |
+
"Re‐alarm extended to 20 min.",
|
| 56 |
+
"Lisdexamfetamine increased to 30 mg daily.",
|
| 57 |
+
"Propranolol prescribed PRN for panic attacks.",
|
| 58 |
+
"Inpatient psychiatric care provided.",
|
| 59 |
+
"Dialectical behavioral therapy provided.",
|
| 60 |
+
"Safety planning implemented.",
|
| 61 |
+
"Multi‐agency meetings convened with foster family, child protection services, endocrinology, and psychiatry.",
|
| 62 |
+
"Referral to outpatient child and adolescent psychiatry.",
|
| 63 |
+
"Psychoeducation for foster family.",
|
| 64 |
+
"Community support and community therapy resources discussed at discharge planning.",
|
| 65 |
+
"Long‐acting insulin (e.g., glargine) discussed as safety back‐up but not implemented.",
|
| 66 |
+
"Follow-up arranged with outpatient child and adolescent mental health service.",
|
| 67 |
+
"Assigned child protection worker involved in community support planning."
|
| 68 |
+
],
|
| 69 |
+
"outcome": [
|
| 70 |
+
"Patient tolerated the passcode‐protected pump well.",
|
| 71 |
+
"No safety concerns observed on the inpatient unit.",
|
| 72 |
+
"No safety concerns observed during leaves of absence.",
|
| 73 |
+
"Overall sense of well‐being improved following optimization of SSRI and ADHD medications.",
|
| 74 |
+
"Discharged.",
|
| 75 |
+
"Follow-up arranged with outpatient child and adolescent mental health service."
|
| 76 |
+
]
|
| 77 |
+
}
|
atoms/PMC12910663_atoms.json
ADDED
|
@@ -0,0 +1,97 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"36-year-old female patient",
|
| 4 |
+
"Past history of asthma",
|
| 5 |
+
"History of right lung adenocarcinoma diagnosed prior to August 2024"
|
| 6 |
+
],
|
| 7 |
+
"presentation": [
|
| 8 |
+
"Cough persisting for >1 month",
|
| 9 |
+
"Asthma symptoms persisting for >1 month",
|
| 10 |
+
"Presented to general physician in August 2023",
|
| 11 |
+
"Mass near hilum of right lung detected on CT",
|
| 12 |
+
"Partial atelectasis of right lower lung detected on CT",
|
| 13 |
+
"Enlarged lymph nodes in mediastinum detected on CT",
|
| 14 |
+
"Multiple small nodules in right lung detected on CT",
|
| 15 |
+
"Inflammation in both lungs detected on CT",
|
| 16 |
+
"Right pleural thickening detected on CT",
|
| 17 |
+
"Right pleural effusion detected on CT",
|
| 18 |
+
"Right breast tumor incidentally identified in June 2024",
|
| 19 |
+
"Solid mass in right breast detected on color Doppler ultrasonography (BI-RADS 4A)",
|
| 20 |
+
"Intravascular tumor thrombus observed",
|
| 21 |
+
"Asthma symptoms recurred in August 2024",
|
| 22 |
+
"Progressive atelectasis detected on thin-layer CT in August 2024",
|
| 23 |
+
"Considerable right chest effusion detected on thin-layer CT in August 2024",
|
| 24 |
+
"Right lung not fully inflated in August 2024",
|
| 25 |
+
"New inflammation noted in right lung in August 2024",
|
| 26 |
+
"Solid mass of 2.25×1.12 cm in upper quadrant of right breast detected on ultrasonography in August 2024",
|
| 27 |
+
"Mass had blurred edges",
|
| 28 |
+
"Mass classified as BI-RADS category 5",
|
| 29 |
+
"Physical examination indicated mass was hard",
|
| 30 |
+
"Physical examination indicated mass had poor mobility"
|
| 31 |
+
],
|
| 32 |
+
"diagnostics": [
|
| 33 |
+
"Lung CT scan revealed mass near hilum of right lung in August 2023",
|
| 34 |
+
"Lung CT scan revealed partial atelectasis of right lower lung in August 2023",
|
| 35 |
+
"Lung CT scan revealed enlarged lymph nodes in mediastinum in August 2023",
|
| 36 |
+
"Lung CT scan revealed multiple small nodules in right lung in August 2023",
|
| 37 |
+
"Lung CT scan revealed inflammation in both lungs in August 2023",
|
| 38 |
+
"Lung CT scan revealed right pleural thickening in August 2023",
|
| 39 |
+
"Lung CT scan revealed right pleural effusion in August 2023",
|
| 40 |
+
"Cytopathology of centrifugal smears from right pleural effusion revealed red blood cells, inflammatory cells, and heterogeneous cell clusters",
|
| 41 |
+
"Cytopathology of bronchoalveolar lavage fluid revealed red blood cells, inflammatory cells, and heterogeneous cell clusters",
|
| 42 |
+
"Genetic analysis detected EGFR exon 19 deletion [c.22402254del; p.L747T751del; VAF=8.49%]",
|
| 43 |
+
"Genetic analysis detected EGFR exon 20 T790M mutation [c.2369C>T; p.T790M; VAF=10.53%]",
|
| 44 |
+
"CT scan of upper abdomen and pelvic cavity in April 2024 indicated mass near hilum of right lung was markedly smaller compared with baseline",
|
| 45 |
+
"CT scan of upper abdomen and pelvic cavity in April 2024 indicated enlarged lymph nodes in mediastinum were no longer detectable",
|
| 46 |
+
"CT scan of upper abdomen and pelvic cavity in April 2024 indicated multiple small nodules in right lung were reduced in size",
|
| 47 |
+
"CT scan of upper abdomen and pelvic cavity in April 2024 indicated inflammation in both lungs had resolved",
|
| 48 |
+
"CT scan of upper abdomen and pelvic cavity in April 2024 indicated notable improvement in right lung cancer lymphadenitis",
|
| 49 |
+
"CT scan of upper abdomen and pelvic cavity in April 2024 indicated notable improvement in right pleural thickening",
|
| 50 |
+
"CT scan of upper abdomen and pelvic cavity in April 2024 indicated notable improvement in pleural effusion",
|
| 51 |
+
"Color Doppler ultrasonography in June 2024 revealed solid mass in right breast classified as BI-RADS category 4A",
|
| 52 |
+
"Postoperative pathology diagnosed tumor as breast cancer secondary to primary lung adenocarcinoma",
|
| 53 |
+
"Immunohistochemistry demonstrated positivity for CK7",
|
| 54 |
+
"Immunohistochemistry demonstrated positivity for Ki-67 (~60% +)",
|
| 55 |
+
"Immunohistochemistry demonstrated positivity for Napsin A",
|
| 56 |
+
"Immunohistochemistry demonstrated positivity for thyroid transcription factor 1 (TTF-1)",
|
| 57 |
+
"Immunohistochemistry demonstrated negativity for estrogen receptor",
|
| 58 |
+
"Immunohistochemistry demonstrated negativity for progesterone receptor",
|
| 59 |
+
"Immunohistochemistry demonstrated negativity for CK5/6",
|
| 60 |
+
"Immunohistochemistry demonstrated negativity for Sox10",
|
| 61 |
+
"Immunohistochemistry demonstrated negativity for GATA binding protein 3",
|
| 62 |
+
"Immunohistochemistry demonstrated negativity for mammaglobin",
|
| 63 |
+
"Immunohistochemistry demonstrated negativity for HER2",
|
| 64 |
+
"Pleural fluid smears in August 2024 indicated cancer cells",
|
| 65 |
+
"Genetic analysis of pleural effusion in August 2024 exhibited EGFR exon 19 deletion",
|
| 66 |
+
"Genetic analysis of pleural effusion in August 2024 exhibited EGFR exon 20 T790M missense mutation",
|
| 67 |
+
"Breast color Doppler ultrasonography in August 2024 detected solid mass of 2.25×1.12 cm in upper quadrant of right breast",
|
| 68 |
+
"Breast color Doppler ultrasonography in August 2024 classified mass as BI-RADS category 5"
|
| 69 |
+
],
|
| 70 |
+
"management": [
|
| 71 |
+
"Thoracic puncture and drainage performed in August 2023",
|
| 72 |
+
"Treated with furmonertinib (80 mg once daily in the morning) starting after August 2023",
|
| 73 |
+
"Right breast tumor resected under local anesthesia in June 2024",
|
| 74 |
+
"Follow-up conducted every 2–3 months after first diagnosis",
|
| 75 |
+
"Last follow-up conducted in February 2024"
|
| 76 |
+
],
|
| 77 |
+
"outcome": [
|
| 78 |
+
"Mass near hilum of right lung markedly smaller compared with baseline in April 2024",
|
| 79 |
+
"Enlarged lymph nodes in mediastinum no longer detectable in April 2024",
|
| 80 |
+
"Multiple small nodules in right lung reduced in size in April 2024",
|
| 81 |
+
"Inflammation in both lungs resolved in April 2024",
|
| 82 |
+
"Notable improvement in right lung cancer lymphadenitis in April 2024",
|
| 83 |
+
"Notable improvement in right pleural thickening in April 2024",
|
| 84 |
+
"Notable improvement in pleural effusion in April 2024",
|
| 85 |
+
"Asthma symptoms recurred in August 2024",
|
| 86 |
+
"Progressive atelectasis detected in August 2024",
|
| 87 |
+
"Considerable right chest effusion detected in August 2024",
|
| 88 |
+
"Right lung not fully inflated in August 2024",
|
| 89 |
+
"New inflammation noted in right lung in August 2024",
|
| 90 |
+
"Solid mass of 2.25×1.12 cm detected in right breast in August 2024",
|
| 91 |
+
"Mass had blurred edges in August 2024",
|
| 92 |
+
"Mass classified as BI-RADS category 5 in August 2024",
|
| 93 |
+
"Physical examination indicated mass was hard in August 2024",
|
| 94 |
+
"Physical examination indicated mass had poor mobility in August 2024",
|
| 95 |
+
"Recurrence of metastatic cancer after local resection considered based on medical history"
|
| 96 |
+
]
|
| 97 |
+
}
|
atoms/PMC12911946_atoms.json
ADDED
|
@@ -0,0 +1,58 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"17-year-old male",
|
| 4 |
+
"Arab ethnicity",
|
| 5 |
+
"History of active smoking",
|
| 6 |
+
"Prior surgical intervention for right-sided hydrocele",
|
| 7 |
+
"Denied history of trauma",
|
| 8 |
+
"Denied systemic symptoms",
|
| 9 |
+
"Denied family history of malignancy"
|
| 10 |
+
],
|
| 11 |
+
"presentation": [
|
| 12 |
+
"Progressive right testicular enlargement over several weeks",
|
| 13 |
+
"Painless right testicular enlargement",
|
| 14 |
+
"Right testis significantly enlarged",
|
| 15 |
+
"Right testis firm",
|
| 16 |
+
"Right testis non-transilluminating",
|
| 17 |
+
"Right testis measured approximately 12 cm in greatest dimension",
|
| 18 |
+
"Scrotal ultrasonography revealed a large solid mass",
|
| 19 |
+
"CT chest, abdomen, and pelvis demonstrated a well-defined right testicular mass",
|
| 20 |
+
"CT chest, abdomen, and pelvis demonstrated extensive retroperitoneal and pelvic lymphadenopathy",
|
| 21 |
+
"CT chest, abdomen, and pelvis demonstrated a para-aortic lymph node mass compressing the right ureter",
|
| 22 |
+
"Right ureteral compression resulted in secondary grade II hydronephrosis",
|
| 23 |
+
"Multiple bilateral pulmonary nodules identified",
|
| 24 |
+
"Axillary lymphadenopathy identified",
|
| 25 |
+
"Findings highly suggestive of metastatic dissemination"
|
| 26 |
+
],
|
| 27 |
+
"diagnostics": [
|
| 28 |
+
"Gross pathology: beige multinodular tumor occupying entire testis",
|
| 29 |
+
"Gross pathology: tumor extending into epididymis and spermatic cord",
|
| 30 |
+
"Specimen weight: 400 grams",
|
| 31 |
+
"Specimen dimensions: 11×8 × 6 cm",
|
| 32 |
+
"Spermatic cord length: 12 cm",
|
| 33 |
+
"Spermatic cord diameter: 2 cm",
|
| 34 |
+
"Largest tumor nodule measured 12 cm",
|
| 35 |
+
"Multiple smaller nodules up to 3 cm seen in spermatic cord",
|
| 36 |
+
"Areas of necrosis were extensive",
|
| 37 |
+
"Histopathology: high-grade undifferentiated malignant neoplasm involving testis, epididymis, and spermatic cord",
|
| 38 |
+
"Histopathology: focal vascular invasion",
|
| 39 |
+
"Surgical margins free of tumor",
|
| 40 |
+
"Immunohistochemistry: strong positivity for SMA",
|
| 41 |
+
"Immunohistochemistry: strong positivity for Desmin",
|
| 42 |
+
"Immunohistochemistry: strong positivity for MyoD1",
|
| 43 |
+
"Diagnosis: Rhabdomyosarcoma (RMS)"
|
| 44 |
+
],
|
| 45 |
+
"management": [
|
| 46 |
+
"Radical right orchiectomy performed",
|
| 47 |
+
"Systemic chemotherapy started using VAC regimen (Vincristine, Actinomycin D, Cyclophosphamide)",
|
| 48 |
+
"Double-J (DJ) stent inserted to relieve ureteral obstruction"
|
| 49 |
+
],
|
| 50 |
+
"outcome": [
|
| 51 |
+
"Follow-up imaging after three cycles of chemotherapy revealed complete resolution of pulmonary metastases",
|
| 52 |
+
"Follow-up imaging revealed significant regression of para-aortic and axillary lymphadenopathy",
|
| 53 |
+
"Hydronephrosis resolved",
|
| 54 |
+
"No evidence of new lesions or tumor progression",
|
| 55 |
+
"Patient showed favorable response to therapy",
|
| 56 |
+
"Continued clinical and radiological improvement"
|
| 57 |
+
]
|
| 58 |
+
}
|
atoms/PMC12914096_atoms.json
ADDED
|
@@ -0,0 +1,59 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"41-year-old male",
|
| 4 |
+
"Kawasaki disease at 3 years of age",
|
| 5 |
+
"Evaluated as potential living liver donor"
|
| 6 |
+
],
|
| 7 |
+
"presentation": [
|
| 8 |
+
"Evaluated as potential living liver donor",
|
| 9 |
+
"Mild anemia on POD 1",
|
| 10 |
+
"Vital signs stable on POD 1",
|
| 11 |
+
"Further progression of anemia on POD 3"
|
| 12 |
+
],
|
| 13 |
+
"diagnostics": [
|
| 14 |
+
"Preoperative contrast-enhanced abdominal CT",
|
| 15 |
+
"22-mm hemangioma in segment 6 of the liver",
|
| 16 |
+
"Gradual peripheral enhancement from arterial phase to delayed phase",
|
| 17 |
+
"No vascular anomalies identified on imaging",
|
| 18 |
+
"Hemangioma not visualized on liver surface",
|
| 19 |
+
"Abdominal ultrasonography showed no evidence of intra-abdominal fluid collection",
|
| 20 |
+
"Drainage fluid appeared lightly blood-tinged",
|
| 21 |
+
"Laboratory tests showed further progression of anemia on POD 3",
|
| 22 |
+
"No evidence of active bleeding observed in the peritoneal cavity",
|
| 23 |
+
"Intrahepatic hematoma in right posterior segment of remnant liver",
|
| 24 |
+
"Rupture at the hemangioma",
|
| 25 |
+
"Hematoma compressing anterior branch of portal vein",
|
| 26 |
+
"Large subcapsular hepatic hematoma predominantly involving posterior segment of liver",
|
| 27 |
+
"Contrast-enhanced CT scan performed on day after surgery",
|
| 28 |
+
"Resolution of the hemangioma lesion confirmed"
|
| 29 |
+
],
|
| 30 |
+
"management": [
|
| 31 |
+
"Extended left lobe graft selected",
|
| 32 |
+
"Estimated volume of 520 mL",
|
| 33 |
+
"36.4% of standard liver volume ratio of recipient",
|
| 34 |
+
"Hybrid extended left hemihepatectomy performed",
|
| 35 |
+
"Hepatic mobilization accomplished by hand-assisted laparoscopy",
|
| 36 |
+
"Right adrenal gland recognized",
|
| 37 |
+
"Parenchymal transection through upper midline laparotomy",
|
| 38 |
+
"Intermittent Pringle maneuver used",
|
| 39 |
+
"Operative time 426 min",
|
| 40 |
+
"Intraoperative blood loss 791 g",
|
| 41 |
+
"Only autologous blood collected preoperatively transfused intraoperatively",
|
| 42 |
+
"Observed conservatively on POD 1",
|
| 43 |
+
"TAE considered as initial treatment",
|
| 44 |
+
"Selective embolization considered technically difficult",
|
| 45 |
+
"Decision made to remove hematoma",
|
| 46 |
+
"Decision made to achieve surgical hemostasis",
|
| 47 |
+
"Emergency laparotomy performed",
|
| 48 |
+
"Hepatic capsule incised",
|
| 49 |
+
"Hematoma evacuated",
|
| 50 |
+
"Arterial bleeding point identified",
|
| 51 |
+
"Hemostasis achieved by suturing",
|
| 52 |
+
"Second operative time 258 min",
|
| 53 |
+
"Second intraoperative blood loss 1139 g"
|
| 54 |
+
],
|
| 55 |
+
"outcome": [
|
| 56 |
+
"Uneventful recovery",
|
| 57 |
+
"Discharged home on POD 8"
|
| 58 |
+
]
|
| 59 |
+
}
|
atoms/PMC12914110_atoms.json
ADDED
|
@@ -0,0 +1,43 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"history": [
|
| 3 |
+
"21-year-old male patient",
|
| 4 |
+
"Left knee injury following contact sport injury",
|
| 5 |
+
"Anterior cruciate ligament reconstruction (ACLR) at local hospital (day 0)"
|
| 6 |
+
],
|
| 7 |
+
"presentation": [
|
| 8 |
+
"Day 10: Knee became painful and swollen",
|
| 9 |
+
"Day 24: Wound did not heal well",
|
| 10 |
+
"Throughout treatment course at local hospital: afebrile and vital signs stable",
|
| 11 |
+
"Day 44: Knee wound partially healed with minimal fluid discharge",
|
| 12 |
+
"X-ray and CT-scan revealed diffuse cortical and intramedullary bone destruction",
|
| 13 |
+
"Day 45 surgery: Bone lesion showed cortical bone necrosis surrounded by periosteal bone reaction",
|
| 14 |
+
"Post-op x-ray illustrated 10-cm metaphyseal bone defect of the distal femur"
|
| 15 |
+
],
|
| 16 |
+
"diagnostics": [
|
| 17 |
+
"Previous culture showed infection by Pseudomonas aeruginosa",
|
| 18 |
+
"Bacterial cultures negative",
|
| 19 |
+
"Mycobacterium PCR results negative",
|
| 20 |
+
"Fungal culture negative",
|
| 21 |
+
"Histology (day 51): Mucorales infection with numerous non-septate, broad, ribbon-like hyphae invading bone tissue"
|
| 22 |
+
],
|
| 23 |
+
"management": [
|
| 24 |
+
"Arthroscopic debridement with drainage (day 10)",
|
| 25 |
+
"Open debridement and VAC therapy for both femur and tibia sites (day 24)",
|
| 26 |
+
"Open debridement and antibiotic cement beads (day 30)",
|
| 27 |
+
"Aggressive open debridement and knee-spanning external fixator (day 45)",
|
| 28 |
+
"Intravenous liposomal Amphotericin B 5mg/kg/day",
|
| 29 |
+
"Local PMMA cement spacer with Amphotericin B and Vancomycin (2 packs Gentafix 3 cement, 4 vials Amphotericin B 50mg, 2 vials Vancomycin 1g)",
|
| 30 |
+
"Re-debridement (third surgery) for replacement of cement with previous combination (day 60)",
|
| 31 |
+
"Intravenous liposomal amphotericin B discontinued after third surgery (total duration: ten days)",
|
| 32 |
+
"Bone grafting using modified Masquelet method (8 weeks after third surgery)",
|
| 33 |
+
"External fixator removed",
|
| 34 |
+
"Started to use functional brace"
|
| 35 |
+
],
|
| 36 |
+
"outcome": [
|
| 37 |
+
"Wound healed well after third surgery",
|
| 38 |
+
"Discharged after third surgery",
|
| 39 |
+
"Six months after fourth surgery: X-ray demonstrated bone graft has partially healed",
|
| 40 |
+
"Ten months after bone grafting: Patient could walk confidently with functional brace",
|
| 41 |
+
"Ten months after bone grafting: No sign of recurrent infection"
|
| 42 |
+
]
|
| 43 |
+
}
|